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ETEC (Enterotoxigenic Escherichia coli) is a gram negative bacterium that is 
responsible for acute watery diarrhoea in humans. ETEC is a significant cause of 
mortality; over 180,000 annual deaths reported by WHO (Qadri et al., 2005) and high 
morbidity in infants. Virulence factors of ETEC have been characterized but underlying 
gene regulatory mechanisms are not yet understood. Moreover, antibiotic resistance in 
bacteria is a serious problem worldwide. Multiple antibiotic resistance in bacteria can be 
driven by transcriptional regulators in the AraC/XylS family. The E. coli mar regulon is 
considered a paradigm for such systems. The mar locus consists of 3 genes; marR, 
marA, and marB. A transcriptional activator encoded by marA enhances drug resistance 
by binding to "marbox" sequences at target promoters. The best characterised MarA 
targets encode the AcrAB-TolC drug efflux pump. 
 
In this work, we have defined a molecular mechanism controlling expression of ETEC 
heat stable enterotoxin. We show that the cAMP receptor protein (CRP) directly 
activates expression of heat-stable toxin and Histone-like nucleoid structuring (H-NS) 
can exclude CRP from the activation-binding site. We also show that heat-stable toxin 
expression can be controlled by osmo-metabolic flux; CRP and H-NS allow the toxin 
gene promoter to respond to both glucose and salt. These conditions are encountered 
on host cell attachment and during oral rehydration therapy. We also identify 33 MarA 







“Knowing is not enough; we must apply. Willing is not enough; we must do.” - 
Goethe 
The journey of PhD studies has been “the most enriching experience of my life”. I 
always believed on the above quote that kept me motivated. However, my PhD would 
have been impossible without people who accompanied, supported, motivated and 
encouraged me all the time during my PhD. I would like to extend my sincere thanks 
and appreciations to all those lovely people. 
 
Firstly I would like to express my sincere gratitude to my supervisor, Dr. David C 
Grainger for the continuous support from the start date and until the very end of my 
PhD. I am very grateful for his trust, support and providing me an opportunity to come to 
the UK for my PhD. The ideas and suggestions he provided me were always brilliant. 
He looked after me by providing his suggestions almost every time I got stuck in my 
research. The invaluable guidance he provided me, have helped me a lot for my 
research and also in writing of this thesis. I could not have imagined having a better 
guide and mentor for my PhD. I feel really lucky and happy to have him as my 
supervisor, who is really talented, enthusiatatic, motivated and always ready for the next 
step forward. I can proudly say that he is my ideal who keeps me determined and 
motivated to achieve success in life. 
 
Similar, profound gratitude goes to Dr. David Lee, Dr. Anne-Marie Krachler and Dr. 




the hard questions which incented me to widen my research knowledge in many 
aspects. Other sincere thanks go to Prof. Laura Piddock, who gave me access to her 
laboratory and for her kind guidance. I also thank Dr. Vito Ricci from Piddock Lab, Dr. 
Ed Bevan and Dr. Laura Sellars for their kind help in some of my experiments. 
 
I thank Dr. James Haycocks who have been a great colleague and a friend. He not only 
provided help by training me when I started my PhD but also is ready to help me with 
his kind suggestions whenever I am in need. Special mention goes to Dr. Gemma 
Warren for helping me by providing comments and proofreading my thesis. 
 
I would like to thank Dr. Shivani Singh for always helping me like a sister throughtout my 
time in the UK. I also thank Mr. Sunindra Nath and Dr. Kiran Chintakayala for being 
such good friends who have always been supportive. I also thank Dr. Lisa Lamberte, 
Jainaba Manneh, Rachel Kettles, Emily Warman, Alistair Middlemiss, Tom Guest and 
all my labmates for keeping me motivated, their support throughout and making the lab 
friendly, full of fun and a wonderful place. I thank Fayyaz for being a wonderful and a 
great friend throughout my time in the UK, who is always available to help. I thank 
Anmol, Yasir, Hrishiraj, Asma, Panchali, Alessandro and Ajit for always being there as 
my friends. I would like to thank everyone at the School of Biosciences who have ever 
helped me in some way or the other. I appreciate the help provided by the reseach 
facilities of School of Biosciences in particular Dr. Norman Day and Lorraine Wallace. I 





I am also grateful to the Darwin Trust of Edinburgh for funding me and for providing the 
financial support throughout my PhD without which, it’s almost impossible to complete 
my PhD.   
 
Finally, I would like to thank the most important people in the world, my family: my Papa 
Ji and Mummy. I thank them for their unbelieveable support, motivation and for just 
being there with me. I can’t thank my parents enough for whatever they have done for 
me. I will always be indebted for that. I would like to thank my little sister Miss. Prakriti 
Sharma for helping me preparing some of my figures, for her kind support all the time 
and being a great friend in my life. I would like to thank my wife Mrs. Neha Dwivedi for 
always being there with me as my partner. She helped me in many of my decisions and 
always been supportive throughout.  
 
I would have not completed my PhD without the support of my family and my 
supervisor. Hence, I would like to dedicate this thesis to my family and my supervisor. 
Thank you so much for everything. 
 
 








Table of Contents 
Index of Figures .......................................................................... 1 
Index of Tables ............................................................................ 6 
Chapter 1. Introduction ............................................................... 7 
1.1 Gene Regulation in Escherichia coli ........................................................ 8 
1.2 Transcriptional Regulation ........................................................................ 8 
1.2.1 RNA polymerase .............................................................................................. 8 
1.2.2 Domain Organisation of Sigma Factors and Alternate Sigma factors ............. 11 
1.2.3 Transcription Initiation .................................................................................... 15 
1.3 Transcription Factors required to activate or repress gene expression
 .......................................................................................................................... 17 
1.3.1 Global and Specific Regulators ...................................................................... 17 
1.3.2 CRP; a conventional global regulator ............................................................. 19 
1.3.3 H-NS; an unconventional global regulator ...................................................... 21 
1.3.4 AraC; a specific regulator ............................................................................... 22 
1.4 Mechanisms of Transcription Activation ............................................... 25 
1.4.1 Class I activation ............................................................................................ 25 
1.4.2 Class II activation ........................................................................................... 25 
1.4.3 Class III activation: ......................................................................................... 26 
1.5 Transcription repression ......................................................................... 26 
1.5.1 Repression by steric hindrance: ..................................................................... 26 
1.5.2 Repression by DNA looping: .......................................................................... 27 




1.6 Transcription regulation by modulation of RNAP activity ................... 27 
1.7 Transcription regulation by altering the preference of RNAP binding 32 
1.8 Diarrhoea and Enterotoxigenic Escherichia coli (ETEC) ...................... 35 
1.9 Heat labile LT toxins ................................................................................. 40 
1.9.1 Secretion of LT toxin requires a Type 2 secretion system (T2SS) .................. 43 
1.10 Heat stable ST toxins are small highly structured enterotoxins ....... 45 
1.11 Colonizaton factors (CFs) ...................................................................... 46 
1.12 The Multiple Antibiotic Resistance operon of E. coli .......................... 46 
1.13 Objectives of this study ......................................................................... 55 
 
Chapter 2. Materials and Methods ........................................... 57 
2.1 General antibiotics and growth media used .......................................... 58 
2.1.1 Antibiotics (Stock Solutions) ........................................................................... 58 
2.1.2 Bacterial Growth Media .................................................................................. 58 
2.1.2.1 Solid media .................................................................................................. 58 
2.1.2.2 Liquid media ................................................................................................ 59 
2.2 Bacterial Strains and Plasmids ............................................................... 60 
2.2.1 Bacterial strains and growth conditions .......................................................... 60 
2.2.2 Plasmids ......................................................................................................... 60 
2.3 Plasmid DNA preparation using QIAprep Spin Mini/Maxi prep kit 
(QIAgen)........................................................................................................... 60 
2.4 Phenol/Chloroform extraction of DNA .................................................... 66 
2.4.1 Reagents and chemicals used: ...................................................................... 66 




2.5 Ethanol precipitation ................................................................................ 66 
2.5.1 Reagents and chemicals used: ...................................................................... 66 
2.5.2 Method: .......................................................................................................... 66 
2.6 Gel electrophoresis .................................................................................. 67 
2.6.1 Reagents and chemicals used: ...................................................................... 67 
2.6.2 Agarose gel electrophoresis ........................................................................... 67 
2.6.3 Polyacrylamide gel electrophoresis ................................................................ 68 
2.7 DNA manipulations .................................................................................. 68 
2.7.1 Polymerase Chain Reaction (PCR) ................................................................ 72 
2.7.2 Megaprimer PCR ............................................................................................ 72 
2.7.3 Colony PCR .................................................................................................... 72 
2.8 DNA purification using QIAquick PCR Purification kit (QIAgen) ......... 72 
2.9 DNA restriction digest .............................................................................. 74 
2.10 DNA Ligation ........................................................................................... 74 
2.11 DNA transformation of bacterial cells .................................................. 75 
2.11.1 Preparation of CaCl2 competent cells ........................................................... 75 
2.11.2 Transformation of chemically competent cells with plasmid DNA ................. 75 
2.12 DNA Sequencing .................................................................................... 76 
2.13 β-galactosidase assays ......................................................................... 76 
2.13.1 Reagents and chemicals used: .................................................................... 76 
2.13.2 Method: ........................................................................................................ 76 
2.14 Radiolabelling of DNA fragments ......................................................... 78 
2.14.1 Reagents and chemicals used ..................................................................... 78 




2.15 Maxam-Gilbert sequencing reactions .................................................. 78 
2.15.1 Reagents and chemicals used ..................................................................... 78 
2.15.2 Method ......................................................................................................... 79 
2.16 DNA sequencing gel electrophoresis ................................................... 79 
2.16.1 Reagents and chemicals used ..................................................................... 79 
2.16.2 Method ......................................................................................................... 79 
2.17 DNAse I footprinting ............................................................................... 80 
2.17.1 Reagents and chemicals used ..................................................................... 80 
2.17.2 Method ......................................................................................................... 80 
2.18 In vitro transcription assays .................................................................. 81 
2.18.1 Reagents and chemicals used ..................................................................... 81 
2.18.2 Method ......................................................................................................... 81 
2.19 Microscopy .............................................................................................. 82 
2.19.1 Reagents and chemicals used ..................................................................... 82 
2.19.2 Preparation of microscope slides ................................................................. 82 
2.19.3 Imaging and analysis .................................................................................... 82 
2.20 Growth assays ........................................................................................ 83 
2.21 Minimum inhibitory concentration (MIC) determination ..................... 83 
2.21.1 Materials, reagents and chemicals used ...................................................... 83 
2.21.2 Method ......................................................................................................... 84 
2.22 Accumulation Assay .............................................................................. 84 
2.22.1 Materials, reagents and chemicals used ...................................................... 84 
2.22.2 Method ......................................................................................................... 85 
2.23 Efflux Assay ............................................................................................ 86 




2.24.1 Materials, reagents and chemicals used ...................................................... 86 
2.24.2 Method ......................................................................................................... 86 
2.25 Crystal Violet Assay ............................................................................... 87 
2.26 Chromatin Immuno Precipitation (ChIP) .............................................. 87 
2.26.1 Materials, reagents and chemicals used ...................................................... 87 
2.26.2 Method ......................................................................................................... 89 
2.26.3 ChIP analysis by PCR .................................................................................. 90 
2.26.4 ChIP analysis by Ilumina MiSeq sequencing ................................................ 90 
2.27 Agencourt AMPure XP magnetic bead clean up ................................. 92 
2.28 Bioinformatic analysis of sequence reads .......................................... 92 
2.29 Bioinformatic identification of MarA binding sites ............................. 95 
2.30 Phylogenetic analysis of the marbox ................................................... 95 
2.31 Pulsed-Field Gel Electrophoresis ......................................................... 96 
2.31.1 Reagents and chemicals used ..................................................................... 96 
2.31.2 DNA Preparation .......................................................................................... 97 
 
Chapter 3. Molecular Mechanisms controlling expression of 
ETEC H10407 enterotoxins. ..................................................... 99 
3.1 Introduction ............................................................................................. 100 
3.2 The estA2 promoter is repressed by H-NS and activated by CRP .... 100 
3.3 The estA2 and estA1 are similarly regulated by H-NS ........................ 103 




3.5 Similar H-NS binding on all the enterotoxin promoters of ETEC H10407
 ........................................................................................................................ 104 
3.6 The estA1 and estA2 promoters of ETEC H10407 respond to Glucose 
and Salt .......................................................................................................... 108 
3.7 The eltAB promoter also responds to glucose and salts ................... 111 
3.8 Regulation of ETEC enterotoxins by H-NS and CRP is conserved in 
other strains .................................................................................................. 111 
3.9 Discussion .............................................................................................. 116 
 
Chapter 4. Identification and verification of MarA binding 
sites across the ETEC H10407 genome ................................ 122 
4.1 Introduction ............................................................................................. 123 
4.2 MarA binding sites across the whole genome of ETEC H10407 ........ 123 
4.3 In vitro characterization of MarA bound targets ................................. 126 
4.4 The mar regulon is conserved amongst the family of enteric bacteria
 ........................................................................................................................ 126 
4.5 Phenotypic landscape of the mar regulon ........................................... 132 
 
Chapter 5. MarA-dependent regulation of xseA is associated 
with DNA repair and quinolone resistance ........................... 137 
5.1 Introduction ............................................................................................. 138 
5.2 Characterisation of PxseA ..................................................................... 138 




5.3 PxseA is a MarA activated promoter .................................................... 141 
5.4 Innate resistance to ciprofloxacin requires MarA mediated xseA 
expression ..................................................................................................... 141 
5.5 xseA determinants for DNA binding, catalysis and XseB interactions 
are required for complementation .............................................................. 145 
5.6 Sub-inhibitory concentration of ciprofloxacin introduces double 
stranded breaks in the cells that lack MarA controlled xseA .................. 145 
5.7 Discussion .............................................................................................. 149 
 
Chapter 6. MarA-dependent regulation of mlaFEDCB is 
associated with altered outer membrane barrier function and 
tetracycline resistance. .......................................................... 154 
6.1 Introduction ............................................................................................. 155 
6.2 Binding of MarA to mlaFEDCB .............................................................. 155 
6.3 MarA activates transcription of mlaFEDCB in vitro and in vivo ........ 155 
6.4 Innate resistance to doxycycline requires MarA mediated mlaFEDCB 
expression ..................................................................................................... 159 
6.5 Defective barrier functions but normal efflux was observed in the cells 
lacking mlaE .................................................................................................. 162 
6.6 Surface hydrophobicity increased in the cells lacking mlaFEDCB ... 167 






Chapter 7. Final conclusions and general discussions. ..... 172 
7.1 Final conclusions and General discussions ....................................... 173 
7.1.1 Overview ............................................................................................... 173 
7.1.2 Understanding why chromatin immunoprecipitation does not 
identify all binding sites for CRP and MarA ............................................... 174 
7.1.3 Potential for overlapping regulation of mlaFEDCB and xseA by SoxS 
and Rob ......................................................................................................... 176 
7.1.4 The Rob paradox and its implications for this work ........................ 178 
7.1.5 Why were targets such as mlaFEDCB and xseA not found in 
previous attempts to map the MarA regulon? ........................................... 180 
7.1.6 Comparison of MarA binding sites in ETEC and Escherichia coli K-
12 .................................................................................................................... 181 
7.1.7 Wider roles for DNA repair systems in modulating the effects of 
quinolones on gram negative bacteria ....................................................... 182 
7.1.8 Future work .......................................................................................... 184 
 
References ............................................................................... 186 
Appendix .................................................................................. 221 






Index of Figures 
Chapter 1: 
Figure 1.1: Central dogma of molecular biology ............................................................. 9 
Figure 1.2: Cartoon representation of RNA polymerase holoenzyme. ......................... 12 
Figure 1.3: Domain organisation of  factors. .............................................................. 14 
Figure 1.4: The transcription cycle. .............................................................................. 18 
Figure 1.5: Ribbon structure of CRP dimer. ................................................................. 20 
Figure 1.6: H-NS structural properties. ......................................................................... 23 
Figure 1.7: Domain organisation of single subunit of AraC. ......................................... 24 
Figure 1.8: Cartoon representation of transcription activation mechanisms ................. 29 
Figure 1.9: Cartoon representation of the mechanism of transcription repression. ...... 31 
Figure 1.10: Cartoon representation to show the regulation by promoter mimic. ......... 33 
Figure 1.11: Cartoon representation showing that some factors can remodel parts of 
RNAP ............................................................................................................................ 34 
Figure 1.12: Representation of ETEC showing the genetic and virulent components. . 37 
Figure 1.13:  Synthesis and secretion of Heat Labile Toxin (LT) and Heat Stable Toxin 
(ST). .............................................................................................................................. 38 
Figure 1.14: Representation of the model of pathogenesis in ETEC. ........................... 39 
Figure 1.15: The structures of LT toxin. ........................................................................ 41 
Figure 1.16: Regulation of eltAB by Glucose ................................................................ 42 
Figure 1.17: Type 2 secretion system that helps in secreting LT ................................. 44 




Figure 1.19: Sequence alignments showing the homology between the endogenous 
peptides and the bacterial toxins. .................................................................................. 48 
Figure 1.20: Cartoon structure to illustrate the activation of marRAB. .......................... 51 
Figure 1.21: Cartoon representation of several instrinsic resistance mechanisms. ...... 52 
Figure 1.22: Structure and binding site of MarA ........................................................... 53 
Figure 1.23: Cartoon representation of the interaction of MarA with αCTD of RNAP. .. 54 
 
Chapter 2: 
Figure 2.1:  pRW50 plasmid map. ................................................................................ 63 
Figure 2.2:  pSR plasmid map. ..................................................................................... 64 
Figure 2.3:  pBR322 plasmid map. ............................................................................... 65 
Figure 2.4: Cartoon representation of ChIP-seq. .......................................................... 93 
 
Chapter 3: 
Figure 3.1: Defined hypothesis about in vivo regulation of enterotoxins by H-NS. ..... 101 
Figure 3.2: Investigation of LacZ activities (miller units) from different promoter 
derivatives of estA2. .................................................................................................... 102 
Figure 3.3: Investigation of the LacZ activity from promoter derivative of estA1. ....... 105 
Figure 3.4: Investigation of the LacZ activities from different promoter derivatives of 
eltAB. ........................................................................................................................... 106 
Figure. 3.5: The various enterotoxin promoters of ETEC H10407 are repressed by H-




Figure 3.6: Effect of titrating glucose and salts individually over the estA1 and estA2 
promoter. ..................................................................................................................... 109 
Figure 3.7: Control of production of ST toxin by glucose. ........................................... 110 
Figure 3.8: Production of ST toxin of ETEC H10407 is controlled by an osmo-metabolic 
flux. .............................................................................................................................. 112 
Figure 3.9: The response from glucose needs an intact CRP site over the PestA2 
promoter. ..................................................................................................................... 113 
Figure 3.10: Effect of titrating glucose and salts individually over the eltAB promoter.
 .................................................................................................................................... 114 
Figure 3.11: Production of LT toxin of ETEC H10407 is controlled by an osmo-
metabolic flux. ............................................................................................................. 115 
Figure 3.12: Transcription levels of enterotoxins of ETEC E24377A .......................... 117 
Figure 3.13: Transcription level changes in the transcriptome of ETEC E24377A post 
intestinal cell attachment. ............................................................................................ 118 
Figure 3.14: A model proposed for the control of enterotoxins expression of ETEC. . 119 
 
Chapter 4: 
Figure 4.1: MarA and RNAP 70 binding ................................................................... 124 
Figure 4.2: DNA sequence motifs derived from MarA binding sites. .......................... 125 
Figure 4.3: Location of MarA and RNA polymerase binding peaks with respect to 
genes. ......................................................................................................................... 128 




Figure 4.5: Conservation of MarA regulon amongst the enterobacteriacea. .............. 131 
Figure 4.6: Phenotypic landscape of the MarA regulon. ............................................. 133 
 
Chapter 5: 
Figure 5.1: MarA and 70 binding across the xseA and regulatory sequence of xseA.
 .................................................................................................................................... 139 
Figure 5.2: Binding of MarA to the xseA gene regulatory region. ............................... 140 
Figure 5.3: DNAse I footprint of MarA binding to the xseA gene regulatory region. ... 142 
Figure 5.4: The xseA promoter activity requires an intact marbox in vivo. ................. 143 
Figure 5.5: Genetic complementation of xseA phenotype. ......................................... 144 
Figure 5.6: An intact marbox is required at the upstream of the promoter for genetic 
complementation of xseA phenotype. ......................................................................... 146 
Figure 5.7: Domain organisation of XseA. .................................................................. 147 
Figure 5.8: The key determinants of xseA are required for its proper functioning. ..... 148 
Figure 5.9: Ciprofloxacin induced damage of E. coli cells in the absence of MarA 
mediated xseA expression. ......................................................................................... 151 
Figure 5.10: Ciprofloxacin induced DNA damage in the absence of xseA expression.
 .................................................................................................................................... 152 
 
Chapter 6: 
Figure 6.1: MarA and RNA polymerase bind together across the mla regulatory region.




Figure 6.2: MarA binds fragments of mlaFEDCB in the presence of the marbox. ...... 157 
Figure 6.3: DNAse I footprint of MarA binding to the regulatory region of mlaFEDCB.
 .................................................................................................................................... 158 
Figure 6.4: In vitro transcription assay revealed the presence of three promoters in the 
regulatory region of mlaFEDCB. ................................................................................. 160 
Figure 6.5: The mlaFEDCB activity requires an intact marbox in vivo. ....................... 161 
Figure 6.6: Genetic complementation of mlaF::kan phenotype. ................................. 163 
Figure 6.7: An intact marbox is required for genetic complementation of mlaF::kan 
phenotype. .................................................................................................................. 164 
Figure 6.8: Cells lacking mlaE are defective for barrier function. ............................... 165 
Figure 6.9: Cells lacking mlaE are not defective for drug efflux. ................................. 166 
Figure 6.10: Cells that lack mlaE have increased surface hydrophobicity. ................. 168 
Figure 6.11: Cells that lack mlaE have increased surface hydrophobicity. ................. 169 
 
Chapter 7: 
Figure 7.1: Overlap in the genome-wide DNA binding profiles of MarA in ETEC H10407 
and SoxS in E. coli K-12. ............................................................................................. 179 







Index of Tables 
Table 1.1: Different classes of CFs: .............................................................................. 49 
Table 2.1: Strains used in the study.............................................................................. 61 
Table 2.2: Plasmids used in the study. ......................................................................... 62 
Table 2.3: Oligonucleotides used in this study. ............................................................. 69 
Table 2.4: Typical thermocycler settings used in the study. .......................................... 73 
Table 4.1: MarA binding sites identified by ChIPseq…………………………………….127 


































1.1 Gene Regulation in Escherichia coli 
Bacteria respond to external stimuli using a variety of molecular pathways. A common 
response is to modify patterns of gene expression. This can be done by mediating a 
series of catalytic reactions. Hence, information encoded by DNA is transcribed to form 
a RNA message that is translated to form a protein. This is known as the central dogma 
of molecular biology (Figure 1.1). Transcription, the first step in gene expression, 
involves copying DNA to make mRNA. This requires an enzyme called RNA 
polymerase. Translation requires ribosomes that assemble proteins using mRNA as a 
template. (Ishihama, 2012, Shimizu, 2013). Gene regulation is the process of increasing 
or decreasing the efficiency of gene expression in response to a stimulus. Thus, the 
earliest gene expression control step is transcription initiation (Sharma and Chatterji, 
2010).  
1.2 Transcriptional Regulation 
1.2.1 RNA polymerase  
In most organisms, RNA polymerase is a multi subunit enzyme that can be imagined as 
a crab claw. A channel runs from the centre of the claws to the active centre cleft 
(Chakraborty et al., 2012). The active site of the enzyme is found at the base of the cleft 
created by the claws. The active site contains 2 magnesium ions that are responsible 
for addition of nucleotides to the 3’ end of the polynucleotide RNA chain (Cramer et al., 
2001). In Gram negative bacteria, RNAPs are approximately 400 kDa in size. The core 
enzyme is composed of the α2ββ’ω subunits (Murakami, 2015).  
The identical α subunits each have a larger amino-terminal domain (αNTD) and a 





Figure 1.1: Central dogma of molecular biology: Genes are expressed based on the 
central dogma, where DNA (blue) is copied to make RNA (mRNA) (green) by the 
process of transcription and RNA then gets translated to form proteins (orange) by the 
















13 amino acid flexible linker (Estrem et al., 1999). The αCTD assists in DNA binding at 
promoters and also interacts with transcription factors (Ishihama, 1992). A group of 
amino acid residues, known as the ‘265 determinant’, allow αCTD to contact the DNA at 
UP elements. The key residue, Arg-265, is a part of helix-hairpin-helix motif. This makes 
contact with the minor groove of DNA (Ross and Gourse, 2005). The β and β’ subunits 
form the catalytic centre for RNA synthesis and are held together by αNTD. Moveable 
structures close to the active centre play a role in translocation of RNAP and in 
selecting nucleoside triphosphates. These structures are referred to as the bridge helix 
and trigger looping (Darst, 2001, Vassylyev et al., 2002).  The ω subunit is a 91 amino 
acid protein that binds the β’ subunits and helps in its maturation (Zhang et al., 1999, 
Mathew and Chatterji, 2006). The ω subunit also plays an important role in regulating 
RNA polymerase in response to guanosine tetraphosphate (ppGpp); a small molecule 
that plays a role in intracellular signalling, and changes in gene expression based on 
environmental signals (Chatterji et al., 2007, Zuo et al., 2013, Ross et al., 2013, Vrentas 
et al., 2005). Although the RNA polymerase core enzyme is catalytically active it cannot 
bind DNA specifically (Vassylyev et al., 2002). This property is provided by the binding 
of the dissociable σ subunit (Vassylyev et al., 2002). The σ subunit has 2 main 
functions: recognition of promoter sequences and facilitation of DNA melting at the 
transcription start sites (Finn et al., 2000, Browning and Busby, 2004, Saecker et al., 
2011). In all bacteria one sigma factor recognises most promoters under normal growth 
conditions and is known as the housekeeping sigma factor (σ70 in Escherichia coli). In 




supplemented with alternate sigma factors. A cartoon representation of the RNA 
polymerase holoenzyme is shown in Figure 1.2. 
1.2.2 Domain Organisation of Sigma Factors and Alternate Sigma factors 
The domain organisation of sigma factors was first determined by proteolysis 
(Murakami, 2015). Thus, after proteolysis, individual σ domains could be isolated. 
Structures were determined for stable domains using X-Ray Crystallography and NMR. 
The first domain structure was obtained from E. coli group 1 σ70 in 1996 (Malhotra et al., 
1996). The 1.2 to 2.4 regions in the N-terminal domain of the sigma factor provided 
details of -10 recognition by σ region 2.4 and melting of promoter DNA by region 2.3 
(Malhotra et al., 1996). A more complete view of sigma factors was provided in the case 
of Thermus aquaticus, where sigma was divided into 2 proteolytic fragments. One of the 
fragments has domain 2 (region 1.2 - 2.4) and domain 3 (regions 3.0 - 3.1) and the 
other fragment has domain 4 (regions 4.1 - 4.2) (Campbell et al., 2002). The modular 
structure of sigma factors is shown in Figure 1.3. 
The genome of E. coli encodes 6 alternative σ factors that can compete with σ70, in 
stress conditions, for binding core RNAP (Gruber and Gross, 2003). The highest 
number of genomic binding sites are for σ70 (1643 binding sites) in E. coli (Cho et al., 
2014). Different stresses can induce different sigma factors. These stresses include 
changes in temperature (σ32), nutrient balance (σ38), and protein folding (σ24). The 









Figure 1.2: Cartoon representation of RNA polymerase holoenzyme. RNA 
polymerase associated with the upstream sequences. αNTD and αCTD are the Amino 
terminal and Carboxy terminal domains. -10 and -35 are promoter recognition 
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 σ38 controls the gene expression in starved cells and is abundant during the 
stationary phase of the bacterial growth cycle (Weber et al., 2005).  
 σ32 is the heat shock factor that is active when there is a change in temperature, 
pH, osmolarity or nutrients (Jenkins et al., 1991).  
 σ28 controls the expression of flagella related genes (Liu and Matsumura, 1996).  
 σ24 responds to many stresses e.g., periplasmic protein stress, heat shock, 
oxidative stress etc. (Raina et al., 1995, Erickson and Gross, 1989, De Las 
Penas et al., 1997).  
 σ19 FecI is an Iron starvation sigma factor that controls the expression of genes 
involved in ferric citrate transportation (Pressler et al., 1988).  
 σ54 is structurally unrelated to the other sigma factors. It is involved in the 
response to nitrogen limitation. The activity of σ54 is always regulator dependent 
(Carmona and Magasanik, 1996). This involves an ATP hydrolysis event 
mediated by AAA+ ATPase transcriptional activators known as enhancer binding 
proteins. This allows DNA melting and transcription initiation (Wedel et al., 1990, 







Figure 1.3: Domain organisation of  factors.  Structural domains of 70 are 
represented in this figure. All four conserved regions, their subregions and the non 
conserved region (NCR (grey)) are shown. The promoter -10, -35 and extended -10 
elements are purple rectangles. Interaction between  subunits and the DNA elements 






















1.2.3 Transcription Initiation 
1.2.3.1 Promoter Recognition and Binding 
The RNAP σ subunit allows specific binding to DNA sequences called promoters 
(Burgess et al., 1969). Hence the efficiency of transcription is related to promoter 
sequence. The -10 (TATAAT) and -35 (TTGACA) hexamers are located at -10 and -35 
base pair upstream of the transcription start site respectively (Hawley and McClure, 
1983). These elements are recognised by the σ2 and σ4 domains of the σ
70 (Campbell 
et al., 2002, Murakami et al., 2002). Some promoters have an extended -10 element; 
the sequence TGn is found immediately upstream of the -10 hexamer. This extended 
TGn is recognized by σ3 domain of σ70. UP elements recognised by the αCTD are 20 
bp in length, AT rich and located at different distances upstream of -35 hexamers 
(Browning and Busby, 2004).  
 
1.2.3.2 Open Complex formation (Isomerisation)  
The interaction of RNAP with its promoter -10 element results in melting of the DNA 
upstream of the transcription start site (the open complex) (Browning and Busby, 2004, 
Browning and Busby, 2016). This process is also known as isomerisation (Borukhov et 
al., 2005). The A11 and the T7 bases of the -10 elements (T-12A-11T-10A-9A-8T-7) are 
flipped out from the base stack and buried in a region of σ2 (Zhang et al., 2012). 
Consequently the A11 and T7 bases are highly conserved in -10 hexamers 
(Shultzaberger et al., 2007). An initiation complex can now form with the addition of 




charged amino acids that prevent spontaneous melting of DNA unless σ70 is properly 
associated with a promoter (Miropolskaya et al., 2012).  
1.2.3.3 Abortive Initiation (DNA scrunching) 
Once the initiating nucleotide is positioned in the active site, a phosphodiester bond can 
form between this initial and an adjacent nucleoside. This leads to the synthesis of 
template dependent RNA transcripts. During initiation the template strand is pulled into 
RNAP in a process known as DNA scrunching. Hence, rather than RNAP moving, the 
RNA chain begins to grow, the complex is held at the promoter and the RNA:DNA 
duplex is pulled into the enzyme. This can result in abortive initiation producing small 
RNAs of 8-9 bp in length (Murakami et al., 2002, Revyakin et al., 2006). Recently, Zuo 
and Steitz solved the structure of a σ70 transcription initiation complex. The crystal 
structure provides details of promoter binding and transcript initiation. It was also shown 
that there is a bridging interaction between the 5’ triphosphate of RNA and σ3.2 loop. 
This interaction suggested a function for σ70 in stabilizing short RNA:DNA hybrids during 
the early steps of transcription (Zuo et al., 2013). 
1.2.3.4 Promoter Escape 
When RNA production extends beyond 9 nucleotides RNAP detaches from the DNA 
and escapes the promoter. The new RNA chain leaves the exit channel that 
accommodates 5 nucleotides of RNA. After promoter escape conformational changes 
occur in the holoenzyme resulting in dissociation of  factor from the core RNA 
polymerase (Hernandez et al., 1996, Roberts et al., 1998). After escaping the promoter, 




The transcription elongation complex is very stable (Krummel and Chamberlin, 1989) 
and translocates at a speed of 30-100 nucleotides per second (Levin et al., 1987). 
Transcription continues until a termination signal is encountered, RNA polymerase is 
freed from the DNA, and can rebind sigma (Vogel and Jensen, 1994, Murakami and 
Darst, 2003).  The transcription cycle is illustrated in Figure 1.4. 
1.3 Transcription Factors required to activate or repress gene expression 
Many promoters have sequences that are suboptimal. At these promoters, regulatory 
proteins, referred to as transcription factors, bind specific DNA sequences and help 
RNAP to initiate transcription. Hence, transcription activators can activate gene 
expression.  Conversely, a repressor is a protein that binds DNA or RNA to inhibit gene 
expression. Promoters have specific sequences of DNA (referred to as operators) that 
bind transcription factors. Binding of transcription factors is permitted by a structural 
motif in the transcription factor. The specificity for DNA targeting by transcription factors 
is further enhanced by dimerisation or multimerisation (Browning and Busby, 2016).  
1.3.1 Global and Specific Regulators  
Transcription factors can be characterised as global or local regulators (Perrenoud and 
Sauer, 2005). Half of the genes of E. coli are regulated by at least one of the 7 global 
transcription factors, which include CRP (cyclic AMP receptor protein), FNR (fumarate 
and nitrate reductase regulatory protein), H-NS (Histone like nucleoid structural protein), 
FIS (Factor for inversion and stimulation), IHF (Integration host factor), ArcA (Aerobic 
respiration regulatory protein) and Lrp (Leucine-responsive regulatory protein). There 
are about 300 transcription factors in the genome of E. coli, equating to 8% of the genes 





Figure 1.4: The transcription cycle.  The process involves 4 steps: 1. Conversion of 
core RNAP into holoenzyme by binding a sigma factor. 2. Binding the promoter region 
forming the initiation complex. 3. Initial polymerisation by the formation of 
phosphodiester bonds. 4. Elongation. The nascent RNA is shown by a solid green line. 




1.3.2 CRP; a conventional global regulator 
CRP has a regulon of around 200 genes consisting of many catabolic enzymes. In 
some pathogens, CRP also regulates various virulence factors. CRP is a 47 kDa 
molecule that binds DNA as a dimer (Figure 1.5) (Lawson et al., 2004). The dimer of 
CRP contains two identical subunits (A and B) and each of the subunits is comprised of 
two domains: the N- terminal domain that is required for cAMP binding and dimerisation, 
and the C-terminal domain required for DNA binding (Busby and Ebright, 1999). 
Dimerisation requires a hydrophobic interaction between amino acids of an alpha helix 
in each N-terminal domain, known as the C helix. Precisely, the C, E and F helix 
residues (112-133, 168-176 and 180-191 respectively) form a helix-turn-helix motif that 
binds the DNA. The recognition helix from this motif is inserted into the major groove of 
the DNA where it contacts specific bases (Lawson et al., 2004). 3’-5’- cyclic adenosine 
monophosphate (cAMP), binds CRP at a site in each monomer to control CRP activity. 
The cAMP binding site is formed by the C helix and β roll motifs consisting of β strands. 
Specific residues needed for cAMP binding are Arg-185, Arg-180, and Glu-181. cAMP 
binding brings the F helix into optimal position to interact with the DNA major groove. 
CRP-cAMP binds a consensus sequence TGTGAN6TCACA which has two-fold 
symmetry (Lawson et al., 2004). CRP binding to the DNA induces a 90° bend (Schultz 
et al., 1991). CRP contacts RNAP via series of 3 activating regions (AR1-3) on the 
surface of the protein (Benoff et al., 2002). AR1 is present in the CRP C-terminal 
domain and contacts αCTD of RNAP. AR2 is in the CRP N terminal domain contacts 








Figure 1.5: Ribbon structure of CRP dimer. The A subunit is in green and B subunit 





1.3.3 H-NS; an unconventional global regulator  
Histone-like nucleoid structuring (H-NS) protein is an abundant (>20,000 copies a cell), 
extensively studied DNA binding protein found in many Gram negative bacteria. H-NS 
binds to around 5% of the genome in E. coli and these loci are often horizontally 
transferred (Ueda et al., 2013). These genes can have an adverse effect on the host 
unless bound by H-NS. Hence, H-NS influences genome evolution and chromosome 
organisation as well as transcription (Rimsky, 2004, Winardhi et al., 2014, Dorman, 
2007, Dorman, 2014, Singh et al., 2014, Lamberte et al., 2017). H-NS binds AT-rich 
regions of DNA by recognising a nucleation site that is distinguished by the presence of 
a central T-A base step (Bhat et al., 2014). Subsequently, H-NS oligomerises across 
and bends the double helix (Pon et al., 2005). If H-NS forms distal clusters on the DNA, 
these can interact resulting in DNA bridging and genome condensation (Wang et al., 
2011). H-NS is a universal repressor of gene expression and is expressed in all growth 
phases of E. coli (Gallant et al., 2004). Repression can involve trapping of RNAP in a 
DNA loop resulting from DNA bridging or complete exclusion of RNAP from the DNA 
(Dame et al., 2002). In E. coli, the proU promoter is the best studied example for 
repression by H-NS (Nagarajavel et al., 2007). In many enterobacteria, the function of 
H-NS is dependent on temperature and osmolarity (Yang et al., 2005).   
E. coli H-NS is a 137 amino acid protein comprised of 2 domains joined by a flexible 
linker (Rimsky, 2004). The N-terminal domain is 83 amino acids long and contains four 
α helices (α1, α2, α3 and α4). These permit self association by “head to head” or “tail to 
tail” contacts (Rimsky, 2004, Arold et al., 2010). The helices α1- α3 form the head to 




2002). The C-terminal part of α3, and the α4 helix, is responsible for the tail to tail 
contact and forms a helix-turn-helix motif (Rimsky, 2004). The C-terminal domain of H-
NS contains 2 β sheets (β1and β2), an α5 helix and a 310 helix (Gordon et al., 2010). A 
small loop between the β2 and α5 helix is the key determinant that binds DNA (Figure 
1.6). The helix contains a side chain, R114, within a sequence of amino acids 
(TWTXGRXP) that forms an AT hook. The R114 side chain contacts the minor grove of 
the DNA (Gordon et al., 2010). Head to head and tail to tail interaction results in 
filamentation. DNA bridging occurs if the AT hook motif in alternate promoters contact 
separate sections of DNA (Arold et al., 2010). 
1.3.4 AraC; a specific regulator 
AraC is a regulator of L-arabinose metabolism. AraC has a C-terminal domain and an 
N-terminal domain. These domains are connected by a flexible linker (Mahon et al., 
2010, Seedorff and Schleif, 2011). The C-terminal domain is responsible for DNA 
binding and the N-terminal domain recognises L-arabinose. 
Figure 1.7 shows the domain organisation of AraC. The broader AraC family is a large 
group of transcription factors; 830 family members have already been identified 
amongst diverse Gram negative bacteria (Egan, 2002, Tramonti et al., 2002, Alekshun 
and Levy, 1999). Many of the family members are also specific regulators but some 
regulate larger sets of genes. AraC family members are identified by a 100 amino acid 
stretch that constitutes the DNA binding domain. The residues form two HTH motifs that 
bind the promoter DNA (Martin and Rosner, 2001, Grainger et al., 2003, Rodgers and 
Schleif, 2009, Munson et al., 2001, Morin et al., 2010). If present, the N-terminal domain 








Figure 1.6: H-NS structural properties. The figure shows the 2 domains of H-NS. The 
NTD is composed of four α-helices (cylinders) and has 2 determinants for self 
association of H-NS. The determinants responsible for head-to-head interaction are 
shown in grey, and the one for tail-to-tail interaction is shown in red. The CTD of H-NS 
is the DNA binding domain composed of 2 β sheets, purple arrows, an α helix and a 310 
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Figure 1.7: Domain organisation of single subunit of AraC.  Strucural characteristics 
of a AraC homodimer are shown. Orange denotes the DNA binding domain, the N-
terminal domain is in fluorescent green, the β - barrel is in blue, the coiled coil in light 







(Ruiz et al., 2003, Parra and Collins, 2012).  
1.4 Mechanisms of Transcription Activation 
The basic rules for transcription activation have been defined at simple promoters 
regulated by a single transcription factor. There are 3 major classes of simple 
transcription activation defined on the basis of transcription factor binding location and 
contacts with RNAP (Busby and Ebright, 1999, Browning and Busby, 2004).  
1.4.1 Class I activation: The transcription activator protein is bound on the DNA 
sequence upstream, and separated from the promoter -35 element. By the direct 
interaction between the activator and αCTD, the RNAP is recruited to the promoter 
(Chen et al., 2003). One example is the lac promoter activated by CRP (Landis et al., 
1999). Note that, because the linker joining the αCTD and αNTD is flexible, αCTD can 
bind at different locations upstream of class I promoters. The residues in αCTD required 
at class I promoters are grouped and termed the 261, 265 and 268 determinants. The 
αCTD 265 determinant aids binding of αCTD to the minor groove of the DNA as 
described previously. Class I activation is more efficient if a promoter UP element is 
present (Busby and Ebright, 1999, Tang et al., 1994, Gaal et al., 1996). Figure 1.8A. 
illustrates class I activation.  
1.4.2 Class II activation: Class II transcription activation, involves activator binding to a 
target that overlaps the promoter -35 element. The activator can contact both the sigma 
and alpha subunits of RNAP (Browning and Busby, 2004). An example of class II 
activation is the E. coli, narG promoter.  In this example, αCTD, and domain 4 of σ70, 
are contacted by FNR and this facilitates recruitment of RNAP (Blake et al., 2002). 




interacts with 287 determinant of αCTD and so stabilises UP element binding by the 265 
deteminant of αCTD. AR2  binds the αNTD (residues 162 to 165) to further enhance 
promoter binding (Busby and Ebright, 1999). The Figure 1.8B illustrates the class II 
activation.  
1.4.3 Class III activation: In this class of activation, the transcription activator is 
required to bind at multiple sites. Hence, class III promoters are activated by a 
combination of class I and class II mechanisms (Busby and Ebright, 1999, Browning 
and Busby, 2004). An illustration of activation by re-orientation of binding sites is shown 
in Figure 1.8C.  An example for class III activation, provided by a mixture of mutiple 
factors, occurs at the  E. coli melAB promoter (Grainger et al., 2003). MelR binds two 
pairs of sites (1,1’ and 2,2’) as a dimer. These sites are separated by a CRP site 
(Grainger et al., 2004b). When CRP is present in the cell, MelR binds to the 2’ site more 
tightly and activates transcription by contacting 70 (Grainger et al., 2004a). CRP 
binding depends on sites 1 and 2 both being prebound by MelR. Hence, two signals 
(melibiose and cAMP) are integrated to regulate transcription (Wade et al., 2001). 
Figure 1.8D. shows MelR type regulation. Complex activation can also involve 
modulation of promoter DNA conformation by an activator. 
1.5 Transcription repression 
Transcriptional repressors function via three major mechanisms (Browning and Busby, 
2004). 
1.5.1 Repression by steric hindrance: This mechanism prevents RNAP binding to the 
promoter. Hence, the promoter contains an operator binding site recognised by the 




the lac promoter. LacI binds to additional operators to completely repress transcription 
of lac ZYA genes (Bell and Lewis, 2001, Wilson et al., 2007). The Figure 1.9A. shows 
the repression by steric hindrance.  
1.5.2 Repression by DNA looping: Transcription is blocked by looping of DNA so that 
RNAP cannot bind or escape the promoter. An example is the gal promoter, bound by 
GalR at 2 operators (OE and OI). Loops are formed by interactions between GalR 
molecules bound at distant sites (Lewis and Adhya, 2002). This interaction is weak and 
an additional factor, HU, stabilises the loop (Semsey et al., 2002, Swint-Kruse and 
Matthews, 2009). Figure 1.9B. shows repression by looping.  
1.5.3 Repression by modulation of an activator protein: Sometimes repressors act 
as anti-activators. This is evident for CytR (repressor) and CRP (activator) that interact 
to regulate genes involved in pyrimidine metabolism. CytR binds between 2 CRP dimers 
and blocks the RNAP αCTD access to the AR1 (Valentin-Hansen et al., 1996, Shin et 
al., 2001). Figure 1.9C. shows the repression by modulation of an activator protein.  
1.6 Transcription regulation by modulation of RNAP activity 
Some regulators control transcription by binding to RNAP but not promoter DNA. 
Hence, these regulators can target both transcription initiation and elongation. For 
example, the E. coli transcription factors Nus (N-Utilization substance factor) A and G 
can control the speed of RNA chain elongation (Burns et al., 1998) (Artsimovitch and 
Landick, 2000). NusG is able to couple transcription and translation by acting as a linker 









































Figure 1.8: Cartoon representation of transcription activation mechanisms A. 
Class I activation:  transcription factor binds upstream and recruits RNA polymerase by 
contacting αCTD. B. Class II activation: an activator is bound adjacent to the promoter 
and contacts domain 4 of sigma. C. Class III activation:the activator changes the 
conformation of the promoter. D. Co-operative binding of two activators; MelR (blue 
circles) and CRP (orange rectangles) drive transcription of melAB operon. MelR 
contacts domain four of σ70. Blue circle represents MelR, CRP dimer is represented by 
orange rectangles grey oval represents the sigma. A, B and C were adapted from 







MelR MelR MelR MelRCRP
Site 1Site 1’ Site 2 Site 2’
-35 -35

















A      Repression by steric hindrance














Figure 1.9: Cartoon representation of the mechanism of transcription repression. 
A. Repression by steric hindrance: the promoter site is blocked by a repressor and 
hence the recognition of the promoter by RNAPs doesn’t occur. B. Repression by 
looping: the intervening promoters are repressed due to looping. C. Transcription 
repression by modulation of an activator: the repressor protein is bound to the activator, 
preventing it from functioning properly by cutting off the promoter recognition by the 

















Not all transcription regulators are proteins. For example, in response to slow growth 
synthesis of 6S RNA, a 180 nt non-coding transcript, occurs. The 6S RNA forms a 
complex with 70 and hence hinders binding to DNA (Figure 1.10) (Cavanagh and 
Wassarman, 2014). The 6S RNA achieves this by mimicking promoter DNA targets for 
housekeeping RNAPs. Hence, the amount of free σ38 increases relative to σ70 bound by 
6s RNA in the cell. A change in overall transcription results (Cavanagh and Wassarman, 
2014).  
In Actinomycetes, RbpA and CarD stabilise the transcription initiation complex (Flentie 
et al., 2016). Hence, domain 2 of 70 is directly bound by RbpA in such a way that RbpA 
is positioned to make stable contacts with the upstream end of unwound DNA in the 
open complex (Hubin et al., 2015). CarD and RbpA function equitably, whereby the C- 
terminal domain of CarD makes stabilising contacts that are complementary to RbpA, 
and the N-terminal domain of CarD makes contact with the RNAP β subunit (Bae et al., 
2015). 
1.7 Transcription regulation by altering the preference of RNAP binding 
Some regulatory factors remodel parts of RNAP to alter DNA binding preference at the 
promoter. A well documented example is T4 phage AsiA protein; a factor that 
appropriates E. coli RNAP to transcribe T4 phage genes (T4 doesn’t code for its own 
RNAP). AsiA is expressed during the early part of the T4 life cycle. Once expressed, 
AsiA, binds and positions domain 4 of 70 in such a way that it cannot bind 
housekeeping promoters (Lambert et al., 2004, Gregory et al., 2004). Instead, domain 4 
of σ70 targets the T4 phage encoded protein known as MotA (Figure 1.11A). MotA is an 







Figure 1.10: Cartoon representation to show the regulation by promoter mimic. 6S 
RNA (violet hair pin loop structure) mimics the promoter and hence can alter the binding 






















Figure 1.11: Cartoon representation showing that some factors can remodel parts 










σ70, which is normally bound by the β flap and the -35 element. In this way, σ70 is 
hindered from binding the host promoters after T4 invasion (Baxter et al., 2006, Hinton, 
2010). Some structural and biochemical studies shows that AsiA has a novel fold that 
helps in binding tightly with σ70 and remaining bound to the holoenzyme during the 
expression of phage genes (Urbauer et al., 2002, Minakhin et al., 2003). 
There is evidence that some bacterial transcription factors work by RNAP appropriation. 
This is best documented for the mar/sox/rob group of regulators (Figure 1.11B). For 
instance, in response to the oxidative stress, the amount of a regulator called SoxS 
increases (Demple, 1996, Pomposiello and Demple, 2001). Although SoxS can bind a 
so called sox-box, which is present at SoxS regulated promoters. SoxS first makes a 
contact with αCTD of RNAP (Griffith et al., 2002). After making this contact SoxS-RNAP 
can bind to SoxS controlled promoters with increased specificity (Shah and Wolf, 2004). 
Similarly, the closely related protein MarA binds αCTD via the 265 determinant normally 
involved in αCTD:DNA interaction (Shah and Wolf, 2004). Thus, this complex has a 
preference for promoters with a MarA binding site rather than an UP element. 
1.8 Diarrhoea and Enterotoxigenic Escherichia coli (ETEC) 
The human gut is home to a vast diversity of bacterial species (Savage et al, 2016). 
These species include E. coli and, for a long time, this was thought to be the most 
prevalent bacterium in the intestine (Tenaillon et al., 2010). However, E. coli make up 
only 0.1% of the total bacterial population in the intestine (Tenaillon et al., 2010). The 
most dominant bacteria in the intestines are obligate anaerobes like Bacteroides fragilis 
(Berg, 1996). Whilst most E. coli are harmless, some E. coli acquire transposons, 




disease (Croxen et al., 2013). Hence, all E. coli share homology in the core genome but 
diverse virulence factors are encoded by pathogenic strains (Croxen et al., 2013). 
Diarrhoeagenic E. coli (DEC) falls into 6 pathotypes; enterotoxigenic E. coli (ETEC), 
enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterohemmorhagic E. 
coli (EHEC), diffusely-adhering E. coli (DAEC) and enetroaggregative (EAEC) (Kaper et 
al., 2004). Of these various pathogens, ETEC causes diseases that are more prevalent; 
600 million episodes are reported every year resulting in 800,000 deaths (Qadri et al., 
2005). Children are most likely to die as a result of ETEC infection but visitors to areas 
where ETEC is endemic (e.g., Asia, Africa and Latin America) are also affected 
(Gaastra and Svennerholm, 1996, Shah et al., 2009). 
The prototypical ETEC strain, H10407, has a genome comprising a 5.1 Mbp 
chromosome and 4 plasmids (Figure 1.12). Two large plasmids (p948 and p666) 
encode a copy each of heat stable toxin (ST) and p666 encodes heat labile toxin (LT). 
The two small plasmids (p58 and p52) encode factors that might be responsible for 
maintaining stability of the larger plasmids (Crossman et al., 2010, Liu et al., 2015). 
Disease caused by ETEC and Vibrio cholera are often indistinguishable. The similarities 
between ETEC and Vibrio cholera mediated disease are due to the similar toxins 
produced during infection. For example, LT of ETEC and cholera toxin (CTX) of Vibrio 
cholera are 80% identical (Sanchez and Holmgren, 2005). Models for the synthesis and 
secretion of toxins by ETEC are shown in Figure 1.13. An overview of pathogenesis is 







Figure 1.12: Representation of ETEC showing the genetic and virulent 
components. Cartoon of E. coli H10407 showing the chromosome bound by 
transcription factors. This figure also shows larger plasmids (p666 and p948) which 
carry the genes that encode the virulence factors and the smaller plasmids (p52and 







Figure 1.13:  Synthesis and secretion of Heat Labile Toxin (LT) and Heat Stable 
Toxin (ST). For LT (steps 1-4): 1. LTA and LTB are synthesized (by eltAB) and transported 
from the cytoplasm to the periplasm with signal peptides. 2. Mature subunits undergo 
proteolysis of signal peptides. 3. The mature subunits are released in the periplasm and 
holotoxin starts to assemble. This assembly is mediated by LTB pentamerisation and it can 
even occur without LTA. However, LTA speeds up the process 3-fold. 4. The type 2 secretion 
system secretes the LT toxin. For ST (steps A-C): A. STa is synthesized (by estA) as a pre-pro 
toxin and the signal sequence is cleaved off by signal peptidases. B. STa is translocated into 
the periplasm by a SecA-dependent pathway and disulphide bonds start to form. C. DsbA 
cleaves 53 amino acid pro-STa; mature toxin is then secreted by the TolC channel. Figure 






Figure 1.14: Representation of the model of pathogenesis in ETEC. For LT (steps 5 
to 10): 5. Recognition and binding of LTB monomer to GM1 receptor. 6. Prior to activation the 
toxin gets internalized. 7. GM1 receptor associates with  cell membrane lipids and mediates 
toxin endocytosis. 8. Transportation of LTA1 subunit to cytoplasm. 9. Toxin activation by nicking 
and reduction. 10. LTA1 activates G protein in Gsα that in turn activates the adenylate cyclase 
(AC). This results in production of cAMP leading to watery diarrhea. The ETEC binds to the 
brush border epithelium of the intestine by using the pathogenesis factors and various genes. 
For ST (Steps D to F): D. Recognition and binding of STa on epithelium and activation of GC-C 
receptor. E. cGMP starts to form and induces the CFTR membrane. F. Accumulation of water 




1.9 Heat labile LT toxins 
LT is a hexameric toxin whose crystal structure was solved in 1991 (Sixma et al., 1991). 
LT is an AB5 toxin consisting of 5 B subunits (11.8 kDa) and 1 A subunit (27.2 kDa). 
The AB5 toxins include pertussis, anthrax, and shiga toxin (Odumosu et al., 2010).  The 
two domains of the A subunit contain cysteine residues that can form disulphide bonds. 
The B subunit can bind to human GM-1 ganglioside, AB blood antigens and 
lipopolysaccharide (Sears and Kaper, 1996, Mudrak and Kuehn, 2010). The bacterial 
LeoA protein can also help to secrete LT by interacting with human Gs cells (Brown and 
Hardwidge, 2007). Thus, the B subunit and LeoA allow the A subunit (which has 
catalytic activity) to enter the cytoplasm of human epithelium with the help of the 
endoplasmic reticulum (ER). The structure of LT is shown in Figure 1.15. This toxin 
activates human adenylate cyclase and overproduction of cAMP results. Accumulation 
of cAMP activates protein kinase A, phosphorylating the cystic fibrosis transmembrane 
conductance regulator (CFTR) on the mucosal membrane. This results in loss of salt 
ions and water into the gut lumen (Sears and Kaper, 1996, Fleckenstein et al., 2010). 
Previous study measured osmolality of less than equal to 100 mosmol/kg hypertonic 
and average glucose concentration of 0.4 to 24 mM in animals (Ferraris et al., 1990). 
The eltAB operon encodes the LT toxin and expression requires a promoter upstream of 
the operon called PeltAB. H-NS represses PeltAB (Yang et al., 2005) and, when ETEC 
cells enter the host, environmental factors trigger eltAB transcription (Sahl and Rasko, 
2012). One such trigger may be the availability of glucose. Previously it was suggested 
that CRP binds directly to PeltAB to influence transcription but subsequent work 
suggested the effect was indirect (Haycocks et al., 2015). Figure 1.16 shows the 






Figure 1.15: The structures of LT toxin. The ribbon structure of LT toxin consisting of 
1 A subunit and 5 B subunits. The structure is obtained from Rasmol PDB viewer using 










Figure 1.16: Regulation of eltAB by Glucose: bacterial cells shown in blue are grown in the presence of limited and adequate 
amount of glucose, the expression of eltAB is driven in the presence of adequate amount of glucose, seen in the top right figure. This 




1.9.1 Secretion of LT toxin requires a Type 2 secretion system (T2SS) 
The T2SS machinery comprises 13 proteins encoded by gspC-O operon (sometimes 
involving gspA, gspB, gspS and also the Sec and TAT components). The genome 
sequencing of ETEC H10407 revealed two operons, one having alpha (α) designated as 
T2SSα and the other having beta (β) designated as T2SSβ. T2SSα have roles in in vivo 
expression & activation while T2SSβ in LT secretion (Yang et al., 2007). The cartoon 
structure of the proteins in the T2SS is shown in Figure 1.17.  
The type 2 secretion system contains four important parts: 1) a periplasmic pseudopilus, 
2) an inner membrane platform, 3) an outer membrane complex and 4) an ATPase 
present in the cytoplasm. The inner platform is formed by GspC, L, F and M. These 
proteins interact with the pseudopilus (GspG and other mini pseudopilins GspH, I, J and 
K), the GspD (secretin) and cytoplasmic ATPase GspE. ATP induced conformational 
changes cause extension of the pseudopilus. This change in the pseudopilus pushes 
proteins from the outer membrane channel (Korotkov et al., 2012, Douzi et al., 2012). 
T2SS substrate is regulated by GspC and is specified through the post synaptic 
drosophila/ zonula occludens-I protein (PDZ) and the homology domain. 
GspC also act as a mediator, which helps to connect the outer membrane complex 
(consisting of GspD and forms a D complex) and the inner membrane complex (Gerard-
Vincent et al., 2002). Zinc containing secretion ATPase GspE, forms a hexamer on the 
inner membrane platform. The mechanism by which, GspE supplies power to T2SS is 
unknown. However, the energy required for the assembly or disassembly of the 
pseudopilus is thought to be derived by the hydrolysis of ATP. GspE interacts with 






Figure 1.17: Type 2 secretion system that helps in secreting LT: T2SS is formed by 
the 3 major defined structures; the ATPase, light green; the periplasmic helical proteins, 
magenta; and the outer membrane complex embedded within the outer membrane, 











(Gray et al., 2011). T2SS cannot function in the absence of ATPase (Possot et al., 
2000).  
The pseudopilus (inside the periplasm) is composed of 5 proteins: GspG, H, I, J and K. 
Since they share sequence identity to the type I pilin, it is termed a pseudopilus. An 
arrowhead is formed by 3 proteins; GspK, I and J. GspK interacts directly with the 
secretin (Forest, 2008). The outer membrane part of T2SS is composed of 12-14 
subunits of GspD which is referred as secretin. The secretin functions as a pore (on the 
outer membrane) to secrete the LT toxin (Strozen et al., 2012).  
1.10 Heat stable ST toxins are small highly structured enterotoxins  
ETEC H10407 encodes two variants of the heat stable toxin; STa/ST1 and STb/ST2. 
These toxins are cysteine rich small peptides of around 18-19 amino acids. The proteins 
are spiral in shape and held in this conformation by 3 disulphide bonds (Tauschek et al., 
2002, Myers et al., 2013). ST toxins are non immunogenic (Fleckenstein et al., 2010) 
and remain active at 95-105ºC even after one hour of boiling (Nair and Takeda, 1998, 
Weiglmeier et al., 2010).  
Initially expressed as a pre-pro peptide of 72 amino acids, the unprocessed ST toxin 
contains a signal sequence for sec-dependent transport. The signal sequence is 
removed in the periplasmic space to generate a pro-peptide. In the periplasm, DsbA, a 
disulphide bond isomerase, catalyses Cys-Cys bond formation in the pro-peptide. DsbA 
also cleaves the 53 amino acid pro-peptide and the mature toxin is then exported via 




Inside the host ST increases the levels of cGMP by binding to the guanylate cyclase C 
receptor (Rao, 1985). This leads to phosphorylation of CFTR protein by CAMP 
dependent kinase (Chao et al., 1994). Hence, increased sodium and chloride ions are 
expelled into the gut lumen. Figure 1.18 shows the structure of the toxic domain of heat 
stable toxins. The toxin resembles human hormones including guanylin, uroguanylin 
and lymphoguanylin (Forte et al., 1999). Figure 1.19 shows an alignment of these 
hormones with bacterial ST toxin derivatives.   
The two variants of ST in ETEC H10407 are encoded by different versions of the estA 
gene. However, nothing is known about regulation of heat stable toxin expression. 
1.11 Colonizaton factors (CFs) 
Gut colonization by ETEC requires colonization factors. These are plasmid encoded 
surface antigens (Fleckenstein et al., 2010, Madhavan and Sakellaris, 2015). Based on 
morphology, the four main types of CF are designated as fimbrial, helical, afimbrial and 
fibrillar. The most commonly found CFs in ETEC are CFA/I, CS1-7, CS14, CS17 and 
CS21, however around 50% of the ETEC strains lack any of these CFs (Isidean et al., 
2011). Table 1.1 lists different ETEC colonization factors andtheir morphology. The 
genes encoding each CF are usually organised as an operon acquired by horizontal 
gene transfer. The operon typically encodes 4 genes; a periplasmic chaperon, a major 
fimbrial subunit, a minor subunit which is located at the fimbrial apex and outer 
membrane usher protein.  
1.12 The Multiple Antibiotic Resistance operon of E. coli  
E. coli strains, including ETEC H10407, encode the multiple antibiotic resistance 






Figure 1.18: The structure of the toxic domain of ST toxin. Shown in ribbon is the 
biological assembly structure of the toxic domain of heat stable enterotoxin. The 
rainbow colour of the ribbon structure shows the different amino acids in the structure 










Figure 1.19: Sequence alignments showing the homology between the 
endogenous peptides and the bacterial toxins. Sequence alignment of human GC-C 
receptor ligands (first two sequences) and putative bacterial GC-C receptor binding 
ligands (last four sequences) using webPRANK. The brackets formed by black solid 
lines show the formation of the disulphide bond between the residues. The abbreviation 
labelled in this figure are as Hs, Homo sapiens; Ec, Escherichia coli; Yk, Yersinia 









Table 1.1: Different classes of CFs: CFs are classified on the basis of morphology, 
where pink denotes fimbrial, yellow denotes fibrillar, blue denotes helical and green 
denotes afimbrial CFs. This table has been generated based on the study by (Anantha 
et al., 2004). 
 






























autorepressor (Alekshun and Levy, 1999). Hence, MarR represses the marRAB operon 
by binding to the operator DNA sequence marO (Martin et al., 1996). Transcription of 
marRAB can occur only when repression by MarR is disrupted. This can result from 
phenolic compounds, antibiotics, oxidative stress or mutation of marR or marO (Cohen 
et al., 1993a). Derepression leads to expression of marA that encodes a global 
transcriptional activator. This leads to activation of genes coding for the AcrAB-TolC 
efflux pumps (Figure 1.20) (Okusu et al., 1996). Thus, increased drug efflux leads to 
better antibiotic tolerance (Figure 1.21). The complete mar regulon (also known as 
mar/sox/rob regulon) is poorly defined. This is partly because the MarA homologs, SoxS 
and Rob, recognise the same DNA sequence as MarA and regulate transcription 
similarly (Martin and Rosner, 2001).  
MarA, SoxS and Rob all belong to the AraC family (Egan, 2002). MarA and SoxS are 
small proteins, of 129 and 107 amino acids respectively, formed of a single domain 
containing 2 HTH motifs connected by a 27 Å rigid helix (Martin et al., 1999, Martin et 
al., 2002). Unlike most AraC family proteins, MarA and SoxS have no ligand sensing 
domain.  Rob is a bigger 289 amino acid protein (Martin and Rosner, 2001) and differs 
from MarA and SoxS by virtue of a C-terminal domain that may be involved in ligand 
binding (Kwon et al., 2000). Structural studies show that MarA binds adjacent sections 
of the DNA major groove as a monomer at a 20 bp consensus sequence referred to as 
the marbox (Figure 1.22A and Figure 1.22B) (Martin et al., 2002, Rhee et al., 1998). 
The marbox is asymmetric and highly degenerate. There are around 10,000 copies of 








Figure 1.20: Cartoon structure to illustrate the activation of marRAB. Cells are 
stressed by the presence of phenolic compounds or antibiotics (grey oval) etc. This 
stress causes the repression activity of MarR (Orange) to be blocked and MarA (Blue) is 
produced, which in turn activates the downstream genes such as zwf, acrAB, tolC etc. 











Figure 1.21: Cartoon representation of several instrinsic resistance mechanisms.  
β-lactam antibiotics targeting a penicillin-binding protein (PBP). Antibiotic A (red 
triangle) enters the cell and, after reaching its target, inhibits the synthesis of 
peptidoglycan. Some antibiotics (green circle) can also enter the cytoplasm but is 
removed by efflux. Antibiotic B and C (purple oval) is not able to reach the target since it 










Figure 1.22: Structure and binding site of MarA: A) MarA (purple) binds the major 
grooves of DNA (black) by its DNA binding domain (generated via Rasmol by using 
PDB 1B10). B) The 20 bp consensus sequence bound by MarA, which is highly 
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H= A,T or C
R= A or G
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Figure 1.23: Cartoon representation of the interaction of MarA with αCTD of 
RNAP. A) The Class I zwf promoter is activated when MarA interacts with αCTD and 
recruits the RNAP to the promoter. On binding, the DNA bends by 35º. B) Zoomed in 







1.13 Objectives of this study 
This work involves determining global gene expressions in ETEC H10407. Haycocks et 
al., 2015 defined the global regulons of CRP and H-NS. They found that genes of major 
toxins in ETEC H10407 were not bound by CRP in vivo. However, previous literature 
showed that the promoter region of toxin genes was bound by CRP in vitro. This was 
also confirmed by Haycocks et al., 2015 in vitro. Interestingly, they found that the toxin 
genes were bound by H-NS both in vivo and in vitro. Additionally, Myers et al., 2013 
showed an increase of FNR binding sites in ∆hns cells. Hence, there is a knowledge 
gap that whether or not H-NS binds CRP site in vivo and play a role in regulating the 
toxin expression. 
Thus, the objectives for Chapter 3 are as follows: 
1) To test that the CRP binding on major toxins estA1, estA2 and eltAB promoters is 
occluded by H-NS; 
2) To test whether estA1, estA2 and eltAB promoters are repressed or activated in 
the presence of H-NS; 
3) To test whether estA1, estA2 and eltAB promoters responds to glucose and salts 
and measure the effect; and 
4) To test whether the regulation of major toxin genes (estA2 and eltAB) is 
conserved in other ETEC isolates. 
Moreover, E. coli strains encode MarRAB that is well implicated in antibiotic resistance. 




antibiotic resistance. There is very little known about the regulon and the genes that are 
regulated by MarA. Hence, we made the following objectives for Chapter 4, 5 and 6: 
1) To determine the binding of MarA across whole genome of ETEC H10407 in vivo 
by ChIP-Seq and confirm the binding sites in vitro by gel shift assays; and 
2) To determine the regulation of some identified targets of MarA; and 
3) To determine the mechanisms additional to AcrAB-TolC efflux pump that 





























2.1 General antibiotics and growth media used 
Sigma-Aldrich Co. Ltd., Fisher Scientific, VWR and Bioline supplied all chemicals. 
Radioactive nucleotides and Phosphor imager screens were supplied by MP 
biochemical, Perkin Elmer and Biorad. To prevent decontamination, solutions were 
sterilised by autoclaving for 15-20 minutes at 121°C as necessary.  
2.1.1 Antibiotics (Stock Solutions) 
 Ampicillin: 100 mg/ml in distilled H2O (dH2O) stored at -20°C 
 Tetracycline: 35 mg/ml in Methanol stored at -20°C 
 Kanamycin: 50 mg/ml in dH2O stored at -20°C 
 Doxycycline: 50 mg/ml in dH2O stored at -20°C 
 Ciprofloxacin: 50 mg/ml in dH2O (acetic acid was added until dissolved) stored 
at -20°C 
Liquid and solid growth media were autoclaved without the antibiotics. The antibiotics 
were added to media 1:1000.  
2.1.2 Bacterial Growth Media 
2.1.2.1 Solid media 
Solid media was used for plating of bacterial cultures and for short-term storage of 
strains. 
2.1.2.1.1 Reagents and chemicals used: 
 MacConkey-lactose agar: 52 g/l from Oxoid 





Solid media was prepared by dissolving the powder in water according to the 
manufacturer’s instructions, followed by autoclaving. After cooling, molten agar was 
mixed with appropriate concentration of antibiotics and the mixture was poured into a 
Petri dish next to a lit Bunsen burner. After pouring, plates were dried at room 
temperature overnight. 
MacConkey-lactose agar was used to monitor cell phenotypes (i.e. Lac+ or Lac-) and 
nutrient agar was used for all other purposes.  
2.1.2.2 Liquid media 
2.1.2.2.1 Reagents and chemicals used: 
 Lennox-Broth media (LB): 20 g/l tryptone, 10 g/l yeast, 10 g/l NaCl 
 M9 minimal media 10 X salts: 60 g Na2HPO4, 30 g KH2PO4,5 g NaCl,10 g 
NH4Cl in 1 L ddH2O. pH maintained to 7.2 using NaOH. 
 M9 minimal media: 10 ml 10 X M9 Salts, 90 ml Sterile ddH2O, 200 µl 1 M 
MgSO4,100 µl 0.1 M CaCl2, 500 μl 20% (w/v) Casamino acids, 1.5 ml 20% (w/v) 
Carbon source.   
LB broth and M9 minimal medium was used for liquid bacterial cultures. For selection 




2.2 Bacterial Strains and Plasmids 
2.2.1 Bacterial strains and growth conditions 
Strains used in this study are listed in Table 2.1. All the strains were stored at -80°C. On 
removal, a small amount of frozen culture was used to inoculate 5-10 ml of liquid 
medium and incubated at 37°C in a shaking incubator overnight. To monitor growth of 
liquid cultures, optical density (OD) at 650 nm was measured in a Jenway 6300 
Spectrophotometer (Thermo Fisher Scientific Inc.). 
2.2.2 Plasmids 
Plasmids used in this study are listed in Table 2.2. Storage of these plasmids was at -
20°C in dH2O. Plasmid maps are shown in Figures 2.1 to 2.3. 
2.3 Plasmid DNA preparation using QIAprep Spin Mini/Maxi prep kit (QIAgen) 
LB (5 ml) supplemented with appropriate antibiotics was used to culture strains carrying 
the desired plasmid DNA. DNA was extracted according to the manufacturer’s 










Table 2.1: Strains used in the study. The genotype and the source for each strain is 
depicted in the table. All strains are K-12 derivatives (until stated). 
Strain  Genotype Source 
E. coli  JCB387 Δnir Δlac (Typas and Hengge, 
2006) 
E. coli  M182 Δlac galK galU strA (Busby et al., 1983) 
M182∆hns Δhns Kan
R This study 
M182∆crp MI182∆crp39 (Busby et al., 1983) 
E. coli  MG1655 F-λ-rph-1 (Blattner et al., 1997) 
E. coli  BW25113 rrnB3 ∆lacZ4787 hsdR514 
∆(araBAD)567 ∆(rhaBAD)568 
rph-1 
(Baba et al., 2006) 
E. coli  BW25113 xseA::kan  Derivative of BW25113  (Baba et al., 2006) 
E. coli  BW25113 yrbE::kan Derivative of BW25113 (Baba et al., 2006) 
E. coli  NCTC 10418 Clinical isolate National Collection of 
Type Cultures 
E. coli  ATCC 25922 Clinical isolate American Type Culture 
Collection 
ETEC H10407 Isolated in Dhaka in 1971, 
Bangladesh, from an adult 
with cholera-like symptoms 
(Sack et al., 1971, 










Table 2.2: Plasmids used in the study. Plasmids with features and source are 
depicted in the table. 
Plasmid Feature Source 
pRW50  A low copy number, 17 kb plasmid with EcoRI and 
HindIII sites used for cloning, promoters upstream 
of the lacZ gene. Encodes TcR and has the RK2 
origin of replication. 
(Lodge et al., 1992) 
pSR A high copy number, 2.6 kb plasmid derived from 
pBR322. Has an EcoRI and HindIII site just 
upstream of the λoop transcription terminator. 
Encodes for AmpR and has CoIE1 origin for 
replication. 
(Kolb et al., 1995) 
pBR322 A medium copy number, 4.4 kb plasmid. It has a 
bla gene that encodes for AmpR and has 
pMB1origin of replication. 
(Balbas et al., 1986) 
pRGM9818 marA over expression plasmid, pUC19 derivative 
encoding marA under the control of the tac 
promoter. 













Figure 2.1:  pRW50 plasmid map. pRW50 was used as a reporter plasmid in LacZ 
assays. The brown bar represents the site where promoter DNA was cloned using the 
EcoR1 and HindIII sites. The lacZ gene is shown in red, and the black bar denotes the 














Figure 2.2:  pSR plasmid map. pSR was used as a reporter plasmid in in vitro 
transcription assays. The brown bar represents the site where promoter DNA was 
cloned using the EcoR1 and HindIII sites upstream of the λoop transcription terminator. 
Green denotes the RNAI that serves as an internal control and the black bar denotes 














                                         
 
Figure 2.3:  pBR322 plasmid map. pBR322 was used to express the target gene in 
genetic complementation assay. The brown bar represents the site where the promoter 















2.4 Phenol/Chloroform extraction of DNA 
Phenol/Chloroform extraction was used to purify plasmids and DNA fragments following 
enzymatic modification. 
2.4.1 Reagents and chemicals used: 
 Phenol/Chloroform/Isoamyl alcohol: pH 6.7/8.0 
 TE buffer: 10 mM Tris (pH 8.0), 0.5 mM EDTA 
2.4.2 Method 
An equal amount of phenol/chloroform was added to aqueous DNA solutions and mixed 
for 10 seconds with a vortex mixer. The samples were then centrifuged for 2 minutes at 
maximum speed in a bench top microfuge. The upper aqueous layer containing DNA 
was carefully transferred to a sterile tube ensuring no proteins, at the interface between 
the aqueous and organic layer, were disrupted. DNA in the aqueous layer was further 
concentrated by precipitation with ethanol before resuspension in a smaller volume.  
2.5 Ethanol precipitation 
2.5.1 Reagents and chemicals used: 
 Ethanol: 100% (v/v) stored at -20°C 
 Ethanol: 70% (v/v) diluted in dH2O stored at -20°C 
 Sodium acetate: 3 M pH 5.2 
2.5.2 Method: 
Two volumes of ice cold ethanol, and 0.1 volumes of 3 M sodium acetate (pH 5.2) were 
added to the DNA solution and incubated at -20°C overnight or at -80°C (20 minutes). 




benchtop microfuge for 15 minutes to collect the precipitated DNA. The pellet was 
washed using 1 ml of ice cold 70% ethanol. The pellet was then recovered by 
centrifugation at 4°C, as described above, and the supernatant was again discarded. 
The DNA pellet was dried, at low or medium heat in vacuum manifold and dissolved in 
the required volume of dH2O.  
2.6 Gel electrophoresis 
2.6.1 Reagents and chemicals used: 
 Gel loading dye: 0.025% (v/v) bromophenol blue; 20% (v/v) glycerol; 0.025% 
(v/v) xylene cyanol; 1 mM EDTA; 10 mM Tris, pH 7.5 
 Ethidium bromide: 10 mg/ml  
 DNA ladder: 100 bp DNA ladder purchased from NEB and diluted 6-fold in DNA 
loading dye. 
2.6.2 Agarose gel electrophoresis 
2.6.2.1 Reagents and chemicals used: 
 5 X TBE Buffer: 0.445 M Tris-borate pH 8.3, 10 mM Na2EDTA (Fisher Scientific) 
 1 X TBE Buffer: Diluted from 5 X TBE Buffer in dH2O 
 Agarose solutions: 1% diluted in 1 X TBE Buffer. This was then heated for a 
further two minutes on a medium power in a microwave. Furthermore, this was 







Samples were mixed in a 1:1 ratio with gel loading dye and loaded onto 1% (w/v) 
agarose gel containing ethidium bromide. Electrophoresis was done at 120 V for 30 
minutes in 1 X TBE buffer. Once the gel running was completed, DNA was visualised 
with a UV-transilluminator. 
2.6.3 Polyacrylamide gel electrophoresis 
2.6.3.1 Reagents and chemicals used: 
 Acrylamide: 30% ((w/v)) (Geneflow) 
 N,N,N′,N′-Tetramethylethylenediamine (TEMED) : Sigma Aldrich 
 Ammonium persulphate (APS) : Sigma Aldrich 
Briefly, 10 ml of 30% acrylamide protogel was mixed with 6 ml of 5X TBE and 44 ml of 
ddH2O. 0.05 g of APS and 50 µl of TEMED was then added to the above mixture. The 
Polyacrylamide gel was then run at 150 V with 0.5 X TBE. 
2.6.3.2 Method: 
DNA-samples were mixed in a 1:1 ratio with gel loading dye. Gels were run at 150 V in 
0.5 X TBE. After running the gel was dried and exposed on to the phosphor screen until 
the next day when it was scanned. 
2.7 DNA manipulations 





Table 2.3: Oligonucleotides used in this study. The name of the gene or DNA 
fragment to be amplified is shown on the left and the oligonucleotide sequence (with 
restriction sites highlighted in bold) in the middle panel of the table.  
Oligonucleotides (5' to 3') for amplification of estA1 promoter fragments 
estA1 up  GGCTGCGAATTCATGAAAATAATATATAAAAAGCGAGTG    This work 
estA1down         GCCCGAAGCTTTTAATAACATCCAGCACAGGCAGGATTAC    This work 
PestA1up GGCTGCGAATTCTAACATGATGCAACTCACAAAAAAAATA 
            AAAAAATTGCAAAATCCGTTTAACTAATCT     This work 
PestA1down GCCCGAAGCTTCATGTTACCTCCCGTCATGTTGTTTCACG 
            GATATTTGAGATTAGTTAAACGGATTTTG      This work 
 
Oligonucleotides (5' to 3') for amplification of estA2 promoter fragments 
estA2 up  GGCTGCGAATTCCCGGGGCGGTTCATTGTTATTTTTTTTGTG  This work 
estA2 down GCCCGAAGCTTTTAATAGCACCCGGTACAAGCAGGATTACAAC   This work 
PestA2 up GGCTGCGAATTCTAGTATGATACACATCACAAAAAAATAAAAA 
            AGTTTGCGCAATCGTTCTGATTTTGAT     This work 
PestA2 down GCCCGAAGCTTCATATTACCTCCGAAACACGTCGTCCACGAAT 
            ATTTAAATCAAAATCAGAACGATTGC                         This work 
 
Oligonucleotides (5' to 3') for amplification of eltAB promoter fragments 
PeltAB up GGCTGCGAATTCTTCTGGTGTGGACTTTCTGGTGCTCCAGGTTGTG   This work 
PeltAB down    GCCCGAAGCTTTTCATTCCGAATCCTGTTATATATGTCAAC    This work 
PeltAB down GCCCGAAGCTTACAATCCGGAAAAAGATAACGCCAC    This work 
 
 
Oligonucleotides (5' to 3') for amplification of CRP site mutator fragment of estA2 460bp up 
PestA2 CRP  GCAAACTTTTTTATTTTTTAGAGTTGTGTAACTTTCTATAC                 This work 
mutator up 
 
Oligonucleotides (5' to 3') for amplification of different DNA targets in ChIP-PCR experiment 
PestA2 up GTTCTCGCAAGGACGAGAATTTC       This work 
PestA2 down GCCCGAAGCTTCATATTACCTCCGAAACACGTCGTCCACGAA 
            TATTTAAATCAAAATCAGAACGATTGC      This work 
PeltAB up GTTCTCGCAAGGACGAGAATTTC       This work 
PeltAB down    GCCCGAAGCTTACAATCCGGAAAAAGATAACGCCAC   This work 
yabN up  GGTGCGGCTGTCGAACAGTAAATAG      This work 






Oligonucleotides (5' to 3') for amplification of MarA targets for EMSA analysis 
 
thrL up  GGCTGCGAATTCGCTTTTCATTCTGACTGCAATG    This work 
thrL down CGCCCGAAGCTTCATGGATGTTGTGTACTCTG     This work 
leuO/L up GGCTGCGAATTCGAAAAGCGTCGGTAGTTAAGCAG     This work 
leuO/L down CGCCCGAAGCTTCATTAAATCAGCTCCAGATG     This work 
degP up  GGCTGCGAATTCCTATAAAACGAATCTGAAGAACAC    This work 
degP down   GCCCGAAGCTTCAGAGAGCGGAGATAACGCCAAAC     This work 
lacZ up  GGCTGCGAATTCGGAAAGCGGGCAGTGAGCG     This work 
lacZ down CGCCCGAAGCTTCATAGCTGTTTCCTGTGTGAAATTG    This work 
ybaO up  GGCTGCGAATTCTAACGAGATCCCTTCCAGCACCG     This work 
ybaO down CGCCCGAAGCTTCATAGCCCTTCCACAGAGAATTTTTTTCTC   This work 
pheP up  GGCTGCGAATTCGGCGTATAAGCTGATGTGGCTG     This work 
pheP down CGCCCGAAGCTTCACGCCTTTCCCCTGTGTGTCTTTTTTGTTGAG   This work 
modE<>acrZ up  GGCTGCGAATTCGTCTTATTGTGACGGAAAACGAACG    This work 
modE<>acrZ down GCCCGAAGCTTAATAACTCTAACATGGTCAACTCC    This work 
ybiV up  GGCTGCGAATTCCGTCGTTAAGAAAAGTACCGTCCAT    This work 
ybiV down  GCCCGAAGCTTAATAACTCTAACATGGTCAACTCC     This work 
ybjC/grxA up GGCTGCGAATTCGCGCGCATACGCTTCCCTCTG     This work 
ybjC/grxA down CGCCCGAAGCTTCATTATTTCTCTCCTCATAG     This work 
ycgZ/bluF up GGCTGCGAATTCTTGAACACTAGTTGGCGAAAAATCTTG    This work 
ycgZ/bluF down CGCCCGAAGCTTCATGCTACGCCTCTGTTAAAAATG    This work 
fnr up  GGCTGCGAATTCAGGTTATCTTTTGCTGTAAACATTAAACAATTTGTG  This work 
fnr down CGCCCGAAGCTTCATAGGTCTGCTCAAGCCGTAATTG    This work 
yneO up  GGCTGCGAATTCGAAAACTGTTTCTTTCAATAGGA     This work 
yneO down  GCCCGAAGCTTGCATTAAGCACAACCCTTATTTTATA    This work 
marR up  GGCTGCGAATTCTTCCGCTTCGGGGTGAAATAGTAG    This work 
marR down CGCCCGAAGCTTCATTAGTTGCCCTGGCAAGTAATTAG   This work 
yeeF up   GGCTGCGAATTCCATAATAATTTTTCTTTAAATGGC    This work 
yeeF down  GCCCGAAGCTTGGACTTGCCAGTGGCTGGTGGCGG     This work 
ompC<>micF up  GGCTGCGAATTCGGTTAAAATCAATAACTTATTCT     This work 
ompC<>micF down GCCCGAAGCTTATTCAGAAATGAATGACGGTAATA    This work 
ypeC up  GGCTGCGAATTCATCGTCCGAAGCAACAGCCCC     This work 
ypeC down CGCCCGAAGCTTCATTGTTATTCTCCTTCACGATCG    This work 
yfeS><cysM up  GGCTGCGAATTCCGGCGTTTCCTCACGAAAATTAA     This work 
yfeS><cysM down GCCCGAAGCTTTGCAATATATTGAATTAGCACGAT    This work 
nudF<>tolC up  GGCTGCGAATTCGACTGCCGTTTGAGCAGTCATGTG    This work 
nudF<>tolC down GCCCGAAGCTTTTCTAGCAGAAGCCGCTACCGCAA    This work 
yhbV up  GGCTGCGAATTCCTGGCTGGAGATGGCAAAATCGCT    This work 
yhbV down  GCCCGAAGCTTTCAATCAGAAACTCACCGTTCTC     This work 
yidQ/ibpA up GGCTGCGAATTCCCCTCAGTCTATGCAATAGACCATAAACTG   This work 
yidQ/ibpA down CGCCCGAAGCTTCATAATCAATAGCTCCTGAAATCAG    This work 
mnmG up GGCTGCGAATTCGTGGATTAATTTACTCAAATAAG     This work 
mnmG down CGCCCGAAGCTTCATGGTGATTGCCTCGCATAACG     This work 
yihT up   GGCTGCGAATTCGATATGGTCATTCAGACGTTGTGA    This work 
yihT down  GCCCGAAGCTTAAATTCGATCGCGAACAAGCGATC     This work 
yiiG up  GGCTGCGAATTCGGATGTCTATATCAAGTGCTACAA    This work 
yiiG down  GCCCGAAGCTTCACTCAGCGAGGTTGGATTCACT     This work 
ETEC_4304 up  GGCTGCGAATTCGTAAGCCTATAGACCTGAAAGAA     This work 
ETEC_4304 down GCCCGAAGCTTGTTCCTTTCCTGTATGGCTGATA     This work 
ETEC_4307 up  GGCTGCGAATTCATGGTGGGAATATATACCATAGC     This work 




yjcB<>yjcC up GGCTGCGAATTCGGCTTGCAGAACACAAAAATGAA     This work 
yjcB<>yjcC down GCCCGAAGCTTTTAATGCCACTGAAAAACCACAT     This work 
yjjQ/P up GGCTGCGAATTCGTAGATATTTTAAATGTCTCCAGG    This work 
yjjQ/P down CGCCCGAAGCTTCATATTTCCTCCACATCCACTG     This work 
ETEC_4702 up GGCTGCGAATTCGACAGATGATAATTATTTCATGA     This work 
ETEC_4702 down GCCCGAAGCTTGACCGCTAATGCTGTTGTCAGCC     This work 
deoB up  GGCTGCGAATTCCGAAAGACGAAAACAGCTGGCA     This work 
deoB down  GCCCGAAGCTTCAGTATACCGTTATTCACTGATA     This work 
ETEC_P948_0770up GGCTGCGAATTCGCAGATTCGAGATTAATTTTGGGTC    This work 
ETEC_P948_0770down  GCCCGAAGCTTTAAAGGATTAGGCAAAAATAGCG    This work 
ETEC_3200 up GGCTGCGAATTCGCCGCCAGACAACAACCCATACTTT   This work 
ETEC_3200 down CGCCCGAAGCTTTGACTATCTCGCGAAAGAGTACACCA   This work 
 
 
Oligonucleotides (5' to 3') for amplification of xseA and regulatory region derivatives 
PxseA1 up GGCTGCGAATTCGTAACCGATTGCATCTACCCCTTTTTGC    This work 
PxseA2 -36C up GGCTGCGAATTCAAATCCTTGCTATCCCCGAAGGGCGG    This work 
PxseA down GCCCGAAGCTTCATGTGAGCGAGATCAAATTCTAAATCAG    This work 
PxseA & xseA –marbox GGCTGCGAATTCCTTGCTATCCCCGAAGGGCGGGTTACTATCG   This work 
xseA down GCCCGAAGCTTTTAATGCACCTTTTTACGCGATTTTTTTACTG   This work 
F63A up GTACGCTGCGCGATGGCCCGCAACAGCAACCG     This work 
F63A down CGGTTGCTGTTGCGGGCCATCGCGCAGCGTAC     This work 
R205A down CGAACCGCCGCCGGCCCCGACGATCAAT      This work 
Q267STOP up CCGCTGAAGTAGTGAGCCGTAATTAGCAAGAGTTAC    This work 
Q267STOP down GTAACTCTTGCTAATTACGGCTCACTACTTCAGCGG    This work 
P353STOP up CGGTTAACACAGCGGCTGAATCAGCAAAATTAGCAGCCGAAGATTCATC  This work 




Oligonucleotides (5' to 3') for amplification of mlaFEDCB and regulatory region derivatives 
PmlaF1 up GGCTGCGAATTCTTTATGCGGCTAAAAAGTAAAAC     This work 
PmlaF2 up GGCTGCGAATTCCACGGCGGGTAATATTCTG     This work 
PmlaE down  GCCCGAAGCTTCATAATTCACCCTTCGTCTTGCG     This work 




Oligonucleotides (5' to 3') for sequencing of plasmid constructs 
pRW50 up GTTCTCGCAAGGACGAGAATTTC       This work 
pRW50 down  AATCTTCACGCTTGAGATAC       This work 
pBR322 up GGCTGCGTGCCACCTGACGTCTAAGAAACC     This work 
pBR322 down GCCCGCAGCATCCAGGGTGACGGTGCCGAG     This work 
pSR up  CCATATATCAGGGTTATTGTCTC       This work 









2.7.1 Polymerase Chain Reaction (PCR) 
Velocity DNA polymerase and buffer, provided by Bioline, was used with 50-200 ng of 
template. All oligonucleotides were generated by Thermo Fisher Scientific. In a reaction 
100 pM of oligonucleotide, was used from the stock of 100 µM making overall 
concentration of 2 µM. Deoxynucleotide triphosphates (dNTPs) were from Bioline; 
where 2 mM (0.5 mM each) were used in a PCR mixture volume of 50 µl. The typical 
PCR cycle used in the study is shown in Table 2.4. 
2.7.2 Megaprimer PCR 
Megaprimer PCR is a technique that is used to introduce point mutations in large DNA 
fragments without useful restriction endonuclease sites near to the base pair being 
mutated. This PCR involves two reactions, wherein the first reaction generates a long 
‘megaprimer’ with a point mutation. In the second reaction this ‘megaprimer’ is used 
with a second flanking primer to generate a larger DNA fragment, with the point 
mutation inserted, suitable for cloning.  
2.7.3 Colony PCR  
To amplify chromosomal DNA, colony PCR was used. A colony was smeared on the 
inside of the PCR tube before addition of Phusion DNA polymerase, buffer (NEB), 
oligonucleotides and dNTPs. To lyse the cells, the starting denaturation time was 
extended to 10 minutes.  
2.8 DNA purification using QIAquick PCR Purification kit (QIAgen)  
After PCR or restriction digestion the DNA was purified using a QIAquick PCR 




Table 2.4: Typical thermocycler settings used in the study. PCR cycle used for 
amplifying different fragments for the purpose of ligation, inserting mutations using 
megaprimer PCR and also for colony PCR 
Step Temperature Duration 
Initialization 95°C 1 min 
Denaturation 95°C 30 s 
Annealing (Ta) X 30 s 
Extension 72°C 30 s 
Final elongation 72°C 5 min 
Final hold 4°C Infinite 
 
Note - The annealing temperature (Ta) varied with the different melting temperature (Tm) 
of different fragments. For this the temperature used was Ta= Tm – 5°C and is 












This kit can extract up to 1 µg DNA. The kit purifies by the principle of adsorption of the 
product onto a silica membrane column, washing by high salt and purified DNA was 
eluted in 30 µl DNase/RNase free water. The purification is performed to remove the 
unused primers, enzymes and the buffer from the PCR product. 
2.9 DNA restriction digest 
Restriction enzymes and buffers were used according to the manufacturer’s 
instructions. 1 µg DNA was used with the enzymes and buffers in a final volume of 50 µl 
with dH2O. This was followed by incubation for 3 hours at 37°C. During the preparation 
of vectors for cloning purposes, the digested plasmid DNA was treated with calf alkaline 
phosphatase (NEB) to remove terminal 5' phosphate groups. The reaction was then 
followed by incubation for a further 30-60 minutes at 37°C. Subsequent DNA-purification 
was done by phenol-chloroform extraction (for pRW50), and QIAgen gel extraction or 
PCR purification kits were used for smaller vectors and insert DNA fragments.  
2.10 DNA Ligation 
For ligation, 1 µl T4 DNA ligase (New England Biolabs) was used with 100 ng of 
restriction digested insert DNA and 100 ng of restriction digested, and phosphatase 
treated, vector DNA. The final volume was 20 µl with dH2O and T4 DNA ligase buffer 
added as required (New England Biolabs). Ligation mixes were incubated for 2 hours at 
room temperature and used to transform chemically competent cells as outlined in the 
next section. Nutrient agar or MacConkey-lactose plates, supplemented with suitable 
antibiotics, were used to select transformants. Candidate transformants were cultured 
overnight. Plasmid was then extracted, and digestion with restriction enzymes was used 




2.11 DNA transformation of bacterial cells 
2.11.1 Preparation of CaCl2 competent cells 
2.11.1.1 Reagents and chemicals used: 
 Calcium Chloride (CaCl2): 0.1M 
 Glycerol: 50% (v/v) 
2.11.1.2 Method: 
5 ml of LB was inoculated with the desired strain, incubated at 37°C overnight, and 1 ml 
used to inoculate 50 ml of LB broth the next day.  This sub-culture was incubated at 
37°C with shaking until the culture reached to an OD650 of 0.3-0.5. The culture was then 
poured into a sterile centrifuge tube and left on ice for 10 minutes. Harvesting of cells 
was done at 4°C for 20 minutes at 2400 x g. The cells were re-suspended in 25 ml ice-
cold 0.1 M CaCl2 and left on ice for 30 minutes. Cells were harvested again by 
centrifugation at 2400 x g for 10 minutes at 4°C and resuspended in 3.3 ml ice-cold 0.1 
M CaCl2 before being stored overnight at 4°C. Glycerol of 15% (v/v) was added to allow 
storage of the cells at -70°C as aliquots. 
2.11.2 Transformation of chemically competent cells with plasmid DNA 
50 ng of plasmid DNA was added to 100 µl of competent cells followed by incubation on 
ice for 1 hour. The cells were heat shocked for 2 minutes at 42°C followed by 3 minutes 
on ice. 1 ml LB was then added to the cells and they were incubated at 37°C in a 
shaking incubator for 60 minutes. Harvesting cells was done by centrifugation for 3 
minute at 2800 x g. The pellet was re-suspended in 100 µl LB before plating on solid 




2.12 DNA Sequencing 
The Functional Genomics and Proteomics Laboratory (University of Birmingham) facility 
was used to perform “plasmid-to-profile” sequencing whereby 300ng plasmid miniprep 
was mixed with a 10 µM sequencing primer. The Table 2.3 outlines primers used in this 
study for the purpose of sequencing inserts in plasmids. 
2.13 β-galactosidase assays 
2.13.1 Reagents and chemicals used: 
 Z-buffer: 0.75 g KCl, 0.25 g MgSO4.7H2O, 8.53 g Na2HPO4, 4.87 g 
NaH2PO4.2H20, 2.70 ml β-mercaptoethanol  
 Toluene 100% (v/v) 
 Sodium deoxycholate: 1% (w/v) 
 ONPG in Z-buffer: 13 mM (made on day of use). 
 Sodium carbonate: 1 M  
 Z-buffer:  0.75 g KCl, 0.25 g MgSO4.7H2O, 8.53 g Na2HPO4, 4.87 g 
NaH2PO4.2H20, 2.7 ml β-mercaptoethanol  
2.13.2 Method: 
β-galactosidase assay is used to monitor lacZ expression from the reporter plasmid 
pRW50 for observing promoter activity. The unit of the activity is the Miller Unit (Miller, 
1972).  
A fresh colony of each strain was used to inoculate 5 ml culture with the suitable 
antibiotic. Cultures were incubated at 37°C overnight in a shaking incubator. The next 
day, 50 µl was sub-cultured in 5 ml of the same medium for each strain/condition. These 




reached. The OD650 was recorded and two drops each of toluene and sodium 
deoxycholate were added to each culture, vortexing for 15 seconds, to lyse cells. To 
ensure the toluene evaporated efficiently, cultures were put back at 37°C with lids open 
for 20 to 30 minutes.  
To assay for β-galactosidase activity, 2.5 ml of 13 mM 2-Nitrophenyl β-D-
galactopyranoside (ONPG) solution was added to 100 µl of each lysate. The resulting 
solution was incubated until it turned yellow. To halt the experiment 1 ml of 1 M sodium 
carbonate was added and the OD420 of the solution was measured. 
The following formula was used to calculate β-galactosidase activity: 
β-galactosidase activity =   
1000 x 2.5 x 3.5 x OD420
OD650 x 4.5 x t x v 
 nmol / min / mg bacterial mass                                                                        
Wherein: 
2.5 =  factor for conversion of OD650 into bacterial mass, based on OD650 of 1 being   
equivalent to 0.4 mg/ml bacteria (dry weight).  
3.5 =  final assay volume (ml) 
1000/4.5 = factor for conversion of OD420 into nmol o-nitrophenyl (ONPG), based on 
           1 nmol/ml ONP having an OD420 of 0.0045               
t =  incubation time (min) 
v =  volume of lysate added (in ml)    
In each experiment, each strain was assayed in triplicate and, once the mean β-
galactosidase activity and standard deviation were calculated, data were depicted as 




performed. The background beta-galactosidase activity from empty pRW50, was 
subtracted from the values shown. The standard deviation was always <10% of the 
mean. 
2.14 Radiolabelling of DNA fragments 
Radio-labelling of DNA fragments allowed DNA detection in electrophoretic mobility shift 
assays (EMSA) and DNAseI footprint assays.  
2.14.1 Reagents and chemicals used: 
 T4 polynucleotide kinase 
 T4 polynucleotide kinase buffer: 10 x 
 Tris-EDTA (TE) buffer: 10 mM Tris-HCl, 1 mM EDTA (pH 8.0) 
 Sephadex G-50: 12% (v/v) Sephadex G-50 in TE buffer.  
2.14.2 Method: 
The reaction mixture contained 16 µl of DNA fragment (100-400 nM), 1 µl T4 
polynucleotide kinase, 2 µl 10 X kinase buffer and 1 µl [γ-32P]-ATP (10 µCi/µl). These 
were incubated at 37°C for 30 minutes. Unincorporated [γ -32P]-ATP was removed with 
a 200 µl volume of Sephadex G-50 spin column. The flow through contained labelled 
DNA fragments and was collected, followed by storage at -20°C.  
2.15 Maxam-Gilbert sequencing reactions 
2.15.1 Reagents and chemicals used: 




 DNAse I blue: 20 mM urea, 1 mM EDTA, 20 mM NaOH, 0.025% (v/v) of each 
bromophenol blue and xylene cyanol. 
 Sodium acetate: 3 M, pH 7.0 
 Piperidine: 10 M diluted in water before use  
 Ethanol: 100% (v/v) 
2.15.2 Method: 
Precipitation of DNA followed by using 20 µl sodium acetate and 700 µl 100% ethanol. 
The DNA pellet was dried and resuspended in 10 M piperidine with incubation for 30 
minutes at 90°C. Precipitation of DNA was done again followed by washing, twice with 
70% ethanol. The dried pellet was resuspended in 20 µl of loading buffer.  
2.16 DNA sequencing gel electrophoresis  
2.16.1 Reagents and chemicals used: 
 6% Denaturing gel was made using UreaGel (Geneflow) concentrate, diluents 
and buffer 
 N,N,N′,N′-Tetramethylethylenediamine (TEMED)  
 10% ((w/v)) ammonium persulphate (APS) solution (diluted in dH2O) 
2.16.2 Method: 
The gel mixture was poured with the aim of obtaining a 0.4 mm thick and 40 cm x 30 cm 
gel. Prior to sample loading, the gels were warmed by electrophoresis at 60 W for 30 
minutes. Once run, the gel was soaked in fixing solution for 15 minutes and transferred 




and then exposed to a Biorad screen in a light-proof autoradiography cassette 
overnight. 
2.17 DNAse I footprinting 
2.17.1 Reagents and chemicals used: 
 Binding buffer: 20 mM Tris pH 7, 10 mM MgCl2, 100 mM EDTA and 120 mM 
KCl. 12.5 mg/ml Herring sperm DNA 
 DNAse I stop solution: 1 ml 3 M NaAc pH 7.0 + 200 µl 500 mM EDTA, made up 
to 10 ml with dH2O 
 Phenol/Chloroform/Isoamyl alcohol: pH 6.7/8.0 
 Ethanol: 100% (v/v) and 70% (v/v) 
 Gel loading buffer:  40% (v/v) deionised formamide, 5 M urea, 5 mM NaOH, 1 
mM EDTA, 0.025% (w/v) bromophenol blue, 0.025% (w/v) xylene cyanol FF 
2.17.2 Method: 
DNA fragments were prepared from maxi preparations of plasmid pSR, carrying the 
fragment to be examined.  After the maxiprep the plasmid was subjected to restriction 
digestion; first digested with HindIII and then treated with alkaline phosphatase. The 
product was purified using the phenol/chloroform method and a second digestion was 
done using the AatII enzyme. The desired DNA fragments were purified by gel 
extraction. The DNA were labelled at the HindIII end using [γ-32P]-ATP and T4 
polynucleotide kinase as described above (10-40 nM). Footprinting reactions contained 
labelled DNA in binding buffer, 12.5 µg/ml Herring sperm DNA, and purified MarA. After 




previously determined by calibration) and left for 40 seconds. The reaction was stopped 
with 200 µl of DNase I stop solution. Next, 200 µl of phenol/chloroform was added, and 
the sample was vortexed and centrifuged. The aqueous layer was then transferred to a 
fresh tube and 1 µl of 20 mg/ml glycogen, along with 400 µl ice-cold ethanol, was 
added. This mixture was left at -80°C for 20 minutes. The samples were then 
centrifuged at 10,000 x g for 15 minutes at 4°C. The DNA pellet was washed with 600 µl 
ice-cold 70% ethanol and re-centrifuged at 10,000 x g for 10 minutes at 4°C. The pellet 
was dried and re-suspended in 8 µl DNAse loading buffer. Before loading, all the 
samples were heated at 90°C for 2 minutes.  
2.18 In vitro transcription assays 
2.18.1 Reagents and chemicals used: 
 In vitro transcription buffer: 20 mM Tris pH 7.9, 5 mM MgCl2, 500 µM DTT, 50 
mM KCl, 100 µg/ml BSA, 200 µM ATP, 200 µM GTP, 200 µM CTP, 10 µM UTP 
with 5 µCi [α-32P]-UTP. 
 Stop solution: 40% (v/v) deionised formamide, 1 mM EDTA, 0.025% (w/v) 
bromophenol blue, 0.025% (w/v) xylene cyanol. 
2.18.2 Method: 
The in vitro transcription experiments were done as described previously by Kolb et al. 
(1995). A Qiagen maxiprep kit was used to purify supercoiled pSR plasmid carrying the 
regulatory region to be analysed. This template (16 µg/ml) was incubated with in vitro 




holoenzyme. Labelled RNA products were analysed on a denaturing polyacrylamide 
gel. 
2.19 Microscopy  
2.19.1 Reagents and chemicals used: 
 PBS Buffer: 140 mM NaCl, 2 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, to 1 L 
in sterile ddH2O. All components were autoclaved before use.  
 Poly-L-lysine: 10 mg/ml (Sigma)  
 Hoechst 33258: 5 µg/ml Hoechst 33258 in PBS containing 40% (v/v) glycerol. 
2.19.2 Preparation of microscope slides   
Once the desired OD650 (0.6 - 0.7) was reached, cells were harvested by centrifugation 
at 2400 x g for 10 minutes from 1.5 ml of culture. The cells were then washed at least 3 
times with PBS. Microscope slides were prepared by drying 5 μl poly-L-lysine onto the 
centre of a slide. The cells were again centrifuged at 2800 x g whereby all supernatant 
was removed and the pellet was resuspended in 10 μl Hoechst 33258. Lastly, cells 
were incubated at room temperature for 5 minutes before 5 μl was pipetted onto the 
centre of the slide and a cover slip was then applied.   
2.19.3 Imaging and analysis  
Slides were imaged using a Nikon Eclipse 90i microscope, Nikon Intensilight C-HGFI 
lamp, Hamamatsu ORCA ER camera (1344x1024 pixels, pixel size 6.45 μm) and Nikon 
Plan Apo VC 100X Oil immersion lens (Numerical Aperture 1.4), with a final optical 
magnification of 100X. A DAPI filter set with excitation filter of 340-380 nm, exposure 




microscopy for visualising the Hoechst 33258 stained nucleoid. Microscopy was carried 
out at room temperature, within 30 minutes of slides being prepared.  
2.20 Growth assays 
An independent colony of each bacterial strain was used to inoculate 5 ml of LB broth 
and incubated overnight at 37°C. The next day OD650 was recorded. The inoculum OD 
was then adjusted to 0.05 in LB broth by using the formula OD1 X V1 = OD2 X V2 
(where OD1 is the OD650 value measured for the overnight culture, V1 is the volume of 
this culture to be used for adding it to the inoculum, OD2 was constant as 0.05 and V2 
is the volume of LB broth in which we are inoculating (5 ml)).  V1 was calculated and the 
required volume was added to 5ml of LB broth (with or without antibiotics) in triplicate. 
Hence, the OD650 of 0.05 and the net volume remains constant. The sub-cultures were 
then incubated in a shaking incubator at 37°C and, at 40 minute intervals, 200 µl was 
transferred to a 96 well plate to measure OD650.  
2.21 Minimum inhibitory concentration (MIC) determination  
2.21.1 Materials, reagents and chemicals used: 
 Sterile micro-titre tray and lid.  
 Multi-channel pipette.  
 Multi-stepper pipette.  
 Gilson pipettes  
 Sterile distilled water (8X 5 ml)  
 Sterile broth (2X 10ml, 8X 5 ml).  




 5 ml overnight broth of strains.  
 2X Round sterile Petri-dish.  
 Antibiotics solution of appropriate concentration. 
2.21.2 Method 
MIC broth microtitre double dilution method (Johnson et al., 1999) was used to assess 
antibiotic sensitivity. These assays were done in a final volume of 100 µl of LB medium 
in a 96 well round bottomed microtitre plate. Each well contained 10 colony forming 
units of E. coli, 100 µl of LB medium and antibiotics as required. The microtitre plate 
was covered with a sterile lid and kept in a gently shaking incubator for 24 hours at 
37°C. The minimum inhibitory concentration was the lowest antibiotic concentration that 
prevented bacterial growth. Results were only accepted if the observed MIC for the 
control NCTC E. coli 10418 and ATCC E. coli 25922 strains was within 1 doubling 
dilution of the expected result. 
2.22 Accumulation Assay:  
2.22.1 Materials, reagents and chemicals used: 
 Isosensitest broth 10 ml and 250 ml volumes Sterile  
 50 mM Potassium phosphate buffer pH 7.0 (filter sterile)  
 0.1M glycine HCl pH 3 (autoclave)  
 Sterile Universals  
 1.5 ml Eppendorfs - labelled with organism, antibiotic and time of sample - in 
triplicate  




 Sterile universal containing magnetic flea  
 Ice refrigerated microcentrifuge  
 500 ml centrifuge buckets  
 Doxycycline 
2.22.2 Method 
From an overnight culture, a 4% (v/v) inoculum was prepared in 250 ml LB. This was 
incubated at 37°C with shaking until OD650 value reached 0.7-0.8. Cells were harvested 
by centrifugation at 3000 x g for 20 min at 4°C and resuspended in 10 ml ice cold 50 
mM phosphate buffer.  This was followed by another centrifugation step at 3000 x g for 
20 min at 4°C. The cell pellet was resuspended in 10 ml of phosphate buffer. The 
suspension was transferred to a sterile universal tube containing a magnetic flea and 
placed in a water-bath at 37°C (unless otherwise stated) on a magnetic stirrer to 
equilibrate for about 10 minutes. 1 ml of sterile phosphate buffer (ice-cold) was 
transferred into 1 set of Eppendorf tubes embedded in ice. Next, at time = 0 sec, a 500 
µl sample was transferred to a new Eppendorf tube. 35 µg/ml doxycycline was mixed 
with the sample still in the water bath. In addition, at timed intervals, duplicate 500µl 
samples were transferred to Eppendorf tubes. Timed intervals were normally 10, 20, 30, 
40, 50, 60, 120, 180, 240, 300 seconds. Once the samples were placed on ice, the 
Eppendorf tubes were centrifuged at maximum speed at 4 C for 5 minutes after which 
they were put back on ice. The supernatant was discarded and cell pellet was 
resuspended in 1 ml of sterile phosphate buffer. This ensures the cells are washed and 
the surface bound doxycycline was removed. The samples were again centrifuged and 




temperature. The centrifugation was again done for 5 minutes at maximum speed, after 
which the supernatant was transferred to freshly labelled Eppendorf tubes. These tubes 
were centrifuged for a further 5 minutes at maximum speed at 4 C. The samples were 
diluted 1:10 before measuring fluorescence. A fluorescence spectrophotometer was 
used to measure the fluorescence from the samples at the correct excitation and 
emission wavelength for the doxycycline which were 425 nm and 520 nm respectively.  
2.23 Efflux Assay 
For the efflux assay, cells were grown as for accumulation assays. After washing the 
cells in PBS, the cell suspension had 0.3 OD650 units. 5 µg/ml of ethidium bromide and 
50 µg/ml of chlorpromazine (CPZ) were added and the suspension was incubated at 
25°C for 1 hour. When the cells were loaded with ethidium bromide, they were washed 
with PBS to remove the excess ethidium bromide and finally suspended in PBS that 
contains 0.4% (v/v) glucose. 
2.24 Hydrocarbon assay 
2.24.1 Materials, reagents and chemicals used: 
 p-xylene 
 PUM buffer : pH 7.1 : 22.2 g K2HPO4 • 3H20, 7.26 g KH2PO4, 1.8 g urea, 0.2 g 
MgSO4 • 7H20 and distilled water to 1000 ml 
 Round bottomed test tubes 
2.24.2 Method 
We used the method proposed by Rosenberg (Rosenberg, 1984). In this method, the 




reaching the early logarithmic phase, cells were harvested at 2400 x g for 15 min and 
then washed twice with PUM buffer before being resuspended in PUM buffer. 1.2 ml of 
the suspension was then placed in round bottomed test tubes and different volumes of 
p-xylene were added (0, 0.1, 0.2 ml). The suspension was incubated at 30°C for 15 min. 
The tubes were then agitated uniformly for 2 min and left it to rest for about 15 min. This 
allows the hydrocarbon layer to rise and the aqueous phase was then carefully taken for 
OD measurement in a cuvette. The absorption was measured at 400 nm. 
2.25 Crystal Violet Assay 
The crystal violet method to assay surface hydrophobicity was described in (Halder et 
al., 2015). The bacterial cells were grown in LB broth and were harvested at 2400 x g 
for 5 min at 4°C. The cells were then washed twice and finally resuspended in 0.5 mM 
potassium phosphate buffer (pH 7.4). The cells were again harvested at 9300 x g for 5 
min and then incubated in 0.5 mM potassium phosphate buffer with 10 g/ml crystal 
violet at 37°C for 10 min. The cells were again centrifuged at 9300 x g for 15 min. The 
supernatant was then transferred to a cuvette and absorbance was measured at 590 
nm. The crystal violet solution was considered to have an OD590 of 100% and the 
percentage uptake of the crystal violet was calculated by using the formula:  
(OD value of sample we are testing / OD value of CV solution)  × 100  
2.26 Chromatin Immuno Precipitation (ChIP) 
2.26.1 Materials, reagents and chemicals used: 




 FA lysis buffer (150 mM NaCl) (50 mM HEPES-KOH, pH 7.0, 150 mM NaCl, 1 
mM EDTA, 1% (w/v) Triton X-100, 0.1% (w/v) sodium deoxycholate, 0.1% (w/v) 
SDS). 
 FA lysis buffer (500 mM NaCl) (50 mM Hepes-KOH, pH 7.0, 500 mM NaCl, 1 
mM EDTA, 1% (w/v) Triton X-100, 0.1% (w/v) sodium deoxycholate, 0.1% (w/v) 
SDS). 
 ChIP wash buffer (10 mM Tris-HCl, pH 8.0, 250 mM LiCl, 1 mM EDTA, 0.5% 
(w/v) Nonidet-P40, 0.5% (w/v) sodium deoxycholate). 
 ChIP elution buffer (50 mM Tris-HCl, pH 7.5, 10 mM EDTA, 0.1% (w/v) SDS). 
 1 X TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). 
 NEXTflex ChIP-seq barcodes – 24 (supplied by BioOscientific). 
 Agencourt AMpure Magnetic Beads (supplied by Beckman Coulter) XP DNA 
clean up kit. 
 Quick Blunting and Quick Ligation kit (supplied by NEB). 
 Klenow fragment (3’-5’ exo-) (supplied by NEB) 
 Monoclonal anti-H-NS antibody 
 Monoclonal anti-70 antibody (supplied by Neoclone). 
 Monoclonal anti-MarA antibody 
 Qubit fluorometer / Assay kit (Life technologies) 
 10 mM Tris-HCl, pH 7.5 / 8.0 
 Protein A sepharose beads (GE healthcare), washed with dH2O and store in a 
50% (v/v) slurry with 1 X TBS. 





An overnight culture of the desired bacterial strain was used to inoculate a subculture in 
10 ml of growth media. The cultures were incubated until the OD650 reached 0.5. 
Formaldehyde (v/v) was added to cultures and incubated for 20 minutes. 3 M glycine 
was added to a final concentration of 0.5 M to quench crosslinking for 5 minutes. The 
cultures were then centrifuged at 2400 x g for 5 minutes. Supernatant was discarded 
and cells were suspended in 10 ml 1X TBS.  The cells were again centrifuged at 2400 x 
g for 5 minutes and again resuspended in 1X TBS. Cells were collected by 
centrifugation and resuspended in 1 ml FA lysis buffer containing 4 mg/ml lysozyme and 
incubated for at 37°C for 30 minutes. Cells were sonicated to fragment the DNA using a 
bioruptor. Three 10 minute cycles each with 30 sec on and 30 sec off were performed at 
4°C. The lysates were then centrifuged at 1500 x g for 5 minutes and the supernatant 
was transferred to a tube. From the tube 400 μl of the supernatant was mixed with 400 
μl of FA lysis buffer. The 800 μl mix was then taken and mixed with 25 μl of the protein 
A beads (in 50% TBS slurry). 1 μl antibody was then added to the tube that was 
covered with parafilm and rotated for 90 minutes. Beads were collected by 
centrifugation at 1500 x g for 1 min. Supernatant was removed and 700 μl of FA lysis 
buffer (150 mM NaCl) was added. The suspension was then transferred to spin-x-
columns, rotated for 3 minutes and centrifuged at 1500 x g for 1 min. Washing steps 
were then started and each step was repeated with rotation and centrifugation. The 
washing was done with 750μl each of the following buffers: FA lysis (150 mM NaCl), FA 
lysis (500 mM NaCl), ChIP wash buffer, TE (300 μl TE). The spin-X column was then 
transferred to a new dolphin-nosed tube and 100 μl of ChIP elution buffer was added 




centrifuged at 1500 x g for 1 min. The eluted samples were de-crosslinked by incubating 
the tube at 100°C for 10 minutes. PCR clean up was then done and DNA was then 
eluted in 30 μl of water.  Precipitated DNA was analysed by PCR or Ilumina sequencing.  
2.26.3 ChIP analysis by PCR 
PCR reactions were prepared using 5 μl of the ChIP isolated DNA and desired 
oligonucleotides. PCR was set up according to the procedure described earlier in this 
chapter.  
2.26.4 ChIP analysis by Ilumina MiSeq sequencing   
Immunoprecipitations were done as described in 2.26.2 with changes at the washing 
steps. In all wash steps 750 μl solutions were used as stated above. This was followed 
by rotation for 3 min and centrifugation at 1500 x g for 1 min. 150 mM NaCl FA lysis 
buffer was used unless stated otherwise. The spin-x column containing the beads was 
washed by twice each by FA lysis buffer and then with 10 mM Tris-HCl, pH 7.5. A 
blunting kit was used to make the blunt DNA fragments; where 10 μl of the quick 
blunting buffer, 10 μl of dNTP mix, 80 μl of water and 2 μl of the blunt enzyme was 
added. After sealing the the lids with parafilm, the columns were rotated for half an hour 
at room temperature in such a way that the tubes weren’t completely inverted. The 
beads were washed twice each with FA lysis buffer and Tris-HCl pH 8.0. Further, 
addition of A tail was achieved by resuspending the beads in 10 μl NEB buffer 2, 2 μl 
100 mM dATP, 88 μl of water and 1 μl of klenow fragment. After sealing the lids, 
columns were rotated for 30 minutes at 37°C in such a way that the tubes weren’t 
completely inverted. The beads were again washed twice each with FA lysis buffer and 




BioOscientific). This was achieved by suspending the beads in 100 μl of 1X ligase 
buffer, 1 μl of the NEXTflex adapter and 4 μl of  the quick ligase supplied in the kit. After 
sealing the lids, columns were rotated for 15 min over the rotating holder at room 
temperature in such a way that the tubes weren’t inverted. The beads were washed with 
FA lysis buffer, then with FA lysis buffer with 500mM NaCl, ChIP wash buffer and TE 
buffer. Finally, a wash with 300 μl of TE buffer was done with rotation. The spin-x 
column was then moved to dolphin nosed tubes and 100 μl of elution buffer was added 
before incubation for 10 min at 65°C. Before centrifugation, the column was transferred 
to a new Eppendorf tube. Centrifugation was done at 1500 x g for 1 minute. The eluted 
sample was incubated for 10 min at 100°C to decrosslink proteins. AMPure magnetic 
bead clean up was used to clean the eluted and decrosslinked sample that was eluted 
in 12 μl of water. A test PCR was setup with the NEXTflex supplied primers to check the 
adapter ligation. The libraries were amplified using PCR and samples were removed at 
different cycle numbers to analyse the formation of adapter dimers. The PCR was then 
setup using the number of cycles which gave no adapter dimers. The libraries were 
purified with AMPure magnetic and loaded on a 1% agarose gel. After running the gel, 
the DNA was stained with ethidium bromide and visualised under a UV transilluminator. 
The sample ideally appears as a 200-600bp smear with no adapter dimer. Finally, the 
sample was cleaned and concentrated using the AMPure magnetic beads and was then 
quantified using a Qubit 2.0 fluorometer. An equimolar mix of libraries was prepared for 
multiplexed sequencing using an Ilumina MiSeq 2500. The complete ChIP-seq protocol 




2.27 Agencourt AMPure XP magnetic bead clean up 
For ChIP-seq experiments, Agencourt AMPure XP magnetic beads, supplied by 
Beckman Coulter, were used both for DNA purification and for size selection of DNA 
libraries containing DNA of variable sizes.  
2.28 Bioinformatic analysis of sequence reads 
The Fastq files obtained from the Ilumina sequencer were converted into Fastq Sanger 
format using FastqGroomer. The files were then aligned to the Genbank reference 
sequences (FN649414.1, FN649418, FN649417, FN649416 or FN649415) using BWA 
for Illumina. The reference sequences correspond to the ETEC H10407 chromosome 
and plasmids p948, p666, p58 and p52 respectively. In addition, the SAM files were 
converted to BAM format using SAM-to-BAM. For each experiment, multiBamSummary 
was used to get coverage per base. Subsequent processing was done using R. Data 
were normalised to the same average read depth and the mean coverage per base was 
determined for each pair of replicates. The anti-MarA and anti-MarR 
immunoprecipitations shared numerous enriched DNA loci likely to be artefacts. DNA 
sequences of the reads have been submitted in ArrayExpress under accession number 
E-MTAB-5521. 
These spuriously isolated DNA sequences were removed by subtracting MarR binding 
signal from the equivalent MarA binding value. Negative values, were replaced with 
zero. The MarR dataset was not examined further. Artemis was used to select the 
binding peaks for MarA or 70. Peaks scoring >2.7-fold (for MarA) or >3-fold (for 70) 
over background were retained in the “create features from graph” function. Some 






Figure 2.4: Cartoon representation of ChIP-seq. The bacterial cells were fixed by 
formaldehyde and treated by lysozyme. A. Cells were sonicated. B. Protein A beads 
A B C
DEFG






(small black dots) were added. C. Immunoprecipitation was carried out with antibodies 
(blue Y shaped). D. Washing was performed with different buffers. E. Non specific 
binding was removed by washing. F. Blunting enzyme was added so the DNA 
fragments all had blunt ends. G. ‘A’ tail addition was performed using a Klenow 
fragment, so all the DNA fragments have an A tail at one end. H. The barcodes for 
sequencing were then ligated onto the A tails and the samples were eluted, 
decrossslinked by boiling. I. Before the PCR AMPure magnetic beads were used to 
clean up the samples. J. The samples were then eluted in 12 µl of water. PCR was then 
set up to amplify the libraries. K. The amplified libraries were again cleaned up and 
concentrated by AMPure magnetic beads. L. Finally the DNA was eluted in 10 µl of 
water. The samples were then sent for quality control followed by sequencing on MiSeq 












threshold. Those duplicates were removed. After visual inspection, 4 peaks for MarA 
binding were added manually. The peak centres were set to be located on the centre of 
the region passing the cut-off rounded to the nearest integer.  
2.29 Bioinformatic identification of MarA binding sites 
After defining the MarA peak centres we created a set of genome features in gff file 
format. Feature boundaries were 100 bp either side of each peak centre. The 201 bp 
DNA sequence corresponding to each feature was extracted using Artemis and 
submitted to MEME to search for motifs. Standard settings were used except that the 
expected number of sites was set to one per sequence and the minimum motif width 
was set to 15 bp. A single statistically significant motif was recovered and this matched 
the known MarA binding consensus. To determine the distance between peak centres 
(for 70) and binding sites (for MarA) we used the fetch closest non-overlapping feature 
tool in Galaxy (Afgan et al., 2016). Peaks for 70 and MarA described as overlapping 
were those centred were within 150 bp of each other. 
2.30 Phylogenetic analysis of the marbox 
Excluding E. coli species, we used BLASTp to search for genomes encoding MarA. We 
manually removed genomes encoding MarA with changes in the amino acid sequence 
of either DNA recognition helix; this is indicative of altered DNA binding specificity. 
Many of the resulting 161 genomes were derived from closely related strains of the 
same species. These were omitted so that 29 representative genomes remained. 
Phylogeny was determined using the sequence of the polA gene from each organism 
and BLASTn pairwise alignments. We used BLASTn to search the 29 genome 




peaks in E. coli. If multiple hits were obtained from a single genome only the best match 
was used. If required, pairwise alignments were optimised manually to remove 
alignment gaps within marbox sequences. If no sequence match was identified this was 
scored as “region absent”. An identified marbox was scored as “conserved” if it matched 
either the equivalent E. coli sequence, or the consensus marbox (5'-gcactaattgctaaa-3') 
in at least 14 of the 15 possible positions. Sites were scored as “conserved with 
mismatches” if the above criteria were satisfied at 13 of the 15 marbox positions. 
Sequences falling below this threshold we scored as “not conserved”.  
 
2.31 Pulsed-Field Gel Electrophoresis 
2.31.1 Reagents and chemicals used 
PIV buffer: 
 1 M NaCl 
 10 mM Tris-HCl (pH 7.6) 
EC lysis solution: 
 6 mM Tris-HCl (pH 7.6) 
 1 M NaCl 
 100 mM EDTA 
 0.2% (w/v) deoxycholate 
 1% (v/v) Sarkosyl (N-lauroylsarcosine (Na salt)) 




 20 µg/ml RNase 
ESP buffer: 
 0.5 M EDTA (pH 9.0 to 9.5) with NaOH adjusted 
 1% (v/v) Sarkosyl 
 50 µg/ml proteinase K 
TE (pH 7.5): 
 10 mM Tris-HCl (pH 7.5) 
 1 mM EDTA 
2.31.2 DNA Preparation 
2.31.2.1 Method 
The chromosomes of E. coli were prepared using the method proposed by (Heath et al., 
1992). Briefly the cells are immobilised in agarose and then incubated and washed with 
different enzymes and detergents which removes unnecessary materials and the 
purified DNA remains immobilised in the plugs of agarose. 
In this method an overnight culture was set up for the required strain. The OD650 was 
measured the next day and it was adjusted to be 1.7 for all the strains. The culture was 
then centrifuged at 2400 x g for 15 min. The cells were suspended in equal volume of 
PIV buffer. The cells were again spun as before and suspended in half volume of PIV 
buffer. The cells were then incubated at 37°C to warm them. In the meantime 1% (w/v) 




the cells and the agarose were mixed gently. This suspension was dispensed in the 
agarose plug moulds and left to solidify.  Two plugs of each sample can be made from 
these amounts of cell suspension. After the solidification the agarose plugs were stored 
in the refrigerator (4°C) for at least 5 minutes before use. Two plugs per sample were 
transferred into each universal and 2.5 ml of EC lysis solution without any enzyme was 
added and the universal was gently shaken at room temperature for 15 min. EC lysis 
solution was then aspirated off the universal. Another 2.5 ml of the EC lysis solution was 
added, but this time with lysozyme and RNase and incubated at 37°C with gentle 
shaking overnight. The next day the solution was removed by aspiration. ESP buffer 
was then added without any enzyme and shaken gently at room temperature for 15 min. 
The solution was then replaced with ESP buffer containing proteinase K and incubated 
with shaking gently at 37°C for 48 hours. After 2 days the ESP buffer with proteinase K 
was removed and the plugs were washed 6 times by 2.5 ml of TE buffer each time 
incubating it for 15 min, gently shaking at room temperature. After the final wash 2.5 ml 
of sterile TE was added to each universal and the plugs were stored at 4°C until used. 
The agarose gel was then prepared for PFGE and the agarose plugs were cut to an 
appropriate size and loaded by hand (using the support of a scalpel) into the well of the 
gel. The final lane of the gel was loaded with a slice of Saccharomyces cervisiae PFGE 
size marker. The conditions used for the PFGE run were: switch time of 60 and 120 sec 
(initial and final respectively), 24 hours of gel run with 6V/cm and 120° angle. The gel 











Chapter 3. Molecular Mechanisms 






In this chapter I have investigated the control of ETEC enterotoxin expression. I have 
shown that regulation of ST and LT enterotoxin expression is controlled by both CRP 
and H-NS. Consistent with this, expression of the toxins is controlled by the extracellular 
signals of osmolarity and glucose availability; signals sensed by H-NS and CRP 
respectively. 
Previously, Haycocks et al. (2015) identified a potential binding site for CRP, in a class I 
position, upstream of the estA1 and estA2 genes (both encoding derivatives of the ST 
toxin). The authors show that CRP was able to bind in vitro using gel shift assays. 
Whilst CRP bound these sites in vitro, binding was not detected globally in vivo using 
ChIP-seq assays. Myers et al. (2013) observed a similar phenomenon for FNR, a 
regulator related to CRP. They show that FNR binding sites are revealed in ∆hns cells. 
Hence we did ChIP-seq assays, set up to investigate the global binding of H-NS, 
revealed H-NS bound across the estA1, estA2 genes and promoter regions. Thus, it 
was suggested that these targets, bound by CRP in vitro, were occluded by H-NS in 
vivo. In this chapter I have tested the H-NS occlusion model outlined in Figure 3.1., 
explained the regulation of the toxins by glucose and salts and also explained the 
relevance of Oral Rehydation Therapy (ORT) in ETEC mediated diseases. 
3.2 The estA2 promoter is repressed by H-NS and activated by CRP 
To examine the effect of H-NS on CRP binding we selected a 460 bp DNA fragment 
containing the estA2 gene and regulatory DNA. We also made a derivative of the 460 
bp fragment that lacked the CRP site and a shorter 93 bp fragment that contains the 







Figure 3.1: Defined hypothesis about in vivo regulation of enterotoxins by H-NS. 
In the figure we show the hypothesis derived for the region of estA2 gene on p948 
plasmid. A. In WT, when H-NS (Fluorescent Green) and CRP (Orange) both are 
present, H-NS nucleates the region across estA2 and occludes CRP to regulate the 
expression of estA2. B. In ∆hns cells, CRP is the only regulator and is able to bind over 














Figure 3.2: Investigation of LacZ activities (Miller units) from different promoter derivatives of estA2. A. The 
enterotoxin genes are shown in blue, the promoters are represented by black bent arrows, the CRP sites are shown in 
orange and the lacZ gene is in red. i. estA2 promoter with 460 bp downstream flanking region containing estA2, ii. the 460 
bp derivative of estA2 lacking CRP site and iii estA2 promoter alone B. The LacZ activity for each of the fragments cloned 




(Figure 3.2A). It has been shown previously that promoters present in short DNA 
fragments are liberated from repression by H-NS (Singh et al., 2014). Hence, we 
expected that the promoter with flanking coding DNA would be repressed by H-NS. To 
test this we cloned the various DNA fragments upstream of lacZ in a reporter plasmid 
pRW50. The LacZ activities obtained using the various plasmids in strain M182 or M182 
hns::kan are shown in Figure 3.2B.  In cells with H-NS, the β-galactosidase activity of 
the 93 bp fragment is 6-fold higher than the 460 bp fragments. This was expected; the 
93 bp fragment contains the estA2 promoter but no 3’ flanking DNA where H-NS can 
bind to repress PestA2. In the absence of H-NS the 93 bp fragment and the wild type 
460 bp fragment have similar activity but mutation of the CRP binding site completely 
eliminates the activity of PestA2. 
3.3 The estA2 and estA1 are similarly regulated by H-NS 
The regulatory region of estA1 carries a sequence very similar to PestA2. We predicted 
that this would be PestA1 and reasoned that 3’ flanking DNA might again bind H-NS in 
vivo. Hence, we cloned PestA1 with or without the adjacent estA1 gene fused to lacZ in 
plasmid pRW50 (Figure 3.3A). M182 and M182 hns::kan were transformed with the 
resulting plasmids and LacZ activities were measured. As predicted, in the presence of 
flanking DNA, transcription from PestA1 was repressed by H-NS but not in the absence 
of flanking DNA (Figure 3.3B).  Note that in comparison to PestA2, PestA1 is poorly 
active and not dependent on CRP. This is because the CRP site at PestA1 is misplaced 





3.4 The eltAB operon is directly repressed by H-NS 
The A and B subunits of the LT toxin are encoded by the eltAB operon. The ChIP-seq 
data of Haycocks et al (2015) also suggest binding of H-NS over the eltAB operon. 
Hence, we reasoned that the eltAB (PeltAB) promoter may also be repressed by H-NS. 
To test this prediction, we prepared two DNA fragments; a 359 bp fragment containing 
only PeltAB, and a 1127 bp fragment also containing the eltA and part of eltB (Figure 
3.4A). Note that PeltAB contains sequences that bind CRP (open orange boxes in 
Figure 3.4A) but binding is poorly specific (Haycocks et al., 2015). The DNA fragments 
were cloned in plasmid pRW50 and used to transform M182 and the hns::kan 
derivative. The LacZ activity was determined and the result is illustrated in Figure 3.4B. 
Consistent with our prediction, LacZ activity dropped 15 fold when the flanking DNA 
downstream of PeltAB was present. There was a relief of this repression in the absence 
of H-NS (Figure 3.4B).   
3.5 Similar H-NS binding on all the enterotoxin promoters of ETEC H10407 
The LacZ activity data suggests that H-NS does not bind the short estA2 and eltAB 
fragments. To test this, H-NS binding to the various fragments was compared using 
ChIP and PCR. The result of the PCR, is shown in Figure 3.5. As predicted, the longer 
estA2 and eltAB fragments were enriched in the immunoprecipitations with anti-H-NS 
(bottom panel). However, no enrichment was seen for the shorter estA2 and eltAB 
fragments (top panel). The yabN locus, that does not bind H-NS, served as a control in 







Figure 3.3: Investigation of the LacZ activities (Miller units) from promoter derivative of estA1. A. estA1 gene 
shown in blue, promoter shown by a black bent arrow, and lacZ gene shown in red. i. estA1 promoter with 460 bp 
downstream flanking region containing estA1 and ii PestA1 on its own. B. LacZ activity for estA2 fragment cloned in front 






Figure 3.4: Investigation of the LacZ activities (Miller units) from different promoter derivatives of eltAB.  
A. The enterotoxin genes are shown in purple, their promoters are shown by a black bent arrow, the CRP sites are small 
orange boxes and the lacZ gene is red. i. eltAB promoter alone with its CRP sites, ii. eltAB promoter with 460 bp 
downstream flanking region containing eltAB. B. LacZ activity for each derivative of pRW50 cloned in front of the lacZ 







Figure. 3.5: The various enterotoxin promoters of ETEC H10407 are repressed by 
H-NS. A. H-NS binding to the PestA2 which includes the gene downstream. B. H-NS 
binding to the PeltAB in the presence of flanking DNA, which includes the gene 
downstream.  ChIP-PCR was used to detect the binding of H-NS to the different 
promoter fragments. Primers used in ChIP-PCR were able to detect PestA2 in both 
derivatives, 93 bp and 460 bp respectively, and were also able to detect PeltAB in both 
derivatives of 359 bp and 1127 bp respectively. yabN was used as a control locus and 








3.6 The estA1 and estA2 promoters of ETEC H10407 respond to Glucose and Salt 
According to our model, CRP is vital for transcription of estA2 and H-NS represses this 
transcription. This suggests that estA2 is regulated by both glucose and osmolarity. The 
transcriptional response to glucose, controlled via cAMP, is mediated by CRP (Busby & 
Ebright, 1999). Hence, when glucose is absent, the cAMP level increases and CRP 
binds DNA (Parkinson et al., 1996). Moreover, the way in which H-NS modulates DNA 
topology depends on the abundance of divalent cations (i.e. presence of salts) (Atlung 
and Ingmer, 1997). Hence, H-NS mediated repression should be relieved by increasing 
osmolarity.  
To check the response of PestA1 and PestA2 to glucose and salt, we established a 
range of conditions across which the estA1 and estA2 promoters responded to these 
signals. We used DNA fragments that included the downstream flanking region to 
ensure that signals sensed by both CRP and H-NS could be integrated. Note that we 
expected little response from PestA1 because of the misplaced CRP site (Haycocks et 
al., 2015). Cells were grown in M9 minimal medium with varying concentrations of 
glucose or salt (a combination of NaCl and KCl). The LacZ activity data is shown in 
Figure 3.6A and B. As expected, the activity of PestA1 was low and the effects of 
glucose and salt were negligible (Figure 3.6 A). Conversely, a response of PestA2 to 
both glucose and salt was detected. Hence, PestA2 was repressed by increasing 
concentrations of glucose (orange line) and activated by increasing concentrations of 
salt (green line) in Figure 3.6B. A cartoon is also shown in Figure 3.7 that depicts the 
control of estA2 expression by glucose. Thus, H-NS is able to repress the PestA2 






Figure 3.6: Effect of titrating glucose and salts individually over the estA1 and estA2 promoter. This figure shows 
the activity observed as a response of increasing glucose and salts concentration over the different promoter::lacZ fusions 
of A) PestA1, B) PestA2. These promoters include downstream flanking regions containing enterotoxin genes. 
Representative of n=3. 








Figure 3.7: Control of production of ST toxin by glucose. A. High glucose levels, no 
expression of toxin is seen as the CRP is absent and cannot bind the promoter region. 
B. Low levels of glucose, CRP activates estA promoter and toxin is produced shown as 





inhibitory effect of glucose must override the stimulatory effect of salt. To investigate this 
we added the glucose and salt individually or mixed together. Consistent with our 
hypothesis, the inhibitory effect of glucose was dominant (Figure 3.8A) and occurred 
even in the absence of H-NS (Figure 3.8B). Conversely, the stimulatory effect of salt 
required H-NS (compare green bars in Figure 3.8A). To determine if the PestA2 glucose 
response required CRP, we compared activity of the 460bp estA2 fragments with or 
without the CRPsite. As expected, the glucose effect is present only for the fragment 
where the CRP site is intact (compare Figure 3.9A and Figure 3.9B). 
3.7 The eltAB promoter also responds to glucose and salts  
The activity of PeltAB was found to increase in the presence of increasing 
concentrations of both the glucose and salt. The enhancement in activity by salt was 
more prominent compared to the effect of glucose (Figure 3.10). We also tested 
combinations of glucose and salt in the presence and absence of H-NS. The results 
suggest that effects of salt and glucose both require H-NS and were not additive 
(Compare Figure 3.11A and B). Since CRP is unlikely to regulate PeltAB directly, the 
effect of glucose is difficult to interpret. Conversely, the effect of salt is likely mediated 
by H-NS.  
3.8 Regulation of ETEC enterotoxins by H-NS and CRP is conserved in other 
strains 
On examining all available ETEC genomes we found that the promoter sequences of 
estA2 and eltAB varied. Hence, we set out to determine if the response of estA2 and 







Figure 3.8: Production of ST toxin of ETEC H10407 is controlled by an osmo-
metabolic flux. This figure shows the effect of 2% glucose, 60 mM NaCl and 20 mM 
KCl over the ST production. The effect was measured by β-galactosidase assay. Briefly 
cells were first grown in M9 minimal media so that glucose and salt concentrations 
could be more accurately controlled. The measurement was done for lysates of A. M182 
(Wild Type) or B. M182 hns::kan (∆hns) containing PestA2::lacZ fusion construct in 












Figure 3.9: The response from glucose needs an intact CRP site over the PestA2 
promoter. A.This figure shows activity of the PestA2 fragment with the downstream 
flanking DNA containing estA2 toxin gene. This activity assay was carried out in M9 
minimal media with and without 2% glucose in both WT and ∆hns cells. B. This figure 
shows activity of the PestA2 fragment including the downstream flanking DNA 












Figure 3.10: Effect of titrating glucose and salts individually over the eltAB 
promoter. This figure shows the activity observed as a response of increasing glucose 
and salts concentration over the promoter::lacZ fusions of PeltAB in the reporter 
plasmid pRW50. The promoters include the downstream flanking regions containing 
enterotoxin gene. Representative of n=3. 
* NaCl and KCl was mixed in a ratio of 3:1 together. The % w/v refers to the NaCl concentration, 









Figure 3.11: Production of LT toxin of ETEC H10407 is controlled by an osmo-
metabolic flux. This figure shows effect of 2% glucose, 60 mM NaCl and 20 mM KCl 
over the LT production. The effect was measured by β-galactosidase assay. Briefly, 
cells were first grown in M9 minimal media so that the glucose and salt concentrations 
could be more accurately controlled. The measurement was done for lysates of A. M182 
(Wild Type) or B. M182 hns::kan (∆hns) containing A) PestA2::lacZ fusion construct in 









that has a sequenced genome and transcriptomics data (Sahl and Rasko, 2012, Kansal 
et al., 2013). I generated ETEC E24377A estA2 and eltAB fragments equivalent to 
those from H10407 and cloned these in front of lacZ gene in pRW50. Promoter activity 
was then measured in response to CRP and H-NS. The regulation was found to be 
similar to that of H10407; estA2 was repressed by H-NS and activated by CRP whilst 
eltAB was repressed by H-NS (Figure 3.12A and B). The global transcriptome response 
of E24377A to glucose and salts has already been examined upon attachment to 
epithelial cells (Sahl and Rasko, 2012). I made use of their transcriptomics data and re-
analysed it relative to my data. The data in figure 3.13A show changes in transcription 
of crp, hns, eltAB and estA2 during attachment. Levels of hns transcription changed 
dramatically after 1 hour post intestinal cell attachment and both eltA and estA2 
transcription correspondingly increased. Levels of crp did not change during host cell 
attachment but we did note a variation in crp transcript levels between experimental 
variants. Hence, when these absolute levels of crp transcripts were plotted against 
estA2 transcript levels, a linear relationship was found. For each data point in Figure 
3.13B the absolute level of hns mRNA is added in parenthesis. The plot show 2 outliers 
in the data points, they are from those samples which had increased hns expression.   
3.9 Discussion 
Enterotoxin production can be controlled by CRP and H-NS in ETEC H10407 and our 
model of regulation is applicable in other ETEC strains. Our model suggests activation 
of heat-stable toxin expression by CRP and repression of both heat-stable and heat- 







Figure 3.12: Transcription levels of enterotoxins of ETEC E24377A A. Activity 
measurements by β-galactosidase assay in WT (M182), Δ hns and Δ crp cells 
containing the estA2 fragment cloned in front of lacZ in pRW50 plasmid. B) Activity 
measurements by β-galactosidase assay in WT (M182), Δ hns and Δ crp cells 












Figure 3.13: Transcription level changes in the transcriptome of ETEC E24377A 
post intestinal cell attachment. A. Log2 fold change in transcript levels of enterotoxins 
(Dashed purple and blue lines for estA2 and eltAB respectively), crp (orange) and hns 
(green) during non-attachment and post attachment to the intestinal cells. B) The 
absolute transcripts were plotted for crp and estA2, which shows a clear linear relation 










a. eltAB is directly repressed by H-NS 
b. estA1 and estA2 are directly repressed by H-NS. 
c. estA2 is directly activated by CRP. 
d. CRP site occluded by H-NS (a case of indirect repression by H-NS). 
Figure 3.14: A model proposed for the control of enterotoxins expression of 
ETEC. The LT and ST can be controlled by the two gene regulators H-NS and CRP. 









Gene expression can be modulated by glucose and salts when regulators like CRP and 
H-NS are involved in regulation. In case of CRP, activation only occurs when there are 
enough cAMP molecules that are bound to CRP. Catabolite repression is the major 
inhibitory effect of glucose present in E. coli. Glucose present in high concentration 
prevents the inducer uptake inside the cells resulting in negatively regulating gene 
expression (Kolb et al., 1993). Tagami et al (1995) have shown that glucose reduces 
the CRP expression from a multicopy plasmid (Tagami et al., 1995). In case of H-NS, 
using single-molecule studies Amit and coworkers (2003) have shown that independent 
of H-NS concentration and with increasing concentration of salts, H-NS loses its effect 
(Amit et al., 2003). Salts disrupt the binding between H-NS and DNA and similar case 
was also observed in its paralogue StpA (Lim et al., 2012).   
The observed regulation pattern in this chapter is pertinent to the disease and its 
treatment. When ST and LT bind to epithelial cells in small intestine, there is an efflux of 
water, charged ions and cAMP. This efflux could maintain a positive feedback loop for 
toxin production. Interestingly, Oral Rehydration Therapy (ORT), which contains 
necessary electrolytes, is given with water to the patients colonised by ETEC (Nalin et 
al., 1968). The ORT solutions contain glucose and salt. Glucose is present in ORT at 10 
fold higher concentrations than those necessary to repress estA2 via CRP. Similarly, 
salt concentrations in ORT are sufficient to induce expression of estA2 and eltAB, 
though the high glucose concentration present for estA2 sites in ETEC H10407 appear 
occluded by H-NS (Haycocks et al, 2015) and similar repression by H-NS was proposed 
for a CRP homologue FNR (Myers et al., 2013). The authors have shown that in the 























Chapter 4. Identification and 
verification of MarA binding sites 











4.1 Introduction  
MarA is an AraC/XylS family transcription factor implicated in multiple-antibiotic 
resistance (mar). Thus, MarA upregulates genes involved in drug efflux to protect cells 
from antibiotics. MarA binds degenerate target site and deleting marA has pleiotropic 
effects on gene expression (Veleba et al., 2012). Also the binding site of MarA; the 
marbox is orientation specific and Jair et al. (1995) have shown that inverting the 
marbox results in complete loss of activity. Due to these reasons, it has been difficult to 
find additional targets for MarA. Hence, in this chapter, chromatin immunoprecipitation 
and next generation Ilumina sequencing (ChIP-seq) was used to map MarA and RNAP 

70 subunit binding across the ETEC H10407 genome. The ChIP-seq was done in 
presence of a MarA overexpressing plasmid known as pRGM9818.  
4.2 MarA binding sites across the whole genome of ETEC H10407   
ChIP-seq was done using ETEC H10407 that shares 3,766 genes with E. coli K-12.  
Hence, ETEC H10407 specific targets of MarA, and sites shared with E. coli K-12, 
should be identified by our analysis. After immunoprecipitation, sequencing and 
bioinformatic analysis we identified 33 and 839 binding peaks for MarA and 70 
respectively. The binding data of MarA (green) and 70 (orange) are plotted against the 
ETEC chromosome and plasmids in Figure 4.1. In each plot, tracks 1 and 2 are the 
genes, track 3 is the MarA binding data and track 4 is the 70 binding data.  Comparing 
tracks 3 and 4, shows that MarA bound to very few loci compared to 70. A DNA 
sequence motif associated with MarA binding peaks was generated using Multiple Em 
for Motif Elicitation (MEME) (Figure 4.2A). The ChIP-seq derived motif and known MarA 






Figure 4.1: MarA and RNAP 70 binding A. MarA and 70 binding across the chromosome and B. the binding on all the 
plasmids of ETEC H10407. In each plot, genes are represented by track 1 and 2 in blue, MarA binding data is in green 























Figure 4.2: DNA sequence motifs derived from MarA binding sites. A. DNA 
sequence motif generated by the MarA binding data from the ChIP-seq experiment 
using MEME. B. DNA sequence motif generated by aligning the MarA binding sites 





motif derived from known MarA binding sites
motif derived from 33 MarA binding peaks











































binding targets and associated motifs are shown in Table 4.1. Each binding peak for 
MarA and 70 was allocated a 100 bp bin. The 100 bp bin is determined by the distance 
between the peak and the nearest start codon. The result is shown in the form of a 
histogram in Figure 4.3A. It was found that both MarA and 70 bind the 100 bp upstream 
of the 5’ end of a gene most often. Of the 33 MarA sites, 15 were within 150 bp of a 
peak for 70 binding. A Venn diagram that illustrates the overlap in MarA and 70 binding 
is shown in Figure 4.3B.  
4.3 In vitro characterization of MarA bound targets 
To validate the MarA binding data from our ChIP-seq analysis, we tested the binding of 
purified MarA to DNA fragments derived from each peak. As a control we also tested 5 
DNA fragments from elsewhere in the genome including the 92 bp estA1 fragment. The 
DNA binding was measured using Electrophoretic Mobility Shift Assays (EMSA). Thus, 
130 bp DNA fragments, corresponding to each MarA target, were generated using PCR 
and then radio labelled. The results are shown in Figure 4.4. Only 1 of the MarA targets 
(ETEC3200) did not bind the MarA protein in vitro. As expected, the control fragments 
did not bind MarA (bottom panel in Figure 4.4). 
4.4 The mar regulon is conserved amongst the family of enteric bacteria 
In many enteric bacteria overexpression of MarA-like regulators is associated with 
multidrug resistance. Hence, we next investigated the conservation of MarA binding 
targets amongst enteric bacteria containing an unambiguous MarA homologue. The 
results are represented in the Figure 4.5. The MarA regulon of E. coli was found to be 
best conserved amongst other Escherichia spp. and Shigella spp. In more divergent 




Table 4.1: MarA binding sites identified by ChIP-seq 
 
ChIP    MEME site       Site Sequence                          H10407                     MG1655       MarA binding   
peak
a
      centre
b
                  (5'-3')
c
                                    genes
d
                          genes
e




206          161         gcacagacagataaa                   ETEC0001                       thrL                +++ 
87300      87344       gcacaattagctaat         ETEC0074<>ETEC0075         leuL<>leuO          +++ 
184212     184180       gcgttatctgttaat                  ETEC0157                      degP                ++ 
428898     428876       gcataaagtgtaaag                   ETEC0400                      lacZ                 ++ 
529310     529338       gcacaaaatgacaaa                   ETEC0500                      ybaO                +++ 
655542     655557       gcactaaatgttaaa                   ETEC0604                      pheP                +++ 
846408     846418       ccacgcaaagctgac             ETEC0765<>acrZ            modE<>acrZ          ++ 
963300     963348       cctatgagcgtaaaa                  ETEC0889                      ybiV                 + 
994036     994060       gcattaattgctaaa        ETEC0916<>ETEC0917        grxA<>ybjC            +++ 
1354006  1354020      gcactaattgcaaaa        ETEC1264<>ETEC1265        ycgF<>ycgZ           +++ 
1536992  1537038      gcacaaattgtttaa                   ETEC1438                       fnr                  ++ 
1717096  1717112      gcactaattgctaaa                   ETEC1580                     yneO                 +++ 
1739002  1739016      ccacgttttgctaaa        ETEC1599<>ETEC1600        marC<>marR         +++ 
2321000  2321062      gcactatttgctaaa                   ETEC2157                     yeeF                 +++ 
2538709  2538641      gcactgaatgtcaaa        ETEC2344<>micF                ompC<>micF          ++ 
2727890  2727941      gcattttttgctaaa                   ETEC2509                     ypeC                 +++ 
2755444  2755459      gcaacaactgttaaa       ETEC2533><ETEC2534        yfeS><cysM            +++ 
2887268  2887307      gcattttttgcaaaa        ETEC2665<>ETEC2666        guaB<>xseA           +++ 
3455714  3455708      ccaatatccggcaaa                   ETEC3200               ETEC specific          - 
3569696  3569763      gcacgtaacgccaac        ETEC3306<>ETEC3307        nudF<>tolC            ++ 
3695690  3695710      gcacaatctgcttac                 (ETEC3426)                     (yhbV)               +++ 
3733124  3733195      ccagctttcgctaac        ETEC3460<>ETEC3461        mlaF<>yrbG           +++ 
4289772  4289787      gcacgaaacgttaaa        ETEC3977<>ETEC3978         ibpA<>yidQ           ++ 
4348148  4348176      gcacgatctgtatac                   ETEC4032                     mnmG               ++ 
4494984  4495025      ccgctttacggtaaa                 (ETEC4151)                     (yihT)                ++ 
4510208  4510184      gcgcgttatgctgac                 (ETEC4166)                     (yiiG)                ++ 
4685066  4685041      aggctaatcgtataa                 (ETEC4304)               ETEC specific          +++ 
4686378  4686377      ccaaaaacaggtaaa                 (ETEC4307)               ETEC specific          ++ 
4737304  4737238      gcaataaaagtcacg        ETEC4370<>ETEC4371        yjcB<>yjcC             ++ 
5066076  5066105      gcatcaaatgataac        ETEC4666<>ETEC4667         yjjP<>yjjQ             +++ 
5093964  5093988      ccgataaatgcgaaa                  ETEC4702                ETEC specific          ++ 
5132420  5132347      gcaggaagcggcgaa                  ETEC4739                      deoB                 ++ 
 
Plasmid p948 Targets 
65178   65159         gcattttctgtcaaa             ETECp9480770              ETEC specific          +++    
 
a
Genome coordinate of MarA ChIP-seq peak centre in H10407. Bold type indicates peaks within 150 bp 
of a σ 70 binding peak. 
b
Genome coordinate of MarA binding site predicted by MEME.  
c
Sequence of MarA binding site predicted by MEME 
d
Nearest gene to MarA binding site. Some MarA targets were between divergent (<>) and convergent 
(><) genes. Genes in parentheses indicate that the ChIP-seq peak is located within that gene.  
e
E. coli K-12 homologues of ETEC genes in the previous column. E. coli K-12 MarA binding sites, listed 
in the Ecocyc database, are highlighted according to experimental confirmation (solid line) or prediction 
(dashed line).  
f
in vitro binding of purified MarA observed at concentration of 0.3 µM (+++), 1.0 µM (++) or 1.7 µM (+). 
Note that five control DNA fragments (cydD, ybiS<>ybiT, ETEC2117, cyoA and PestA did not bind MarA 
at any of these concentrations (Figure 4.4). 
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Figure 4.3: Location of MarA and RNA polymerase binding peaks with respect to 
genes. A. Histogram that depicting the distance between ChIP-seq binding peaks and 
the nearest 5' end of a gene; MarA binding data is represented in green and RNAP 70 
binding data in orange. Each binding peak was allocated to a series of bins occurring at 
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Figure 4.4: In vitro verification of MarA binding to the identified DNA targets.  
A. EMSA gels, where MarA bound to various fragments. MarA-DNA complex is shown 
as a  brown arrow and the free DNA as a blue arrow. B. EMSA gels where no MarA 
binding was observed. 
yhbV mlaF/yrbG ibpA/yidQ mnmG yihT





















Figure 4.5: Conservation of MarA regulon amongst the enterobacteriacea. Heatmap explaining the conservation of 
the marboxes identified in ChIP-seq (x-axis) in the genomes of different enteric bacteria (y-axis). The cladogram shows 




pneumoniae, Enterobacter cloacae and Raoultella ornithinolytica, share a similar subset 
of marbox sequences. These sites include the marbox sequences adjacent to micF and 
tolC and the auto-regulatory site present on the upstream of the marRAB operon. A site 
present upstream of the mlaFEDCB operon is the best conserved MarA site identified in 
our data; the sequence is present in all but the most divergent Cedecea neteri ND14b 
genome.  
4.5 Phenotypic landscape of the mar regulon 
The binding peaks of MarA that are specific to ETEC H10407 reside mostly inside 
prophage genes and are unlikely to be functional. Hence, we concentrated on the 28 
targets that are identical in E. coli K-12. This allowed us to make use of the significant 
resources available for the K-12 strain. To better understand the downstream effects of 
MarA, we specifically made use of phenotypic analysis data for the E. coli K-12 Keio 
collection. Data are shown as a heatmap in Figure 4.6 (Nichols et al., 2011). In the 
heatmap, the rows represent the strain of E. coli lacking the MarA target gene and 
columns represent various antibiotics bundled according to the cellular processes 
inhibited. The coloured boxes represent the growth of the strain lacking the MarA target 
gene, in the presence of the various antibiotics and relative to the wild type cells. 
Hence, genes important for innate resistance to antibiotics are highlighted by red 
coloured boxes. The figure shows that the broadest sensitivity results from deletion of 
tolC; the strain becomes sensitive to many antibiotics such as nalidixic acid, novobiocin, 
erythromyocin, chloramphenicol, minocycline, doxycyclines etc. However, there are 
gaps in the protection offered by tolC. In particular, xseA (encoding the larger subunit of 







Figure 4.6: Phenotypic landscape of the MarA regulon. Heatmap generated using the growth data from Nichols et al., 
2011. This heatmap illustrates the fitness score in the presence of different antibiotics of the strain lacking MarA target 
genes compared to the parental strain. The antibiotics are bundled by their mode of action or the cellular processes they 
target and are labelled at the top of the heatmap.  Below the heatmap the antibiotics are subdivided in different classes. 
The classes are as follows: i, quinolones; ii, non-quinolone topoisomerase inhibitors; iii, antifolates; iv, macrolides; v, 
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against the quinolone family and tetracycline family of antibiotics (Harris et al., 1998, 
Malinverni and Silhavy, 2009). We focus on these targets in the following two chapters. 
 
4.6 Discussion  
MarA is a member of the AraC/XylS family of transcription factors found conserved in 
many bacteria, particularly the Enterobacteriaceae. MarA is a transcriptional activator 
inducing transcription of many genes and can enhance drug resistance. Conventionally, 
MarA mediated antibiotic resistance has been attributed to regulation of genes encoding 
the AcrAB-TolC efflux system. These are amongst only 12 well characterised targets 
listed in the Ecocyc database (Karp et al., 2014, Keseler et al., 2017). However, there 
are more than one hundred MarA molecules in the cells that are drug resistant (Martin 
et al., 2008). We reasoned that MarA must control expression of more genes than is 
currently known.  
Barbosa and Levy used E. coli microarrays and identified over 60 genes putatively 
controlled by MarA (Barbosa and Levy, 2000). From those, only 3 genes were found in 
common in the studies by Pomposiello and co-workers (Pomposiello et al., 2001). A 
study by Seo et al. (2015) has revealed 25 SoxS targets using ChIP-exo (Seo et al., 
2015). Of these targets 7 are common in my MarA ChIP-seq experiment. This shows an 
overlap between MarA and SoxS regulons. However, this overlap is not suprising since 
MarA and SoxS are very similar proteins recognising the same binding site (Li and 
Demple, 1994). Recently, another study have shown control of expression of E. coli 
OmpF prorin by BluR, YcgZ and Lon (Duval et al., 2017). E. coli bluR and ycgZ were 




genes are regulated by MarA and in turn they regulate expression of a porin, OmpF that 
was previously known to regulated by micF (Cohen et al., 1988, Ziervogel and Roux, 
2013). 
Previously it was shown that to bind specific promoters the concentration of regulator is 
also important. For example, to bind promoters like acrAB, a high concentration of MarA 
is required (Martin et al., 2008). It could be because of this reason our ChIP-seq on 
ETEC H10407 did not reveal acrAB as a target. Since, we carried out our experiment in 
a strain that has a MarA overexpressing plasmid known as pRGM9818 and may be the 
strain was not able to produce enough MarA that was required to bind acrAB. 
E. coli antibiotic resistance is known to be regulated by MarA. However, other 
pathogenic bacteria also maintain antibiotic resistance by MarA like regulators. 
Southern hybridisation experiments in previous studies with an E. coli marRAB probe 
have shown that marRAB locus is highly conserved in many other pathogens as 
Shigella flexneri, Salmonella enterica, Klebsiella pneumonia etc (Cohen et al., 1993b). 
Like MarA, a homologue RamA is known to be regulator of acrAB-tolC in Salmonella 
enterica (Abouzeed et al., 2008). RamA is also an AraC/XylS family member that has a 
structure similar to MarA and binds DNA similarly (Ricci et al., 2012). There are no signs 
of presence of RamA in Shigella or E. coli (Ricci and Piddock, 2009). 
Even after so many studies MarA regulon was still unknown. Hence, in this work the 
direct MarA regulon has been defined by ChIP-seq and verified using EMSA 
experiments. We show that, in addition to the ArcAB-TolC efflux pump, MarA targets 
genes that play a role in transport, DNA damage repair, and transcription regulation. 




mlaFEDCB (involved in lipid trafficking). However, there are many MarA targets that 
were revealed by our analysis that plays a role in amino acid synthesis. The role of 
MarA for these targets is still to be explored.   
   








Chapter 5. MarA-dependent 
regulation of xseA is associated with 





The ChIP-seq analysis in Chapter 4 identified MarA binding at the regulatory region of a 
gene known as xseA. This gene encodes the larger subunit of Exonuclease VII; an 
enzyme implicated in DNA repair (Chase and Masker, 1977, Repar et al., 2013). The 
phenotypic analysis of MarA target genes suggested that xseA is a determinant for 
quinolone resistance. We have verified the binding of MarA to xseA and characterised 
regulation of xseA by MarA. Moreover, we have investigated the structure/function 
analysis by Poleszak et al (2012) and have found out the functional properties of xseA 
required for quinolone resistance. 
5.2 Characterisation of PxseA 
5.2.1 Binding of MarA to xseA promoter (PxseA) 
Our ChIP-seq data suggest that, in conjunction with RNA polymerase, MarA binds a site 
overlapping the xseA promoter -35 element (Figure 5.1A). We propose that MarA 
binding could activate xseA transcription. Figure 5.1B shows the sequence of the xseA 
regulatory region, where green denotes the putative marbox and orange denotes 
PxseA. In order to verify binding of MarA to the predicted marbox at the xseA regulatory 
region, we generated two DNA fragments; xseA1 and xseA2 (Figure 5.1B; 5’ end of 
fragments represented by inverted triangles). Note that, xseA2 contains a mutation (-
36C) as well as being truncated, to complete inactivation of the marbox. An EMSA 
experiment was done to test that MarA binding with each fragment (Figure 5.2); MarA 
binds xseA1 (marbox intact) but did not bind xseA2 (marbox inactive). To further verify 
MarA binding we used DNAseI footprinting; we cloned xseA1 into a plasmid pSR and a 






Figure 5.1: MarA and 70 binding across the xseA and regulatory sequence of 
xseA. A. MarA binds in conjunction with RNAP and recognizes overlapping targets 
upstream of xseA. MarA binding is shown in green, 70 in orange and the genes are 
represented in blue. B. The regulatory sequence upstream of xseA. The start codon is 
depicted in blue, marbox in green in reverse orientation represented by an arrow. 
Davies and Drabble (1996) have identified the transcription start site +1, underlined and 
shown by the bent arrow. The promoter -10 and -35 elements are shown in orange. The 
inverted triangles show xseA1 and xseA2 fragments that were used in this study; where 




























Figure 5.2: Binding of MarA to the xseA gene regulatory region. The panels 
illustrate results of EMSA. A. MarA makes a complex with DNA when the marbox was 
intact (xseA1). B. When marbox is removed, the complex of MarA with DNA is not 
formed (xseA2). MarA was used at a final concentration of 0.3, 1.0, and 1.7 µM as 


















This fragment was end labelled, bound with purified MarA, and treated with DNAseI. 
The gel was calibrated using a Maxim/Gilbert G+A ladder. The ladder was numbered in 
accordance with the xseA start site (+1). The result is illustrated in Figure 5.3. Lane 1 
shows the digested DNA fragment in the absence of MarA. Protection of the MarA 
binding site and DNAseI hypersensitivity on either side of the binding site is evident 
when MarA is added. Hence, MarA binds the marbox predicted by MEME.   
5.3 PxseA is a MarA activated promoter 
To assess whether PxseA was dependent on MarA; xseA1 and xseA2 were fused to 
lacZ in plasmid pRW50 and cells were transformed with the resulting plasmid. We 
determined β-galactosidase activity and the results are shown in Figure 5.4. The data 
show that PxseA is active when the marbox is present but not when the marbox was 
deleted. This suggests transcription activation of PxseA by MarA. Rob and SoxS would 
likely have overlapping regulatory effects and for this reason we deleted the marbox 
rather than deleting marA. 
5.4 Innate resistance to ciprofloxacin requires MarA mediated xseA expression  
We determined the minimum inhibitory concentration (MIC) of ciprofloxacin and found 
approximately 40 fold reduction in xseA::kan cells. To assess whether the ciprofloxacin 
hypersensitivity phenotype was dependent on xseA and the PxseA marbox we did 
genetic complementation experiments. Hence, derivatives of plasmid pBR322, encoding 
xseA downstream of PxseA, with or without the marbox, were made. In the presence of 
ciprofloxacin the plasmid encoding xseA downstream of PxseA was able to rescue the 
growth of E. coli strain BW25113 xseA::kan but pBR322 by itself was not (Figure 5.5).  





Figure 5.3: DNAse I footprint of MarA binding to the xseA gene regulatory region. 
For the experiment xseA1 and purified MarA were used. The first lane had the DNAse I 
digested DNA without any MarA. MarA was titrated over the digested DNA from the 
second lane. A Maxam-Gilbert G+A sequencing ladder was used to calibrate the gel. 
The positions relative to the start site (+1) of xseA are labelled. The triangle indicates 
addition of MarA at concentrations of 0.3, 1.0, 1.7, 2.4, and 3.3 µM. The marbox is 





















Figure 5.4: The xseA promoter activity requires an intact marbox in vivo. LacZ 
assay using JCB387 containing the pRW50 derivative of xseA1 (intact marbox) and 




























Figure 5.5: Genetic complementation of xseA phenotype. The graphs show the 
OD650 values of the BW25113 and xseA::kan grown in the absence of pBR322 (left 
panel), in the presence of pBR322 on its own (middle panel), and pBR322 carrying the 
xseA gene (right panel). The cells were grown in absence or presence of 0.005 µg/ml 
ciprofloxacin. Briefly the pBR322 on its own and a derivative of xseA (marbox present) 
were transformed in BW25113 and xseA::kan cells, and growth was recorded. 
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absence of ciprofloxacin deletion of marbox has a very little effect (Figure 5.6A), but in 
the presence of ciprofloxacin deleting the marbox prevented growth (Figure 5.6 B).  
5.5 xseA determinants for DNA binding, catalysis and XseB interactions are 
required for complementation  
Genes, xseA and xseB encode the large and small subunits of exonuclease VII 
respectively. However, xseA alone is targeted by MarA (Table 4.1). Hence, xseA might 
have stand alone functions. To understand the mechanism of resistance we made 
mutations according to the structure/function analysis of Poleszak et al (2012). There 
are 4 functional regions in xseA: an N-terminal OB-fold, a catalytic domain in the centre, 
a coiled coil domain and a shorter C-terminal domain (Poleszak et al., 2012). Out of 
these four regions the OB folds binds DNA, and the coiled coil domain binds XseB. To 
determine the role of each of these activities, we introduced point mutations in xseA 
encoded by pBR322. These mutations are represented in Figure 5.7. The growth assay 
data is shown in Figure 5.8. Disrupting any of the xseA determinants that are required 
for proper functioning of exonuclease VII, results in hypersensitivity to ciprofloxacin.   
5.6 Sub-inhibitory concentration of ciprofloxacin introduces double stranded 
breaks in the cells that lack MarA controlled xseA  
Our data suggests that MarA controlled expression of xseA is vital for the cells treated 
with ciprofloxacin. We reasoned that xseA might help to reduce the frequency of double 
strand DNA breaks in cells exposed to ciprofloxacin. To test our prediction we used 
microscopy and visualised DNA damage in Hoescht stained cells. Note that quinolones 
are known to include cell filamentation and nucleoid fragmentation (Georgopapadakou 






Figure 5.6: An intact marbox is required at the upstream of the promoter for 
genetic complementation of xseA phenotype. The graph shows the OD650 values of 
the BW25113 xseA::kan grown in: A. absence or B. presence of 0.005µg/ml 
ciprofloxacin. Briefly the pBR322 derivative of xseA1 (marbox present) or xseA2 
(marbox inactive) were transformed in xseA::kan cells and growth was recorded. 











































Figure 5.7: Domain organisation of XseA. The domain of XseA is organised in four 
regions. The OB fold shown in green binds DNA, the catalytic domain shown in purple is 
responsible for the catalytic function, the coiled coils domain shown in red binds XseB 
and the C-terminal domain (CTD) is shown in orange. The figure is based on Poleszak 























Figure 5.8: The key determinants of xseA are required for its proper functioning. 
This figure shows that xseA on pBR322 is able to complement. If any of the 
determinants, e.g., the OB fold domain that binds DNA, the catalytic activity of xseA, the 
coiled coil domain responsible for XseB interaction or another coiled coil was mutated or 
disrupted then xseA loses the complementation effect in the presence of ciprofloxacin in 
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concentration of ciprofloxacin displayed this phenotype but wild type cells did not 
(Figure 5.9A, B). On complementation cells start to mimic the WT cells (Figure 5.9C). 
This effect is totally dependent on the marbox (Figure 5.9D). To verify that the observed 
changes in nucleoid conformation resulted from DNA double strand breaks, we 
performed pulse field gel electrophoresis. As expected, the chromosome of the 
untreated cells ran as tight bands and no smearing was observed, as seen in lane 1 and 
2 (Figure 5.10). The chromosome of the ciprofloxacin treated cells results in DNA 
damage but no smear was observed in the case of wild type cells (lane 3). However, the 
treated cells lacking xseA runs as a smear in lane 4. Presence of pBR322 on its own in 
the treated cells lacking xseA had no effect (lane 5). The effect was negated in the 
presence of pBR322 encoding xseA under control of PxseA and marbox (lane 6). This 
effect was again lost when the marbox was deleted as seen in lane 7 (Figure 5.10). 
 
5.7 Discussion 
DNA damage by antibiotics in bacteria can occur by different ways. Firstly, for example, 
in case of bleomycin, antibiotic can directly interact with the DNA and can result in 
double stranded breaks. However, the mechanism of how the damage occurs is still not 
understood (Hecht, 2000). Second example is based on quinolones that inhibits the 
ligase domain in topoisomerase (Hawkey, 2003). Moreover, many antibiotics exert 
metabolic changes in the cells such as production of reactive oxygen species (ROS) 
(Dwyer et al., 2014). These are mostly in the form of hydroxyl radicals that results in 
double stranded breaks. Also oxidised guanine starts to incorporate in the bacterial 




However, bacteria have mechanisms to repair the damaged DNA sometimes introduce 
mutation in their genome. Out of all, SOS reponse is activated on DNA damage by the 
activation of a protein known as RecA (Rajagopalan et al., 1992). SOS genes are 
normally repressed by another protein known as LexA. The polymers of RecA bind 
single stranded DNA and when gets activated leads to the cleavage of LexA which in 
turn leads to thhe activation of SOS genes. These genes include DNA repair enzymes 
(Brent and Ptashne, 1981).  
Recently, Wilkinson et al (2016) have shown that E. coli RecBCD (involved in double 
stranded DNA repair) is inactivated by a small phage protein Gam. This inactivity is due 
to the competition with RecBCD DNA bidning site. This process is found conserved in 
other pathogens such as Klebsiella pneumonia. Expression of Gam in such pathogens 
results in increased sensitivity to fluroquinolones (Wilkinson et al., 2016b).  
This chapter shows that MarA also targets processes involved in DNA repair; MarA 
controls xseA that encodes the enzyme exonuclease VII (Chase et al., 1986). Cells 
lacking xseA are hypersensitive to the presence of ciprofloxacin. This is because 
ciprofloxacin results in double stranded breaks that are presumably more frequent when 
xseA is absent. Quinolone resistance can arise from the combined effect of Quinolone 
Resistance Determining Regions (QRDR) mutations (first mutation in gyrA and second 
mutation in parC) (Hopkins et al., 2005) as well as AcrAB-tolC over-expression (Cohen 
et al., 1989). However, the xseA has not been noted previously. Poleszak et al., 2012 





Figure 5.9: Ciprofloxacin induced damage of E. coli cells in the absence of MarA 
mediated xseA expression. All the cells were grown in a subinhibitory concentration of 
ciprofloxacin and were DAPI stained. A. Hoescht stained WT cells that behave as 
normal in the presence of ciprofloxacin. B. xseA cells that become sensitive in the 
presence of ciprofloxacin and, when DAPI stained, cells visualized under microscope 
have a filamentous cell like structure with fragments of chromosome inside. C. Genetic 
complement of xseA; the cells starts to behave as WT but still are longer then WT.  D. 
The marbox is essential for complementation. The term “complement” denotes 
BW25113 xseA::kan transformed with pBR322 encoding xseA under control of the 
xseA1 fragment (+ marbox) or the xseA2 fragment (- marbox). All the above images 














Figure 5.10: Ciprofloxacin induced DNA damage in the absence of xseA 
expression. Integrity of chromosomal DNA was analysed using PFGE. The cells used 
were BW25113 (WT) and xseA::kan derivative (Δ). The cells were transformed with a 
derivative containing either the plasmid on its own (empty pBR322), denoted as Δ1; 
pBR322 encoding xseA under the control of the xseA1 fragment, denoted as Δ2; or 
xseA2, denoted as Δ3. The size markers are labelled and the absence or presence of 
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nuclease VII. This corresponded with our investigation. There are several new 
mechanisms, which suggest that after being induced by MarA, XseA stimulates DNA 
























Chapter 6. MarA-dependent 
regulation of mlaFEDCB is 
associated with altered outer 






The identified MarA binding sites in Chapter 4 included the regulatory region of an 
operon known as mlaFEDCB. Maintenance of OM lipid asymmetry (mla) operon 
encoded genes have functions associated with lipid trafficking. The phenotypic analysis 
of MarA targets suggests that mlaFEDCB is a determinant for MarA controlled 
resistance to tetracycline family of antibiotics. In this chapter, we have verified the 
binding of MarA upstream of mlaFEDCB, characterised nearby promoters, and 
investigated the regulation of mlaFEDCB by MarA. Moreover, we examined the 
functional aspects of mlaFEDCB associated with drug resistance.  
6.2 Binding of MarA to mlaFEDCB 
Our ChIP-seq data suggest co-binding of MarA and RNAP 70 to the mlaFEDCB locus. 
(Figure 6.1A). To verify the binding of MarA, we generated two DNA fragments 
containing the mlaFEDCB regulatory region with and without the marbox respectively: 
mlaF1 (135 bp) and mlaF2 (92 bp) (Figure 6.1B) DNA fragments. These DNA fragments 
were radiolabelled and used for in vitro EMSA experiments. The data are shown in 
Figure 6.2. As expected, MarA bound to the fragment with the intact marbox but not the 
fragment without the marbox. To verify the exact site of MarA binding, we used DNAseI 
footprinting with the 135 bp DNA fragment. The results were consistent with the ChIP-
seq analysis and EMSA, MarA binds the predicted marbox (green in Figure 6.3).  
6.3 MarA activates transcription of mlaFEDCB in vitro and in vivo 
To date, no promoters have been mapped at the mlaFEDCB regulatory region. To find 






Figure 6.1: MarA and RNA polymerase bind together across the mla regulatory 
region. A. Graph showing the binding of MarA and RNAP to the mlaFEDCB locus. 
MarA binding data is shown in green, RNAP binding profile shown in orange. Genes are 
represented by labelled blue arrows. B. The regulatory region upstream of mlaF. The 
start codon is shown in blue, marbox in green and is in forward orientation as 



































Figure 6.2: MarA binds fragments of mlaFEDCB in the presence of the marbox. 
EMSA gels, A. MarA bound with the mlaFEDCB fragment containing the marbox, B. 
MarA did not bind with the mlaFEDCB fragment lacking marbox. MarA was added at a 























Figure 6.3: DNAse I footprint of MarA binding to the regulatory region of 
mlaFEDCB. Experiment was done using the mlaFEDCB regulatory region containing 
marbox. The first lane had the DNAse I digested DNA without MarA. MarA was titrated 
over the digested DNA from the second lane. A Maxam-Gilbert G+A sequencing ladder 
was used to calibrate the gel. The positions relative to the start site (+1) of mlaFEDCB 
are labelled. The triangle indicates addition of MarA at concentrations of 0.3, 1.0, 1.7, 




















this purpose, we cloned the 135 bp DNA fragment, containing the mlaFEDCB intragenic 
region, upstream of the λoop transcription terminator in pSR. The resulting construct 
was used as a template for in vitro transcription with MarA and RNAP. Figure 6.4 shows 
the transcripts that were generated by RNAP. Note that the pSR replication origin 
encodes a 108 nt transcript (RNAI) that acts as an internal control in these assays. The 
results show generation of three transcripts (128, 148 and 157 nt long) that must initiate 
within the cloned mlaFEDCB fragment. The transcript start sites are located between 5 
and 7 bases downstream sequences similar to promoter -10 elements. We refer to the 
promoters as mlaP1, mlaP2 and mlaP3 respectively (Figure 6.1B). The marbox is 
proximally adjacent to the mlaP2 -35 element and transcription from mlaP2 is activated 
on MarA binding (Figure 6.4). This shows that MarA activates mlaFEDCB transcription 
in vitro. 
To assess transcription activation in vivo we generated pRW50 derivatives containing 
the mlaF1 or mlaF2 fragments with or without the marbox respectively. These 
constructs were then used to transform JCB387 cells and LacZ activities were 
determined by β-galactosidase assay. The results are shown in Figure 6.5 and are 
consistent with the in vitro assays; reduction in transcriptional activity was observed 
when the marbox was deleted. The residual activity observed after the deletion of 
marbox is likely from the P3 promoter.       
6.4 Innate resistance to doxycycline requires MarA mediated mlaFEDCB 
expression  







Figure 6.4: In vitro transcription assay revealed the presence of three promoters 
in the regulatory region of mlaFEDCB. Assays were done using the mlaFEDCB 
fragment containing the regulatory region cloned in plasmid pSR. A Maxam-Gilbert G+A 
sequencing ladder was used to calibrate the gel. The RNAI acts as an internal 
control,itis a transcript derived from the pSR replication origin. The mlaFEDCB fragment 
containing the regulatory region drives the formation of transcripts P1, P2 and P3. The 


















Figure 6.5: The mlaFEDCB activity requires an intact marbox in vivo. LacZ assay 
was done using JCB387 containing the pRW50 derivative of mlaFEDCB with or without 

























we sought to determine the MIC of doxycycline; an 8-fold MIC reduction occurred in 
mlaE::kan cells. To assess whether the doxycycline hypersensitivity phenotype was 
dependent on the mla operon and the marbox, we used genetic complementation. 
Hence, we generated derivatives of pBR322 encoding mlaFEDCB, and the upstream 
regulatory region, with or without the marbox. In the presence of doxycycline, the 
plasmid encoding mlaFEDCB was able to rescue the growth of E. coli strain BW25113 
mlaE::kan but pBR322 by itself was not (Figure 6.6). However it was found that intact 
marbox was important for complementation. Since, in the presence of doxycycline, 
deletion of the marbox prevented growth (Figure 6.7). 
6.5 Defective barrier functions but normal efflux was observed in the cells lacking 
mlaE 
The barrier function of the bacterial outer membrane is dependent on its asymmetry; the 
outer leaflet is marked by the presence of lipopolysaccharides whereas phospholipids 
typify the inner leaflet. The mlaFEDCB operon encodes an ABC transport system that 
removes phospholipids from the outer leaflet (Malinverni and Silhavy, 2009). Moreover, 
a gene encoding MlaE from the same operon is known to form a protein channel that 
acts as a bridge between the cytoplasm and the periplasm. Therefore, we reasoned the 
mla locus could provide enhanced resistance to drugs via altered outer membrane 
barrier function or via ABC transporter activity and MlaE (Malinverni and Silhavy, 2009). 
To assess the possibilities two key factors, drug accumulation and drug efflux 
respectively, were compared in wild type and mlaE::kan cells. Doxycycline accumulation 






Figure 6.6: Genetic complementation of mlaF::kan phenotype. OD650 values of 
BW25113 and mlaF::kan grown in: absence of pBR322 (left panel), in the presence of 
pBR322 on its own (middle panel), and pBR322 carrying the mlaFEDCB operon (right 
panel). The cells were grown in absence or presence of 1 µg/ml doxycycline, top and 
bottom panels respectively. Briefly the pBR322 on its own and a derivative of 
mlaFEDCB (marbox present) were transformed in BW25113 and mlaE::kan cells and 
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Figure 6.7: An intact marbox is required for genetic complementation of 
mlaF::kan phenotype. The graph shows the OD650 values of the BW25113 mlaE::kan 
grown in: A. absence or B. presence of 1 µg/ml doxycycline. Briefly the pBR322 
derivative of mlaFEDCB with or without the marbox was transformed in mlaE::kan cells 





































Figure 6.8: Cells lacking mlaE are defective for barrier function. Graph showing the 
accumulation of doxycycline. BW25113 cells are shown in solid blue line, the mlaE::kan 



















































Figure 6.9: Cells lacking mlaE are not defective for drug efflux. Graph showing the 
efflux of ethidium bromide. BW25113 cells are shown in solid blue line, the mlaE::kan 













































efflux remained the same in both the strains (Figure 6.9). For this reason it could be 
assumed that drug efflux will also remain the same in both the strains. The increased 
permeability suggests that MarA controls outer membrane barrier function by regulating 
mlaFEDCB.    
 
6.6 Surface hydrophobicity increased in the cells lacking mlaFEDCB  
 
A greater amount of phospholipid in a bacterium’s outer leaflet should correspond to 
greater surface hydrophobicity. Therefore, to measure such an effect, the partitioning of 
cells between the organic and aqueous phase of a two solvent system (PUM buffer and 
p-xylene) was assessed. Cells in PUM buffer were allowed to mix with p-xylene. The 
organic and aqueous phases were then allowed to reach equilibrium. To detect the 
segregation of cells we used light absorbance. Cells with greater hydrophobicity should 
move towards the organic phase equating to a reduced light absorbance by aqueous 
phase (Rosenberg et al., 1980). As expected, we found such a change; cells without 
mlaFEDCB, compared to wild type cells migrate to the organic phase more readily 
(Figure 6.10). We also assessed binding of cells with the hydrophobic dye crystal violet 
(Halder et al. 2015).  We found that the cells lacking mlaFEDCB were more successful 
at removing crystal violet from aqueous solution (Figure 6.11).  
 
6.7 Discussion 
Cell permeability in E. coli depends on the assymetric distribution of lipids in the outer 
membrane. OmpF is a porin, which is a major component of outer membrane that 







Figure 6.10: Cells that lack mlaE have increased surface hydrophobicity. Graph 
showing the percentage absorption of the aqueous layer of the mixture containing the 
indicated volume of p-xylene. BW5113 cells are represented by a solid blue line, 







0 0.1 0.2 0.3
WT
DmlaE
























Figure 6.11: Cells that lack mlaE have increased surface hydrophobicity.  Graph 
showing the OD590 of a crystal violet solution after mixing and incubating it with 
BW25113 (solid blue bar) and mlaE::kan derivative (open bar). Low OD590 value shows 






















(Chou et al., 1993, Delihas and Forst, 2001, Cohen et al., 1989). MarA activates a small 
inhibitory RNA known as micF, that downregulates expression of OmpF. Hence, the 
cells become resistance to many antibiotics by the decrease in the permeability (Cohen 
et al., 1988).  
In this chapter we studied the role of MarA in the regulation of mlaFEDCB. Many genes 
are targeted by MarA including those that have involvement with transport systems. An 
example is mlaFEDCB. The mlaFEDCB locus enables MarA to govern the control of 
lipid trafficking, hydrophobicity of cell surface and outer membrane permeability 
(Malinverni and Silhavy, 2009, Chng et al., 2010). The tetracycline family of antibiotics 
have different properties; tetracycline is less hydrophobic than doxycycline (Leive et al., 
1984). Thus we found that the cells lacking mlaFEDCB become more sensitive to 
doxycycline than tetracycline. The data was taken and re-analysed from Nichols et al. 
(2011) (Figure 4.6). Similar to our findings others have noted a positive correlation 
between the mar resistance and compound hydrophobicity (Asako et al., 1997, 
Ankarloo et al., 2010). Interestingly, the Mla system is already predicted to have an 
import function; preventing phospholipid accumulation in the outer leaflet of the outer 
membrane. This accumulation indicates disruption in packing of the OM that reduces 
barrier function (Nikaido, 2005).   
Until Thong et al (2016) have revealed it was unknown how MlaFEDB is organised and 
the role of each protein was also unknown. The authors have shown that MlaD and 
MlaB are required for the assembly and activation of the complex. They also show that 
all the proteins in the complex MlaFEDB interact tightly with each other to form a stable 




and is involved in binding to phospholipids (Thong et al., 2016). The mechanism of 
working, organisation and roles are well understood. However, the consequences 
associated with antibiotic resistance were unknown. Hence, the regulation and function 
of mlaFEDCB associated multiple antibiotic resistance was explained and it was 






































7.1 Final conclusions and General discussions 
7.1.1 Overview 
ETEC is a major cause of infection in both humans and animals (Gupta et al., 2008). 
Since its discovery approximately 50 years ago (Sack et al., 1971), ETEC and its 
virulence factors have been actively researched. We show that enterotoxin encoding 
gene expression is under the control of CRP and H-NS. We have also shown that there 
are many genes that can be controlled by MarA. Of particular interest were xseA and 
mlaFEDCB. MarA dependent regulation of these genes gives increased resistance to 
quinolones and tetracyclines.  
Our model for regulation of enterotoxin expression has implications related to treatment 
of ETEC diarrahoea. Oral rehydration therapy, which is used to rehydrate patients, may 
have consequences for toxin gene regulation. For example, rehydration solutions 
contain sugar and salts; expression of ST toxin decreases when glucose is present and 
increases when salt is present. This is because CRP and H-NS are sensors of glucose 
and osmolarity respectively.  
With respect to the MarA regulon, we were able to understand the regulation of two new 
targets. First, xseA encodes the larger subunit of exonuclease VII that has a role in DNA 
repair. Thus, cells that lack xseA become sensitive to fluoroquinolones. We suggest that 
after being activated by MarA, xseA helps in the repair of the DNA breaks generated by 
the action of fluoroquinolones. This may provide with an opportunity to acquire 
mutations that enhance quinolone resistance. Second is the mlaFEDCB operon that 




gene of this operon become sensitive to tetracyclines. Our accumulation assay shows 
that after getting activated by MarA, mlaFEDCB helps form an enhanced barrier for 
tetracycline uptake. In the future, inhibitors of XseA and MlaFEDCB could increase the 
efficiency of quinolones and tetracycline. We suggest that MarA targets found in this 
study can also be targeted by Rob, SoxS, and other MarA-like regulators. Hence, a 
deep understanding of such regulation is necessary in order to completely understand 
multiple antibiotic resistance systems.  
In this chapter I will discuss my data in the context of findings from other laboratories, 
further consider my interpretation of the data presented and highlight some future 
research directions.  
7.1.2 Understanding why chromatin immunoprecipitation does not identify all 
binding sites for CRP and MarA 
It is well established that chromatin immunoprecipitation, followed by either microarray 
deep sequencing analysis, is unable to identify all binding targets for a given gene 
regulatory protein (Grainger et al., 2005, Grainger et al., 2007, Shimada et al., 2008). In 
some instances, it may be that such false negative signals arise because epitopes on 
the surface of the protein of interest are occluded by other factors. For example, an 
adjacently bound DNA binding protein. In other instances, known targets may have 
been erroneously identified. However, the most common reason for DNA targets for a 
given protein not being isolated by chromatin immunoprecipitation appears to be 
occlusion of protein binding sites by other factors. These are often nucleoid associated 
proteins. This is best demonstrated for FNR, where 111 of 187 targets are blocked by 




CRP and MarA. Hence, in Chapter 3, I show that H-NS is able to block binding of CRP 
to the estA promoters and that this has an important regulatory effect. Binding sites for 
CRP can also be occluded by specific transcriptional regulators. Thus, at the well 
characterised lacZYA promoter, CRP binding sites overlap with binding sites for the Lac 
Repressor protein (Liu et al., 2004). This likely explains why CRP binding at the lac 
operon promoter is not detected using chromatin immunoprecipitation in the absence of 
lactose (Haycocks et al., 2015). 
The issue of DNA binding site occlusion is particularly pertinent to interpretation of my 
MarA ChIP-seq data. For instance, the marbox upstream of acnA, which was not 
detected in this work, overlaps with binding sites for CRP, FNR, and AcrA (Gruer and 
Guest, 1994). Indeed, examination of the Ecocyc database reveals that around half of 
all previously described MarA binding sites overlap with a known binding target for at 
least one other transcription factor (Keseler et al., 2017). Of course, if one considers 
competition with SoxS and Rob, it is easy to see how MarA could be excluded from 
many targets. Consistent with this, published in vitro binding constants suggest that 
almost all known marboxes are actually preferentially bound SoxS or Rob (Table 7.1). 
Consistent with this, the MarA ChIP-seq presented in this work identifies known 
marboxes only if they bind MarA tightly in vitro (Table 7.1). Thus, although the acrAB 
operon promoter is considered a target for MarA, the locus actually has a much higher 
affinity for SoxS and Rob with SoxS also being more efficient at activating acrAB 
expression than MarA (Table 7.1). It is also notable that the evidence for around half of 




example, although they are considered targets, MarA binding to pqiA, inaA, hdeA, sodA, 
fpr and purA cannot be detected in vitro (Table 7.1).  
7.1.3 Potential for overlapping regulation of mlaFEDCB and xseA by SoxS and 
Rob 
It is entirely possible that the MarA targets identified here will also be targets for SoxS 
and/or Rob. Indeed, this seems very likely given the known similarities in the DNA 
binding properties of these proteins (Martin and Rosner, 2001, Alekshun and Levy, 
1997). Importantly, overlapping regulation would not alter the main conclusion that the 
mlaFEDCB and xseA promoters are regulated by MarA; if the genes can also be 
regulated by SoxS or Rob this in no way alters our interpretation. Whilst the issue of 
overlapping regulation has not been addressed in this thesis experiments that would 
tackle the problem can be proposed. For instance, in vitro DNA binding assays such as 
those presented in Figure 4.4 could be used to assess the relative binding affinities of 
MarA, SoxS and Rob for the different targets. Similarly, monitoring reconstituted in vitro 
transcription from the mlaFEDCB P2 promoter could also address the topic. It should 
also be possible to probe the contributions of the various transcription factors in vitro. 
Thus, ectopic overexpression of MarA, SoxS or Rob could be used to determine the 
relative abilities of these proteins to activate transcription. Furthermore, in vivo DNA 
binding of the different regulators could be assessed by chromatin immunoprecipitation. 
To this end, Seo et al. (2015) have already mapped genome wide SoxS binding using a 
technique called ChIP-exo (Seo et al., 2015). Briefly, in ChIP-exo experiments, 
Immunoprecipitated protein DNA complexes are treated with an exonuclease to 
       






 MarA binding in vitro
b




         Relative activation  Other comments
e
 
    MarA SoxS Rob           (SoxS/MarA)
d
     
 
micF      yes   25 50 n.d.         1 
marRAB      yes   75 75 20         1.1 
ybjC      yes   320 100 35         0.8  
fumC      yes   320 75 75         5.3  
rob      yes   400* 100* <100*         n.d.  
nfsB      yes   >500* <200* <200*         0.6  
acrAB      yes   800 128 35         1.8     
acnA      yes   1000 350 500         3.2     
zwf      yes   >1000  >1000 1000         2.3  
pqiA      none
          
  n.d. n.d. n.d.         4  Martin et al. 2011 unable to detect binding of MarA or SoxS in vitro at 
concentrations tested.  
inaA      none
       
  n.d. n.d. n.d.         0.8  Martin et al. 2011 unable to detect binding of MarA or SoxS in vitro at 
concentrations tested.  
hdeA      none
   
  n.d. n.d. n.d.         n.d.  Schneiders et al. 2004 identified a potential MarA site but binding could not be 
detected in vitro.  
sodA      none
   
  n.d. n.d. n.d.         2.3  Martin et al. 2011 unable to detect binding of MarA or SoxS in vitro at 
concentrations tested.   
fpr      none
   
  n.d. 200 n.d.         23  Martin et al. 2011 detected binding of SoxS but not MarAin vitro at concentrations 
tested.  
purA      yes   n.d. n.d. n.d.         n.d.  Schneiders et al. 2004 detected MarA binding in vitro but no comparison with 





Genes listed are those described in Ecocyc as being MarA targets on the basis of high quality evidence (usually in vitro DNA binding assays). Predicted targets 
listed by Ecocyc are not included. Underlined genes were identified by ChIP-seq as MarA binding targets in this work. Genes in bold were identified by ChIP-exo 




evidence for purified MarA binding to the proposed target.  
c
Affinities are reported where binding of MarA and SoxS were directly compared in the same paper. An asterisk indicates values estimated from published images 
of gel electrophoretic mobility shift assays rather than values directly provided by the authors. In the table, the order in which genes is based in affinity for MarA in 
vitro. If a binding constant could not be determined this is shown as n.d.  
d
Martin et al. 2011 directly compared the ability of MarA and SoxS to activate transcription of the respective genes. A relative activation of >1 indicates more 
efficient activation by SoxS. If the comparison has not been done this is shown as n.d.    
e
In some instances Ecocyc lists genes as being MarA targets on the basis of DNA binding data. On inspection, DNA binding experiments were indeed done but no 
binding was detected under the conditions tested. 
   
    
generate short DNA fragments that precisely correspond to the DNA binding targets in 
the immuno precipitated protein. Using this approach, 25 binding sites for SoxS were 
identified in E. coli and 7 of these were also identified as MarA binding sites in my 
experiments. The overlap between the MarA and SoxS data is shown in Figure 7.1. 
Note that this comparison shows binding of SoxS but not MarA to the acrAB promoter 
as eluded to above. 
7.1.4 The Rob paradox and its implications for this work 
As noted elsewhere, members of the AraC family of transcription factors bind to DNA 
using a ~100 amino acid dual helix-turn-helix (HTH) motif (Rhee et al., 1998). In most 
cases, each HTH motif engages the DNA major groove and these sites of engagement 
are separated by one turn of the double helix (Rhee et al., 1998). The MarA and SoxS 
proteins are 127 and 107 amino acids in length respectively and share 42% sequence 
identity (66% similarity). Differences in their DNA binding determinants result in MarA 
and SoxS preferentially recognising distinct subsets of marboxes (Martin et al., 2000). 
Conversely, Rob is a 289 amino acid protein that contains a dual HTH DNA binding 
domain and a C-terminal multimerisation domain. Comparison of the dual HTH motif in 
MarA, with the equivalent amino acid sequence in Rob, reveals 43% sequence identity 
(62% similarity). However, Rob binds the DNA major groove using only one of its two 
HTH motifs (Kwon et al., 2000). The second HTH interacts non-specifically with the 
minor grove via a surface exposed arginine side chain (Kwon et al., 2000). As a result, 
Rob binds DNA less specifically, but with a higher affinity, than MarA and SoxS (Kwon 
et al., 2000). Hence, all marboxes appears to bind Rob with a higher affinity than SoxS
       
 
Figure 7.1: Overlap in the genome-wide DNA binding profiles of MarA in ETEC H10407 and SoxS in E. coli K-12. 
Venna diagram showing the MarA targets obtained from our analysis in light green colour on the left and the SoxS target 
obtained from Seo et al.(2015) is shown in green color on the right. The targets that are in common between MarA and 
SoxS are shown in the overlapping region of the two circles. The numbers in red denotes the number of targets. 
   
    
or MarA ((Kwon et al., 2000), Table 7.1). The three proteins also differently expressed; 
Rob is produced constitutively whilst MarA and SoxS are up-regulated in response to  
stress (Barbosa and Levy, 2000). Despite this, MarA and SoxS are able to outcompete 
Rob for binding many marboxes (Barbosa and Levy, 2000). This behaviour appears 
paradoxical but is possible because Rob is usually sequestered in foci whilst MarA and 
SoxS form ternary complexes with RNA polymerase that have an elevated affinity for 
marbox containing promoters (Barbosa and Levy, 2000, Kwon et al., 2000). Thus, MarA 
targets that are identified in this thesis are likely to bind Rob tightly in vitro but this is 
unlikely to be indicative of specific Rob binding.   
 
7.1.5 Why were targets such as mlaFEDCB and xseA not found in previous 
attempts to map the MarA regulon? 
Most of the DNA targets identified here for MarA have not been identified by previous 
genome-wide analyses of the MarA system. Briefly, transcriptome analyses identified 
hundreds of genes putatively controlled by MarA (Barbosa and Levy, 2000, Pomposiello 
et al., 2001). However, only 3 genes were common to independent studies (Martin and 
Rosner, 2002). Additionally, many of the targets identified by our work, including both 
mlaFEDCB and xseA, were not identified by either transcriptome analysis (Pomposiello 
et al., 2001, Barbosa and Levy, 2000). In part, the failure of transcriptome analyses to 
identify many MarA targets may be due to complications arising from contributions to 
regulation made by SoxS and Rob, which can compensate for loss of MarA (Zhang et 
al., 2008, Chubiz and Rao, 2011). Hence, MarA regulated genes cannot necessarily be 




MarA. Interestingly, in the work of Pomposiello et al., (2001) global gene expression 
was probed after treatment with stressors known to induce the MarA and SoxS systems 
and, as such, this data is difficult to interpret. An added complication, particularly for 
xseA, is that the effect of MarA on gene expression can be modest in certain conditions. 
Such smaller changes in gene expression are often removed from transcriptome 
datasets.  
Although not an attempt to map the MarA regulon, Ruiz & Levy (2010) conceived a 
genetic screen to identify chromosomal mutations altering MarA multidrug resistance. 
This genetic screen also failed to identify the MarA target genes found in this thesis. In 
this case, there is an obvious explanation; Ruiz & Levy did not directly screen for 
mutations abrogating MarA mediated multidrug resistance. As Ruiz & Levy note, “we 
would obtain many mutants that affected MDR by mechanisms unrelated to MarA”. 
Instead, Ruiz & Levy screened for chromosomal mutations that prevented repression of 
the hdeAB promoter by MarA. Clearly, there is no reason to think that mlaFEDCB or 
xseA mutation would alter hdeAB repression. The same is true of most MarA regulated 
genes. Hence, the screen of Ruiz and Levy simply identified hdeAB specific regulators 
and mutations that alter intracellular MarA levels (Ruiz and Levy, 2010). 
 
7.1.6 Comparison of MarA binding sites in ETEC and Escherichia coli K-12 
A key assumption of this work is that the MarA binding sites that I have identified using 
ChIP-seq in ETEC strain H10407 are also MarA targets in the E. coli K-12 lab strain. 




assumption. To better understand if other targets are shared, and to what extent, 
between the two strains a bioinformatics comparison was made. The xseA/mlaFEDCB 
genes and intergenic regions are identical in E. coli K-12 and ETEC. This is also the 
case for the majority of MarA targets we identified. Thus, the 200 base pairs upstream 
of each MarA target identified by ChIP-seq in ETEC are at least 99% identical at the 
DNA sequence level to the equivalent region in E. coli K-12. Similarly, the DNA 
sequence of the downstream gene has a minimum of 97% sequence similarity in all 
cases. Importantly, deletions or insertions never occur in either genes or regulatory 
regions when comparing MarA targets in ETEC and E. coli K-12. Hence, juxtaposition of 
regulatory elements is also conserved in all cases. It is possible that some of the 
apparent differences are simply mistakes in the ETEC H10407 genome sequence that 
is not as carefully curated and rechecked as that of E. coli K-12. 
 
7.1.7 Wider roles for DNA repair systems in modulating the effects of quinolones 
on gram negative bacteria 
This thesis demonstrates that the MarA regulated xseA gene, encoding the large 
subunit of exonuclease VII, can play an important role in modulating the effect of 
ciprofloxacin on E. coli. Unsurprisingly, because drugs like ciprofloxacin induce the 
formation of DNA double strand breaks, the same is true of other protein complexes 
involved with DNA repair. Most notably, the RecBCD complex has helicase and 
nuclease activity and also plays an important role. An interesting comparison is the 
different methods used to regulate xseA and recBCD expression (Figure 7.2). Briefly, 
       
 
Figure 7.2: Comparison of the xseA and recBCD gene regulatory systems. All these systems are transcribed by σ70.  
A. xseA regulatory system, B. ptrA-recB-recD operon and C. recC regulatory system. MarA and LexA are shown in green 
and yellow. The promoters are shown in black bent arrows.  
   
    
recC is monocistronic and transcribed from a σ70 dependent promoter for which there 
are no identified regulatory proteins. Conversely, recB and recD reside in an operon 
with a third gene called ptr that encodes a protease. This operon is also transcribed 
from a σ70 dependent promoter that is usually repressed by the LexA protein (Claverie-
Martin et al., 1987, Wade et al., 2005). Thus, the RecBCD complex is formed in 
response to stresses that induce the SOS system (Newmark et al., 2005). Hence, XseA 
and RecBCD are produced in response to different environmental signals to contribute 
to DNA repair. Interestingly, the activity of RecBCD can also be regulated post-
translationally by a phage encoded protein called Gam (Wilkinson et al., 2016b). Briefly, 
Gam functions as a DNA mimic and occupies the DNA binding pocket of RecBCD to 
inhibit activity of the complex (Wilkinson et al., 2016a). Thus, DNA repair systems can 
be controlled by many different signals. We note that all of the genes discussed in this 
section are transcribed from promoters dependent on the housekeeping RNA 
polymerase sigma factor. This is unlikely to be coincidental and probably represents a 
need for such genes to be expressed in many different growth conditions is a stress is 
encountered. 
7.1.8 Future work 
This thesis provides a platform for understanding the role of CRP and MarA in 
controlling gene regulation in ETEC and other bacterial strains. Whilst the CRP regulon 
is well-defined the set of genes controlled by MarA is much less well understood. 
Hence, it will be important to also investigate the genome-wide DNA binding by MarA in 
other important pathogens such as Klebsiella spp., Salmonella spp., Shigella spp. and 




in addition to SoxS and Rob. For instance, in Klebsiella spp. the RamA protein plays a 
key role in activating gene expression to provide protection against certain antibiotics. It 
is not clear why such ancillary protreins exist in bacteria other than E. coli and 
understand their presence is of key importance. This should be possible using 
techniques similar to those described here that should also enable a better 
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Abstract
Enterotoxigenic Escherichia coli (ETEC) cause severe diarrhoea in humans and neonatal farm animals. Annually, 380,000
human deaths, and multi-million dollar losses in the farming industry, can be attributed to ETEC infections. Illness results
from the action of enterotoxins, which disrupt signalling pathways that manage water and electrolyte homeostasis in the
mammalian gut. The resulting fluid loss is treated by oral rehydration. Hence, aqueous solutions of glucose and salt are
ingested by the patient. Given the central role of enterotoxins in disease, we have characterised the regulatory trigger that
controls toxin production. We show that, at the molecular level, the trigger is comprised of two gene regulatory proteins,
CRP and H-NS. Strikingly, this renders toxin expression sensitive to both conditions encountered on host cell attachment
and the components of oral rehydration therapy. For example, enterotoxin expression is induced by salt in an H-NS
dependent manner. Furthermore, depending on the toxin gene, expression is activated or repressed by glucose. The precise
sensitivity of the regulatory trigger to glucose differs because of variations in the regulatory setup for each toxin encoding
gene.
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Introduction
ETEC are Gram negative bacteria that cause severe diarrhoea,
known as non-vibrio cholera, in humans [1,2]. First isolated in
1971, ETEC are responsible for 210 million infections annually,
mostly in developing countries, leading to 380,000 deaths [3].
Disease results primarily from the action of two enterotoxins. The
heat-labile toxin (LT) is similar in structure and function to cholera
toxin [4,5]. The heat-stable toxin (ST) mimics the human
hormone guanylin [6]. Both toxins are secreted by ETEC during
infection. Made up of two subunits, encoded by the eltAB operon,
LT has the configuration AB5 [5,7]. In the gut, LT binds to host
cell GM1 gangliosides and is endocytosed [8,9]. This triggers
constitutive cAMP production in the affected cell [8]. The ST
toxin, encoded by the estA gene, also interferes with cell signalling
[6]. Hence, ST binds to the guanylate cyclase C receptor and
stimulates overproduction of cGMP. The combined actions of LT
and ST cause loss of H2O, and electrolytes, from epithelial cells
into the gut lumen [4]. Oral Rehydration Therapy (ORT) is used
to redress the resulting electrolyte imbalance and rehydrate the
patient [10]. In its most simple form, ORT requires only an
aqueous solution of glucose and salt. Hence, the availability of
metabolites and cations are a central theme of ETEC mediated
disease. The effect of ORT on human physiology is well
understood: glucose and Na2
+ are transported across the epithelial
membrane, along with water, to promote rehydration [11].
Surprisingly, despite the existence of molecular mechanisms that
allow bacteria to respond to these signals, the consequences for
ETEC are unknown.
In E. coli, the transcriptional response to glucose is controlled by
cAMP receptor protein (CRP) [12]. In the absence of glucose,
intracellular cAMP levels increase and CRP binds DNA targets
with the consensus sequence 59-TGTGA-n6-TCACA-39 [13].
Subsequently, gene expression is reprogrammed to make use of
alternative carbon sources [14]. Note that the gene regulatory
network managed by CRP includes many indirect pathways
[14,15]. Hence, CRP is also a pleiotropic regulator of transcrip-
tion. Whilst indirect regulatory effects are difficult to characterise,
genes that are directly controlled by CRP can be divided into
distinct classes [12]. At Class II targets, CRP binds to a site
overlapping the promoter -35 element and interacts directly with
both the N-terminal and C-terminal domains of the RNA
polymerase a subunit (aNTD and aCTD). At Class I targets,
CRP binds further upstream and interacts only with aCTD. This
interaction can be further stabilised by UP-elements, AT-rich
DNA sequences, adjacent to the CRP site, that facilitate aCTD-
DNA interactions [12]. At both classes of promoter, the various
contacts enhance gene expression by stabilising the transcription
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initiation complex. Unsurprisingly, most genes regulated by CRP
encode proteins involved in metabolism. However, in some
bacteria, CRP has been co-opted as a virulence regulator [16].
The Histone-like Nucleoid Structuring (H-NS) factor is a
component of bacterial nucleoprotein. Consequently, H-NS also
influences gene expression on a global scale [17]. Briefly, H-NS
targets sections of the genome with a low GC content [17].
Depending on H-NS conformation, the resulting nucleoprotein
complexes can be filamentous or bridged in organisation [18].
Filamentous complexes favour gene regulation by excluding RNA
polymerase, and transcriptional regulators, from their targets
[19,20]. Bridged complexes favour RNA polymerase trapping
[21]. In all scenarios, it is thought that H-NS acts primarily to
silence transcription [22]. The conformation of H-NS, and hence
the way in which it modulates DNA topology, can be controlled by
divalent cations. Consequently, H-NS mediated repression can be
relieved by increased osmolarity [23]. Like CRP, H-NS has been
incorporated into the virulence gene regulatory networks of many
bacteria [17].
In this work we define the molecular trigger that controls toxin
expression in ETEC. We show that CRP and H-NS are key
regulatory factors. Strikingly, this allows ETEC to integrate
extracellular signals of osmolarity and metabolism to control toxin
production. Hence, we propose that ETEC toxicity responds
directly to osmo-metabolic flux. Interestingly, the precise regula-
tory settings are different for each toxin encoding gene. The
differences result from i) varying promoter configurations and ii)
competition between CRP and H-NS for overlapping DNA
targets. This is significant since fluctuations in osmolarity, and
changes in the availability of metabolites, are central to ETEC
infection and its treatment.
Results
Binding of CRP and H-NS across the ETEC H10407
genome
The prototypical ETEC strain H10407 reproducibly elicits
diarrhoea in human volunteers and has a well-defined genome
that shares 3,766 genes with E. coli K-12 [1]. Pathogenicity arises
from 599 ancillary genes encoded by 25 discrete chromosomal loci
and 4 plasmids. The plasmids, named p948, p666, p58 and p52,
encode the enterotoxins. Derivatives of the estA gene are found on
plasmids p666 (estA1) and p948 (estA2). A single copy of the eltAB
operon is encoded by plasmid p666. We used Chromatin
Immunoprecipitation (ChIP) coupled with next-generation DNA
sequencing (ChIP-seq) to map CRP and H-NS targets across the
ETEC H10407 genome. The binding profiles are shown in
Fig. 1A. In each plot genes are illustrated by blue lines (tracks 1
and 2), DNA G/C content by a cyan and pink graph (track 3), H-
NS binding is in green (track 4) and CRP binding is shown in
orange (track 5). As expected, H-NS binding is inversely correlated
with DNA G/C content (compare tracks 3 and 4). Similarly, CRP
binding occurs in expected locations; 96% of the CRP binding
sites are associated with the DNA logo shown in Fig. 1B (i.e. the
known CRP consensus sequence (13–15)). We identified a total of
111 high-confidence CRP targets (Table 1). Of these targets 93%
were present in the genome sequences of both ETEC H10407 and
E. coli K-12. The most common location for CRP sites was in
intergenic regions (66% of targets) whilst a smaller number of
targets were found within genes (34%). Consistent with expecta-
tions, CRP sites were most frequently located ,40.5 bp, or
,92.5 bp, upstream of experimentally determined transcription
start sites (TSSs). Surprisingly, CRP binding was restricted to the
ETEC chromosome (Fig. 1Ai). Conversely, H-NS bound to
chromosomal and plasmid loci (Fig. 1Ai), including all toxin
encoding genes (Fig. 1Aii).
Unoccupied high-affinity CRP binding targets on p948
and p666 are bound by H-NS
To better understand the lack of CRP binding to p948 and
p666 we took a bioinformatic approach. CRP targets were aligned
to generate a position weight matrix (PWM). The PWM was then
used to search p948 and p666 for CRP sites. A continuum of over
100 potential CRP targets was identified. However, we recognise
that the vast majority of these are likely to be false positives.
Hence, we next sought to differentiate between genuine CRP sites
and spurious predictions. To do this, predicted sites were scored,
grouped, and ranked on the basis of their match to the PWM
(Fig. 2A, S1 Table). Electrophoretic mobility shift assays (EMSA)
were then used to measure binding of CRP to a target from each
group so that a meaningful cut-off could be established. The result
is illustrated graphically in Fig. 2B. The raw data are shown in
S1A Fig. We found that predicted sites with a score,10 did not
bind CRP. To assess the affinity of CRP for all predicted targets
scoring .10 a second set of EMSA experiments was done (S1B
Fig.). Hence, we identified a total of 5 potential CRP targets on
p666 and p948. Interestingly, the estA1 and estA2 genes, which
both encode ST, were amongst the 5 targets (Fig. 2C). Remark-
ably, all 5 of the plasmid borne CRP targets identified in silico,
and bound tightly by CRP in vitro, were occupied by H-NS in
vivo (Fig. 2C).
The estA2 gene is transcribed from a Class I CRP
dependent promoter
To understand if CRP could regulate ST production we focused
first on estA2. This derivative of the toxin is more commonly
associated with human disease and ETEC H10407 is somewhat
unusual in also encoding estA1 [24]. The sequence of the estA2
regulatory region is shown in Fig. 3A. A 93 bp DNA fragment,
containing the regulatory region, was cloned into the lacZ reporter
plasmid pRW50 to generate a lacZ fusion (S2A Fig.). The estA2
TSS was then determined using mRNA primer extension analysis.
We detected a single extension product, of 109 nucleotides (nt) in
length (Fig. 3B). The position of the TSS is labelled ‘‘+1’’ in
Fig. 3A. Promoter -10 (59-TTAAAT-39) and -35 (59-TTGCGC-
39) elements were observed at the expected positions upstream of
the TSS. Throughout this work we refer to this promoter,
highlighted purple in Fig. 3A, as PestA2. To confirm CRP binding
Author Summary
Diarrheagenic illness remains a major disease burden in
the developing world. Enterotoxigenic Escherichia coli
(ETEC) are the leading bacterial cause of such disease;
hundreds of millions of cases occur every year. The severe
watery diarrhoea associated with ETEC infections results
from the action of enterotoxins. The toxins target human
gut epithelial cells and trigger the loss of water and
electrolytes into the gut lumen. Oral rehydration therapy
can counteract this process. Hence, glucose and salt
solutions promote rehydration of the patient. In this work
we show that the gene regulatory mechanisms controlling
toxin expression respond directly to sugar and salt.
Furthermore, we describe a molecular mechanism to
explain these effects. Hence, we provide a starting point
for the optimisation of oral rehydration solutions to reduce
toxin expression over the course of an ETEC infection.
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at the predicted site we used DNase I footprinting (Fig. 3C). As
expected, CRP protected the predicted target from digestion.
Additionally, CRP induced DNase I hypersensitivity in the centre
of the site. Note that the CRP site is centred 59.5 bp upstream of
the TSS and adjacent to an AT-rich sequence that may be an UP
element (Fig. 3A). Thus, we hypothesised that PestA2 is a class I
CRP activated promoter. To test our hypothesis we first
determined whether CRP could indeed activate PestA2. To
do this, we compared LacZ expression in M182Dlac and
M182DlacDcrp cells carrying the PestA2::lacZ fusion. The data
show that loss of CRP results in a 3-fold decrease in LacZ
expression from PestA2 (Fig. 3D). We next tested the ability of
CRP to activate PestA2 in vitro. The 93 bp DNA fragment was
cloned upstream of the loop terminator in plasmid pSR. In the
context of this construct a 112 nt transcript is generated by RNA
polymerase from PestA2 in vitro. The amount of transcript can
then be quantified by electrophoresis. The result of the analysis,
with and without CRP, is shown in Fig. 3E. As expected, an
intense band corresponding to the 112 nt transcript was observed.
Production of the transcript was stimulated by CRP. Note that
CRP had no effect on production of the 108 nt control RNAI
transcript from the plasmid replication origin. Finally, we
examined the AT-rich DNA sequence (highlighted blue in
Fig. 3A) located between the CRP site and the promoter -35
element. We found that increasing the GC content of the putative
UP-element altered migration of the 93 bp DNA fragment on an
agarose gel, consistent with a change in DNA topology (S3A Fig.).
Moreover, these changes to the UP-element rendered PestA2
insensitive to CRP in vivo and in vitro (S3B Fig.).
H-NS excludes CRP from the estA2 promoter and
represses estA2 transcription
Promoters can be liberated from H-NS repression if separated
from flanking, H-NS bound, DNA [25]. We reasoned that this
Fig. 1. Distribution of CRP and H-NS across the ETEC H10407 genome. A) The panel shows maps of the ETEC H10407 chromosome (i) and
associated plasmids (ii). In each plot, tracks 1 and 2 (blue lines) show the position of genes, track 3 (purple and cyan graph) is a plot of DNA GC
content, track 4 (green) is the H-NS binding profile and track 5 (orange) is the CRP binding profile. B) A DNA sequence motif generated by aligning
regions of the ETEC H10407 chromosome bound by CRP.
doi:10.1371/journal.ppat.1004605.g001
The Molecular Basis for Control of ETEC Enterotoxin Expression
PLOS Pathogens | www.plospathogens.org 3 January 2015 | Volume 11 | Issue 1 | e1004605
Table 1. High-confidence CRP binding sites on the ETEC H10407 chromosome identified by ChIP-seq.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
45284 TGTGATTGGTATCACA ETEC_0040 caiT
92014 AGTGATGGATGTCACG (ETEC_0078) (cra)
176905 AGCGTTCCACGTCACA (ETEC_0150) (hemL)
408885 TGTGATCTCTCTCGCA ETEC_0385/ETEC_0386 yahN/yahO
461874 TGTGCGCAAGATCACA ETEC_0434 ddlA
463095 TTTGCGCGAGGTCACA (ETEC_0436) (phoA)
468009 AGGGATCTGCGTCACA ETEC_0443 aroM
492973 ATCGATTGCGTTCACG ETEC_0464 tsx
540805 TGTGATCTTTATCACA ETEC_0511 maa
574230 GATGACGACGATCACA (ETEC_0538) (ybaT)
683187 AGTGATCGAGTTAACA ETEC_0628 cstA
697540 AGTGATTTGCGTCACA ETEC_0639 rnk
739223 CGTTACCCTTGTCGCA ETEC_0680 rihA
941002 TGTGATGAGTATCACG ETEC_0869 ybiJ
958866 TGTGTACGAAATCACA ETEC_0886/ETEC_0887 ybiS/ybiT
1128472 n.d. (ETEC_1030) (yccS)
1205350 AGTGATGTAGATCACA ETEC_1101 ycgZ
TGAGATCGAGCACACA
1263558 TTTGACGGCTATCACG ETEC_1166 ptsG
1274886 TGTGATCTGGATCACA ETEC_1176/ETEC_1177 ycfQ/bhsA
1301786 GATGATCCGCATCACA (ETEC_1206)/ETEC_1207 ETEC-specific/ETEC-specific
1348166 ATTGAACAGGATCACA (ETEC_1259)/ETEC_1260 (rluE)/icd
1376374 GGTGAGCTGGCTCACA ETEC_1292/ETEC_1293 ycgB/dadA
1388620 AGTGAGCCAGTTAACA (ETEC_1303) (dhal)
1541732 CGTGAACCGGGTCACA ETEC_1443/ETEC_1444 ycjZ/mppA
1567885 GTTAAGTAAAATCACA ETEC_1462/ETEC_1463 paaZ/paaA
1701402 TGTGATGGATGTCACT ETEC_1568 ydeN
1767726 TGTGATTAACAGCACA ETEC_1628 mlc
1777143 TGTGATCTAGCGCCAA ETEC_1637 pntA
1811426 CGTGATCAAGATCACG (ETEC_1668A) (ETEC specific)
1859265 ATTGAGCGGGATCACA (ETEC_1713) (sufS)
1887513 AGTGATGCGCATCACG ETEC_1737 aroH
TGCGAGGTGTGTCACA
2126754 TGTGGCGTGCATCACA n.a. n.a.
2201816 GGTGACGCGCGTCACA ETEC_2057 yedP
2210222 CGTGATCTCGCGCACA ETEC_2065/ETEC_2066 yedR/ETEC-specific
2458348 TGTGATCTGAATCTCA ETEC_2278 cdd
TGCGATGCGTCGCGCA
2492757 ATTGATCGCCCTCACA ETEC_2309 yeiQ
2555083 CGTGACCAAAGTCTCA (ETEC_2360) (yfaQ)
2729713 TTTGAAGCTTGTCACA ETEC_2510/ETEC_2511 mntH/nupC
2735124 AGTTATTCATGTCACG ETEC_2514 yfeC
2795423 TGTGAGCCATGACACA (ETEC_2572)/ETEC_2573 (aegA)/narQ
2810983 CGTGATCAAGATCACA ETEC_2586 hyfA
2887131 TTTGATCTCGCTCACA (ETEC_2666)/ETEC_2665 (xseA)/guaB
3012645 TGTGATCCCCACAACA (ETEC_2793) (ung)
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Table 1. Cont.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
3048307 TTTGACGAGCATCACC (ETEC_2822) (emrB)
3132920 GGTGACCGGTTTCACA ETEC_2905/ETEC_2906 ascG/ascF
3161660 TGTGACCGTGGTCGCA (ETEC_2933) (nlpD)
3184337 CGTGATGCGTGTAACA (ETEC_2956)/ETEC_2955 (cysI)/cysH
3196088 TGTGATTACGATCACA ETEC_2966/ETEC_2967 ygcW/yqcE
3223792 AGTGATCTTGATCTCA ETEC_2986 sdaC
AGTTATGTATCTATCA
3234980 TGCGATCGTTATCACA (ETEC_2994)/ETEC_2995 (fucU)/fucR
3265047 TGTGACCTGGGTCACG ETEC_3017 rppH
3324543 TGTGGGCTACGTAACA (ETEC_3075) (ydhD)
3361162 n.d. ETEC_3105 serA
3368992 TTTGATGCACCGCACA (ETEC_3113) (ygfI)
3382158 TGTGATCTACAACACG ETEC_3126 cmtB
3390811 TGTGATTTGCTTCACA ETEC_3133 galP
3408173 TGTGATGTGGATAACA ETEC_3154 nupG
3442697 TGTGATGATTGTCGCA ETEC_3186 ETEC-specific
3558573 AGTGATTTGGCTCACA ETEC_3291 ygiS
3580767 AGTGACTTGCATCACA (ETEC_3318) (yqiH)
3635301 ATTGATCTAACTCACG ETEC_3362 uxaC
3642302 CTTGAAGTGGGTCACA (ETEC_3372) (yqjG)
3665634 TGTGATCAATGTCAAT ETEC_3393/ETEC_3394 garP/garD
TGTGCTTTAGCGCGCA
3721308 GGTGATTGATGTCACC (ETEC_3446) (greA)
3785700 CGTGGGTCGCATCACA (ETEC_3510) (mreC)
3878729 GGTGATTTTGATCACG ETEC_3614/ETEC_3615 ppiA/tsgA
3908574 GGTGATCGCGCTCACA (ETEC_3645) (hofM)
3918861 TGTGAGTGGAATCGCA ETEC_3652/ETEC_3653 yhgE/pck
3986400 CGTGATTTTATCCACA ETEC_3707 rpoH
4105040 AGTAAGGCAAGTCCCT n.a. n.a.
4111116 TGTGACGGGGCTAACA (ETEC_3806) (wecH)
4153055 TGTGATCTGAATCACA ETEC_3840 yibI
TGTGATCTACAGCATG
4153191 TGTGATTGATATCACA ETEC_3841 mtlA
TGTGATGAACGTCACG
4158433 n.d. ETEC_3846 lldP
4196869 TGCAATCGATATCACA ETEC_3886 dinD
4251326 CTTACTCCTGCTCACA ETEC_3938 ETEC specific
4266125 GGTGATGGCATCCGCG (ETEC_3956) (nepI)
4290730 GGTGAGCAAAACCACG (ETEC_3979) (yidR)
4322430 ATTGACCTGAGTCACA (ETEC_4010) (yieL)
4340544 CTTGACCACGGTCAGA (ETEC_4025)/ETEC_4024 (atpA)/atpG
4344649 TGTGATCTGAAGCACG ETEC_4030 atpI
4373517 TGTAATGCTGGTAACA (ETEC_4051) (ilvG)
4402013 CGTGCTGCATATCACG (ETEC_4077) (rffM)
4412999 CGTGATCAATTTAACA ETEC_4085/ETEC_4085 hemC/cyaA
4438352 GGTGATGAGTATCACG ETEC_4107/ETEC_4108 ysgA/udp
The Molecular Basis for Control of ETEC Enterotoxin Expression
PLOS Pathogens | www.plospathogens.org 5 January 2015 | Volume 11 | Issue 1 | e1004605
might be why, when isolated on the 93 bp fragment, PestA2 was
active and dependent on CRP. To test this logic we generated a
further two PestA2::lacZ fusions using the pRW50 plasmid system.
The additional PestA2 DNA fragments were both 460 bp in length
and include the full estA2 gene that was entirely bound by H-NS
in our ChIP-seq assay (Fig. 2C). The CRP site was ablated in one
of the additional fragments by introducing point mutations that
are predicted to disrupt CRP binding. The sequence of the DNA
fragments is shown in S2A Fig. The lacZ fusions are illustrated
graphically in Fig. 4A. Our expectation was that the longer
460 bp fragment would bind H-NS whilst the starting 93 bp
fragment would not. To test this prediction we used ChIP. Thus,
we compared H-NS binding to the different PestA2 containing
fragments in vivo. Fig. 4B shows results of a PCR analysis to
measure enrichment of the PestA2 locus. As expected, PestA2 was
only enriched in anti-H-NS immunoprecipitates when in the
context of the 460 bp fragment. Crucially, enrichment is specific
because, in a set of control PCR reactions, there was no
enrichment of the yabN locus in any immunoprecipitate.
Our ChIP analysis suggests that the 460 bp fragment containing
PestA2 is subject to regulation by H-NS. To confirm that this was
the case, the various pRW50 derivatives were used to transform
M182Dlac and M182DlacDhns cells. We then measured LacZ
activity, driven by PestA2, in the transformants. Consistent with
our expectations the data show that PestA2 is repressed 5-fold by
H-NS only in the context of the 460 bp DNA fragment (Fig. 4C).
Importantly, mutations in the CRP binding site abolish PestA2
activity in the absence of H-NS. Hence, the measured LacZ
expression must be driven by PestA2 rather than any spurious
promoters located within the estA2 gene. Taken together our
ChIP-seq and LacZ activity data show that H-NS prevents CRP
from activating PestA2.
The estA2 and estA1 promoters are differently regulated
by CRP but similarly regulated by H-NS
The estA1 regulatory region, located on plasmid p666, contains
a sequence similar to PestA2 (Fig. 5A). We expected that this
sequence would be the estA1 promoter (PestA1). To test this
expectation we created a 92 bp PestA1::lacZ fusion, equivalent to
the 93 bp PestA2::lacZ fusion described above, and mapped the 59
end of the resulting mRNA. As expected, the primer extension
product was 109 nt in length (Fig. 5B). Hence, PestA1 and PestA2
use equivalent TSSs. However, we were surprised that the
intensity of the PestA1 primer extension product increased in cells
lacking CRP (Fig. 5B). Closer examination of the alignment in
Fig. 5A shows that, whilst PestA1 and PestA2 are similar, there are
differences in the sequence and position of key promoter elements.
To try and understand which changes result in the aberrant
behaviour of PestA1 we made a set of hybrid promoters. The
hybrid constructs are derived from the CRP-activated estA2
promoter. In each hybrid, named PestA2.1 through PestA2.7, a
region of PestA2 was replaced with the equivalent region from
Table 1. Cont.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
TGTGATTTGAATCACT
4508745 TGTGATATTTGTCACA (ETEC_4165)/ETEC_4164 (fdhD)/fdoG
4517442 CGTGATCGCTGTCCCA (ETEC_4173) (rhaA)
4564670 TGCGATCCGCCTCATA ETEC_4216/ETEC_4217 ptsA/frwC
4668870 TGTAACAGAGATCACA ETEC_4289/ETEC_4290 malE/malK
4725047 TGTGCGGATGATCACA n.a. n.a.
4731402 TGTGATCTTGCGCATA (ETEC_4365) (aphA)
4761367 CGTGATGGCTGTCACG ETEC_4389 fdhF
4846352 n.d. ETEC_4464 ETEC-specific
4848117 CGTGAGTTCTGTCACA n.a. n.a.
4863253 TTTGATCAACATCGCA (ETEC_4478) (ETEC-specific)
4873926 GGTGATCTATTTCACA ETEC_4486/ETEC_4487 aspA/fxsA
4930149 TGTGATGAACTTCAAA ETEC_4545/ETEC_4546 yjfY/rpsF
4940903 TGTGATCACTATCGCA ETEC_4557/ETEC_4558 ETEC-specific/ytfA
4993073 TGTGACTGGTATCTCG (ETEC_4604) (valS)
5002854 TGTAACCTTTGTCACA ETEC_4610/tRNA-Leu yjgB/tRNA-Leu
5030724 TGCGATGAATGTCACA ETEC_4633/ETEC_4634 gntP/uxuA
5129400 CGTACCGTCGGTCACA (ETEC_4736) (yjjI)
5129944 TGTGATGTATATCGAA ETEC_4736/ETEC_4737 yjjI/deoC
aChomosome coordinate of the ChIP-seq peak in H10407. Underlined text indicates that the ChIP-seq peak maps to sequence that is not conserved in E. coli K-12.
bCRP binding site sequence predicted by MEME. ‘‘n.d.’’ indicates that MEME did not detect a putative binding site.
cGenes in parentheses indicate that the ChIP-seq peak is located within that gene. Downstream genes are only listed if the annotated gene start is #300 bp
downstream of the CRP ChIP-seq peak. ‘‘n.a.’’ indicates that no genes starts are #300 bp from the CRP ChIP-seq peak.
dE. coli K-12 homologues are listed for the ETEC genes in the previous column. Genes in parentheses indicate that the ChIP-seq peak is located within that gene. ‘‘n.a.’’
indicates that no genes starts are #300 bp from the CRP ChIP-seq peak. ‘‘ETEC-specific’’ indicates that there is no K-12 homologue. Underlined genes have been
identified as CRP targets in a previous ChIP-chip study [15]. Bold genes are listed as CRP targets in the Ecocyc database.
doi:10.1371/journal.ppat.1004605.t001
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PestA1 (see underlined sequences in Fig. 5C). The ability of the
different hybrid promoters to drive lacZ expression, with and
without CRP, was then tested. The results are shown in Fig. 5D.
Note that, in Fig. 5D, the composition of each hybrid promoter is
indicated in the grid below the graph. For example, PestA2.1 is
derived from PestA2 but contains the PestA1 CRP site. As
expected, both PestA1 and PestA2 were able to drive lacZ
expression but CRP had opposite effects. Moreover, maximal
expression from PestA1 was 3-fold lower than from PestA2. Only
PestA2.3 and PestA2.5, which both carried the same changes in
the promoter -35 element, exhibited a reversed dependence on
CRP. Hence, the PestA1 -35 element must be responsible for the
altered CRP dependence. All other hybrid promoters exhibited an
overall reduction in activity compared to the parent PestA2
construct. We conclude that this combination of changes results in
the lower activity of PestA1. Note that both PestA1 and PestA2
were bound by H-NS in our ChIP-seq analysis (Fig. 2C). We
reasoned that cloning PestA1, with flanking DNA, would reveal H-
NS mediated repression. We generated a derivative of the
PestA1::lacZ fusion where the downstream boundary was extend-
ed to include the entire estA1 gene (S2B Fig., Fig. 5Ei). As
expected, transcription from PestA1 was repressed by H-NS in the
presence of downstream DNA (Fig. 5Eii).
The eltAB operon is indirectly repressed by CRP and
directly repressed by H-NS
We next turned our attention to the LT toxin promoter (PeltAB)
[26,27]. Previously, Bodero and Munson [27] showed that
transcription from this promoter was repressed by CRP. A
mechanism for repression was proposed whereby CRP acted
directly by binding three DNA targets overlapping PeltAB [27].
Even so, no CRP binding at PeltAB was identified by our ChIP-
seq analysis (Fig. 6A). It is possible that this is because H-NS also
excludes CRP from this locus (Fig. 6A). However, we also failed to
identify CRP targets at PeltAB in our bioinformatic screen, even
below the stringent cut-off (Fig. 2, S1 Table). In retrospect, this
appears to be because all of three PeltAB CRP binding sites
contain at least 4 mismatches to the consensus for CRP binding
(Fig. 6A). Hence, we measured the affinity of CRP for PeltAB
using EMSA assays. In parallel, we tested CRP binding to PestA2
as a control. As expected, CRP bound tightly to PestA2 at low
concentrations (Fig. 6B, lanes 1–6). At high CRP concentrations
further non-specific binding was observed (evidenced by a
conspicuous ‘‘smear’’ in DNA migration in lane 7). In the
equivalent experiment, with PeltAB, no specific binding of CRP
was observed (lanes 8–13). However, non-specific CRP binding
was again detectable at high protein concentrations (lane 14).
Hence, CRP does not bind specifically to PeltAB. We hypothesised
that previously observed changes in PeltAB activity, in cells lacking
CRP, may occur indirectly. To test this, we cloned a 359 bp DNA
fragment, containing PeltAB, into our pRW50 lacZ expression
system. We also made a truncated 118 bp derivative of this
construct where two of the three putative CRP targets were
removed. A derivative of the truncated 118 bp construct, where
the remaining CRP site was completely ablated by point
mutations, was also made. The DNA sequences of the different
constructs are shown in S2C Fig. They are illustrated graphically
in Fig. 6Ci. Consistent with previous measurements, we found that
transcription from PeltAB increased 2.5 fold in the absence of
CRP. However, the response of PeltAB was identical when the
CRP binding sites were removed (Fig. 6Cii). Hence, although
CRP represses transcription from PeltAB, this must occur
indirectly.
Given the configuration of H-NS binding at the eltAB locus
(Fig. 6A) we reasoned that PeltAB would be repressed by H-NS in
the presence of sufficient flanking DNA. As we had done
previously for PestA1 and PestA2, we compared the binding of
H-NS to PeltAB in the presence and absence of the downstream
flanking sequence. The different DNA constructs are illustrated in
Fig. 7A and results of ChIP experiments to measure H-NS binding
are shown in Fig. 7B. As predicted, enrichment of PeltAB, in
immunoprecipitations with anti-H-NS, was only observed in the
presence of downstream DNA. Importantly, this enrichment was
specific to PeltAB and not observed for the control locus yabN.
Corresponding LacZ activities, for the different DNA constructs,
measured in M182 or the Dhns derivative, are shown in Fig. 7C.
Incorporation of flanking DNA downstream of PeltAB resulted in
a 15-fold reduction in LacZ activity that was largely relieved in the
absence of H-NS.
CRP and H-NS allow the estA1, estA2 and eltAB promoters
to respond to glucose and salt
Given the established regulatory connections between CRP and
glucose, and between H-NS and salt, we next measured changes in
the activity of PestA1, PestA2 and PeltAB in response to glucose
and salt. A complete description of assay conditions is provided in
the Materials and Methods section. Briefly, to establish the range
Fig. 2. Unoccupied CRP sites on p666 and p948 align with H-NS
bound regions. A) A histogram showing the number of putative CRP
binding sites in each of 7 discrete bins. Each bin is delineated by the
‘‘score’’ of the putative CRP site. A high score indicates a better match
to the Position Weight Matrix that represents the consensus for CRP
binding. B) The graph illustrates binding of CRP to a target from each of
the bins shown in Panel A. CRP was used at concentrations of 0, 175,
350 or 700 nM. C) ChIP-seq data for CRP and H-NS binding at five
regions of plasmids p666 and p948 that contain unoccupied CRP
targets bound by CRP in vitro. The CRP and H-NS binding profiles are
plots of sequence read counts at each position of the genome on both
the top (above the central line) and bottom (below the central line)
strand of the DNA. The y-axis scale is the same in each panel. The scale
for H-NS binding is 1,785 reads on each strand and for CRP binding is
14,000 reads on each strand.
doi:10.1371/journal.ppat.1004605.g002
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of conditions across which the promoters were able to respond, we
examined the effect of titrating glucose or salt into the growth
medium individually. In all experiments, we used the promoter::
lacZ fusions that included downstream flanking DNA. This was to
ensure that signals sensed by both CRP and H-NS could
be integrated. As expected, the activity of PestA1 was low.
Consequently, the effects of glucose and salt were negligible (S4A
Fig.). Conversely, the activity of PestA2 was sensitive to both
glucose and salt (S4B Fig.). Thus, lacZ expression driven by PestA2
was repressed by glucose (orange line) and enhanced by salt (green
line). As expected, PeltAB activity increased in the presence of
both salt and glucose, but induction by salt was more prominent
(S4C Fig.). We hypothesised that, for PestA2, the inhibitory effect
of glucose should override the stimulatory effect of salt. Our
reasoning was that, although H-NS can repress PestA2, the
promoter is ultimately dependent on CRP for activity. Hence, we
examined the effect of adding salt and glucose, to cells carrying the
PestA2::lacZ fusion, separately and in combination (Fig. 8A). As
predicted, the inhibitory effect of glucose was dominant (Fig. 8Ai)
and was still observed in the absence of H-NS (Fig. 8Aii).
Conversely, the stimulatory effect of salt required H-NS (compare
green bars in Fig. 8). Importantly, in a separate experiment, we
also showed that the effect of glucose on PestA2 activity requires
that the CRP site is intact (S4D Fig.). The combined effect of salt
and glucose on PeltAB was more difficult to predict because CRP
acts via an undefined, and indirect, mechanism. The result of the
analysis (Fig. 8B) shows that the stimulatory effects of salt and
glucose on transcription from PeltAB are not additive. Moreover,
the stimulatory effect of glucose requires H-NS.
The response of PeltAB and PestA2 to CRP and H-NS is
conserved in other ETEC isolates and during host cell
attachment
Examination of all sequenced ETEC genomes reveals slight
variations in the sequence of the eltAB and estA2 promoter
sequences (recall that ETEC H10407 is somewhat anomalous in
also encoding estA1). Thus, we next sought to understand if our
model for regulation of LT and ST expression was broadly
applicable. We focused our efforts on ETEC E24377A since i) the
genome has been sequenced and ii) a vast array of independently
generated transcriptomic data are available for this organism
Fig. 3. The estA2 promoter is activated by a Class I CRP dependent mechanism. A) Sequence of the estA2 gene regulatory region. The CRP
binding site is shown in orange, the UP element is blue and the promoter -10 and -35 elements are shown in purple. The different promoter positions
are numbered relative to the transcription start site (+1). B) Location of the PestA2 transcription start site. The gel shows the product of an mRNA
primer extension analysis to determine the estA2 transcription start site (Lane 5). The gel was calibrated using arbitrary size standards (A, C, G and T in
Lanes 1–4). C) Binding of CRP to PestA2. The panel shows the result of a DNAse I footprint to monitor binding of CRP to the 93 bp PestA2 DNA
fragment. The gel is calibrated with a Maxim-Gilbert DNA sequencing reaction. CRP was added at concentrations of 0.35–2.1 mM. D) CRP is required
for transcription from PestA2 in vivo. The panel shows a cartoon representation of the 93 bp PestA2::lacZ fusion and a bar chart illustrates LacZ activity
in lysates of cells carrying this fusion. Assays were done in LB medium. E) i) Stimulation of PestA2 by CRP in vitro. The figure shows the results of an in
vitro transcription reaction. The 112 nt transcript initiates from PestA2 and the 108 nt RNAI transcript is an internal control. CRP was added at a
concentration of 350 nM and RNA polymerase was added at a concentration of 400 nM. ii) quantification of band intensities from the in vitro
transcription analysis.
doi:10.1371/journal.ppat.1004605.g003
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[28,29]. Using ETEC E24377A DNA as a template, we generated
a 460 bp PestA2, and 1126 bp PeltAB DNA fragment. The
sequences are shown in S2D Fig. The DNA fragments were cloned
into pRW50 and the ability of the promoters to drive lacZ
expression in response to CRP and H-NS was measured. As
expected, transcription from PestA2 was repressed by H-NS and
activated by CRP whilst PeltAB was repressed by H-NS (Fig. 9A).
We observed no effect of CRP on transcription from PeltAB in the
context of the 1126 bp ETEC E24377A fragment. This is not
unexpected because CRP acts indirectly and these indirect CRP
effects have only previously been observed in the context of short
DNA fragments containing PeltAB that are not subject to direct
repression by H-NS. We note that Sahl and Rasko previously
examined the global transcriptome response of E24377A to
glucose levels and bile salts [28]. In exact agreement with our
model for toxin regulation, and the data in Fig. 9A, this study
confirmed that i) salt induced expression of both toxins and ii)
glucose inhibited expression of estA2 [28]. Fortuitously, changes in
the ETEC E24377A transcriptome, prompted by ETEC attach-
ment to human gut epithelial cells, have also been quantified
comprehensively [29]. Briefly, in these experiments, ETEC were
added to sets of Caco-2 intestinal epithelial cell tissue cultures.
Over a time course, ETEC that had adhered to host cells were
separated from non-adhered ETEC. The transcriptomes of
adhered and non-adhered ETEC were then compared. By mining
these data, we next sought to determine if our model was
consistent with observed changes in the transcription of crp, hns,
eltA and estA during host cell attachment. Briefly, our data predict
that changes in estA expression should be directly correlated to
changes in the level of CRP and inversely correlated with changes
in levels of H-NS. Conversely, levels of eltA expression should be
inversely correlated with levels of H-NS. The result of the analysis
is illustrated in Fig. 9B. The data show that the relative levels of
crp transcription in attached and unattached cells are similar
(orange line). However, levels of hns transcription change
dramatically (green line) 60 minutes after host cell attachment.
As predicted by our model, levels of estA2 and eltA transcription
(dashed lines) inversely track changes hns transcript levels. When
undertaking this analysis we noticed that, although there was little
change in the relative level of crp mRNA between attached and
unattached ETEC cells, the absolute level of crp mRNA did
fluctuate across the time course of the experiment and between
biological replicates. Strikingly, when these absolute mRNA levels
are compared there is a clear linear relationship between crp and
estA2 expression (Fig. 9C). Note that in Fig. 9C the absolute level
of hns mRNA has been added in parenthesis for each data point.
Remarkably, the only two outlying data points in this plot
correspond to the two samples with increased hns expression. We
conclude that regulation of estA2 and eltA by CRP and H-NS is
important during the attachment of ETEC to human intestinal
epithelial cells, and that the regulatory control of ETEC toxins is
conserved across different strains.
Disrupting the regulatory switch attenuates ETEC
virulence
Taken together, our data suggest that CRP and H-NS form a
regulatory switch that controls ETEC toxicity. We next sought to
examine the effect of disabling the switch on virulence. This is not
straightforward because no animal model faithfully mimics the
disease caused by ETEC in humans. However, intranasal mouse
models have been used as a proxy for measuring E. coli
pathogenicity [30]. Importantly, pathogenic E. coli cause more
severe disease in this model than non-pathogenic strains [30].
Furthermore, ETEC strains lacking genes encoding toxins and
known colonisation factors are less virulent in this model [31]. We
opted to disrupt the regulatory switch by removing the crp rather
than the hns gene. This was a deliberate decision since E. coli
strains lacking hns are severely attenuated for growth in laboratory
conditions. Conversely, the crp null derivative of ETEC H10407
was only mildly compromised for growth in liquid culture. Hence,
we compared pathogenicity of ETEC H10407, and the crp
derivative, using the intranasal mouse model [30]. Note that the
outcome of this experiment is difficult to predict since the effects of
CRP on pathogenicity likely go far beyond the control of toxin
expression. However, it is reasonable to assume that ETEC
virulence should differ in cells lacking crp. The median survival of
mice challenged with wild type ETEC was 53 hours and the
Fig. 4. The estA2 promoter is repressed by H-NS. A) The panel shows different PestA2::lacZ fusions. The lacZ gene is shown as a red arrow and
the estA2 gene is shown as a blue arrow. PestA2 is illustrated using a bent arrow and the CRP binding site is shown as an orange box. B) H-NS binds to
PestA2 only in the presence of flanking DNA. ChIP-PCR was used to measure binding of H-NS to the different PestA2 derivatives cloned in pRW50. PCR
products were generated using primers that could detect PestA2 in the context of both the 93 bp fragment and the longer 460 bp fragment. C) The
values are b-galactsidase activity values for lysates of M182, or M182Dhns, carrying the different PestA2 derivatives. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g004
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mortality rate was 100%. Conversely, the median survival of mice
challenged with Dcrp ETEC was 72 h and 20% of the mice
survived (Fig. 9D). Thus, whilst the full extent to which CRP co-
ordinates the ETEC virulence programme remains to be
determined, CRP is clearly central to the pathogenic response.
Discussion
A complex hierarchy of salt and glucose-dependent
regulation controls toxin expression
We propose that toxin expression in ETEC can be controlled by
osmo-metabolic flux. This is relevant to conditions in the small
intestine (osmolarity equivalent to 300 mM NaCl) disease symp-
toms (the extrusion of cations and cAMP into the gut lumen) and
treatment (the ingestion of solutions containing glucose and salt)
[7–11,32]. A molecular model, describing how the different signals
are integrated, is illustrated in Fig. 10. Two gene regulatory
proteins, CRP and H-NS, are central to our model. Hence, H-NS
directly represses the expression of eltAB, estA1 and estA2
(pathways ‘‘a’’ and ‘‘b’’ in Fig. 10). For estA2 and eltAB this
repression can be relieved, in an H-NS dependent manner, by
increased osmolarity. At PestA2 CRP directly activates transcrip-
tion by a Class I mechanism (pathway ‘‘c’’). H-NS can interfere
with this process by competing with CRP for binding at PestA2
(pathway ‘‘d’’). Finally, CRP can indirectly repress expression of
eltAB via an unknown pathway that is influenced by H-NS (‘‘e’’).
Both pathways ‘‘c’’ and ‘‘e’’ are sensitive to glucose availability
because of their dependence on CRP. We speculate that pathway
Fig. 5. Comparison of PestA1 and PestA2 reveals differential activity and regulation by CRP. A) Comparison of PestA1 and PestA2. The
panel shows the DNA sequences of PestA1 and PestA2. Bases that are identical are highlighted by a solid vertical line. The CRP sites are shown in
orange, the UP element in blue and the core promoter elements in purple. The sequences are numbered with respect to the transcription start site (+
1). B) Location of the PestA1 transcription start site. The gel shows products from an mRNA primer extension analysis (Lanes 5 and 6). The gel was
calibrated using arbitrary size standards (A, C, G and T in Lanes 1–4). C) Sequences of hybrid estA promoters. The sequences labelled estA2.1 through
estA2.7 are derivatives of the 93 bp PestA2 DNA fragment where different sequence elements have been replaced with the equivalent sequence from
PestA1. D) The bar chart shows b-galactosidase activity measurements for lysates obtained from cultures of M182, or the Dcrp derivative, containing
the indicated hybrid promoter fragment was fused to lacZ. E) The panel shows different PestA1::lacZ fusions. The lacZ gene is shown as a red arrow
and the estA1 gene is shown as a blue arrow. PestA1 is illustrated using a bent arrow and the CRP binding site is shown as an orange box. Assays were
done in LB medium.
doi:10.1371/journal.ppat.1004605.g005
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‘‘e’’ may include H-NS since the effects of salt and sugar on eltAB
expression were epistatic (Fig. 8). Our model for H-NS repression
of eltAB is consistent with previous work [26]. However, our
conclusion that eltAB is indirectly repressed by CRP disagrees with
a previous study [27]. Even so, we were able to faithfully
reproduce most of the observations previously described by
Bodero and Munson [27]. We note that Bodero and Munson
previously suggested that CRP may bind targets at PeltAB with a
7, rather than 6, base pair spacer between the two CRP half sites.
Such CRP targets have never been described amongst hundreds of
known CRP regulated promoters. Furthermore, we found no such
CRP sites in our ChIP-seq analysis. Given that these DNA
sequences can be deleted, without negating the effect of CRP on
PeltAB activity, the regulatory effect of CRP must be indirect.
Oral Rehydration Therapy is likely to impact on toxin
expression
Our model for regulation of ST and LT expression is pertinent
to both ETEC mediated disease and its treatment. ST and LT
trigger the extrusion of H2O, cations, and cAMP (the cofactor for
CRP) from the small intestine into the gut lumen [4–9].
Furthermore, solutions of salt and glucose are consumed by
patients to reverse this process [10,11]. We speculate that, during
infection, extrusion of electrolytes and cAMP into the gut lumen
could create a positive feedback loop to drive toxin expression.
Importantly, our model also suggests that ORT may provide
benefits beyond stimulating rehydration of the patient. The
concentration of glucose used in ORT is ,10-fold higher than
is required to repress estA2 expression. Hence, even if 90% of
glucose present in ORT solutions is absorbed before reaching the
site of infection, sufficient glucose should be present to down
regulate toxin expression. Furthermore, even though salt is able to
induce expression of estA2 and eltAB, the effect is only observed at
concentrations far higher than those found in ORT solutions.
Differential regulation of estA1 and estA2 by CRP
Our observation that estA1 and estA2 are oppositely regulated
by CRP is intriguing given the similarities between the promoter
sequences of these genes. Differential regulation is dependent on
the promoter -35 element (Fig. 5). At Class I CRP regulated
promoters an aCTD protomer sits between CRP and domain 4 of
the RNA polymerase s subunit, which is bound to the promoter -
35 element [12]. Thus, one possible explanation is that changes in
the -35 element result in subtle repositioning of s. This could
result in unproductive interactions between aCTD and s when
CRP is present.
Fig. 6. The eltAB promoter is indirectly repressed by CRP. A) The Panel shows ChIP-seq data for CRP and H-NS binding at the eltAB locus. The
sequence of 3 putative CRP binding sites proposed by Bodero and Munson (2009) are shown. The CRP and H-NS binding profiles are plots of
sequence read counts at each position of the genome on both the top (above the central line) and bottom (below the central line) strand of the DNA.
The y-axis scale for H-NS binding is 1,785 reads on each strand and for CRP binding is 14,000 reads on each strand. B) Results of an Electorphoretic
Mobility Shift Assay to measure binding of CRP to the 93 bp PestA2 fragment (Lanes 1–7) or the 359 bp PeltAB fragment (Lanes 8–14). Specific and
non-specific binding of CRP is indicated to the left and right of the gel. CRP was added at a concentration of 0.2–7.0 mM. C) Panel (i) shows different
PeltAB::lacZ fusions. The lacZ gene is shown as a red arrow and the eltAB operon is shown in purple. PeltAB is illustrated using a bent arrow and the
putative CRP binding sites are shown as open orange boxes. In panel (ii) the values are b-galactsidase activity measurements taken in M182 or the
Dcrp derivative. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g006
Fig. 7. The eltAB promoter is directly repressed by H-NS. A) The panel shows two PeltAB::lacZ fusions. B) The results of a ChIP-PCR analysis
used to measure binding of H-NS to the two different PeltAB derivatives shown in Panel A. C) The values are b-galactsidase activity measurements for
lysates of M182, or the Dhns derivative, carrying the different PestA2::lacZ fusions. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g007
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H-NS prevents CRP regulation of select target genes
Our data indicate that several strong CRP binding sites in the
H10407 genome are occluded by H-NS. This strongly suggests
that the CRP regulon has evolved to incorporate additional
environmental signals through the action of H-NS. The repressive
effect of H-NS on transcription has been widely described [23]. H-
NS represses transcription predominantly by occluding the
binding of RNAP or by trapping RNAP at promoters [20].
Recently, it was shown that H-NS occludes many binding sites for
the CRP homologue, FNR, in E. coli [21]. Thus, occlusion of
transcription factor binding sites appears to be a major function of
H-NS, especially for CRP family proteins. Note that, in order to
exclude CRP from target promoters, sites of H-NS nucleation and
CRP binding need not overlap precisely. For example, at both
estA1 and estA2, maximal H-NS binding is observed within the
coding sequence of the gene (Fig. 2C). Despite this, H-NS
oligomerisation across adjacent DNA is sufficient to prevent
CRP binding.
Conclusions
In summary, our model provides a framework for better
understanding ETEC mediated disease and its treatment. More-
over, our catalogue of CRP and H-NS binding targets provide a
useful community resource for further studies of all E. coli strains.
In particular, our ChIP-seq data for CRP report .50 targets not
identified previously in E. coli K-12 and 8 ETEC-specific targets.
Finally, our data show how very small changes in the organisation
Fig. 8. H-NS and CRP integrate signals of osmolarity and
metabolism to control expression of LT and ST. The figure shows
b-galactosidase activity measurements for lysates obtained from
cultures of M182 (i) or the Dhns derivative (ii) containing A) PestA2 or
B) PeltAB fused to lacZ in plasmid pRW50. Cultures were grown in the
presence and absence of 2% glucose and/or salt (60 mM NaCl and
20 mM KCl). Assays were done in M9 minimal medium so that the
glucose and salt concentrations could be more accurately controlled.
doi:10.1371/journal.ppat.1004605.g008
Fig. 9. Modulation of estA2 and eltA transcription during attachment of ETEC E24377A to gut epithelial cells. A) The figure shows b-
galactosidase activity measurements for lysates obtained from cultures of M182 or the Dhns and Dcrp derivatives containing PestA2 (460 bp
fragment) or PeltAB (1126 bp fragment) from ETEC 24377A fused to lacZ in plasmid pRW50. B) The panel shows log2 fold changes in the transcription
of crp, hns, eltA and estA in ETEC E24377A cells over a two hour incubation with a Caco-2 intestinal epithelial cell culture (29). The log2 values
represent the fold change in transcription between ETEC cells attached and unattached to Caco-2 cells at each time point. C) The panel shows a
scatter plot of absolute crp and estA2 mRNA levels in ETEC E24377A attached to Caco-2 intestinal epithelial cells. Each data point represents a
different biological replicate. For each data point the absolute level of hns mRNA is shown in parenthesis. D) The panel shows the survival rate of
BALB/C mice (n = 30) after intranasal inoculation with wild type ETEC H10407 or the Dcrp derivative.
doi:10.1371/journal.ppat.1004605.g009
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of gene regulatory regions can have major effects on gene
expression, such that transcription responds differently to the same
environmental cues.
Materials and Methods
Strains, plasmids and oligonucleotides
ETEC strain H10407 is described by Crossman et al. [1]. The
C-terminal crp-36FLAG tag was introduced into the H10407
chromosome using the recombineering method of Stringer et al.
[33]. Wild type E. coli K-12 strains JCB387 and M182 have been
described previously [34,35]. The Dhns M182 derivative was
generated by P1 transduction of hns::kan from E. coli K12
derivative YN3144 (a gift from Ding Jin). Plasmids pRW50 and
pSR are described by Lodge et al. [36] and Kolb et al. [37]. More
detailed descriptions of strains and plasmids, along with the
sequences of oligonucleotides, are provided in S2 Table.
ChIP-seq
Cultures were grown to mid-log phase in M9 minimal medium
with 1% (w/v) fructose at 37uC. Targeted ChIP experiments
(Fig. 4 and 6) were done exactly as described by Singh and
Grainger [38] using PestA2 or PeltAB fragments cloned in pRW50
carried in strain M182. The ChIP-seq was done as described
extensively by Singh et al. [25] using strain H10407. Briefly, H-NS
and CRP-36FLAG were immunoprecipitated using protein A
sepharose (GE Healthcare) in combination with 2 mL of anti-H-
NS or 2 ml of anti-FLAG respectively. After immunoprecipitation
and washing, beads were resupended in 100 mL 16 Quick
Blunting Buffer (NEB) with dNTPs (as specified by the manufac-
turer) and 2 mL Quick Blunting Enzyme Mix, and incubated for
30 minutes at 24uC with gentle mixing. After being collected by
centrifugation, the beads were again washed and the associated
DNA was A-tailed by resuspension of beads in 100 mL 16 NEB
buffer #2 supplemented with 2 mM dATP and 10 units of
Klenow Fragment (39R59 exo-; NEB). Following incubation for
30 minutes at 37uC, with gentle mixing, the beads were again
collected and washed. Illumina adapters (1 ml NEXTflex ChIP-seq
barcoded adapters; BioO Scientific) were added to beads
resuspended in 100 mL 16 Quick Ligation reaction buffer and
4 mL Quick T4 DNA Ligase (NEB), and incubated for 15 minutes
at 24uC with gentle mixing. After washing the beads, the DNA was
the eluted into a fresh tube by addition of 100 mL ChIP elution
buffer (50 mM Tris–HCl, pH 7.5, 10 mM EDTA, 1% SDS) and
incubation at 65uC for 10 minutes. The eluate was collected by
centrifugation for one minute at 4000 rpm. Crosslinks were
reversed by incubation for 10 minutes at 100uC. Samples were
purified by phenol extraction and precipitated with ethanol, 40 mg
glycogen and 8.3 mM sodium acetate. DNA was pelleted for
15 minutes at 4uC at top speed in a microcentrifuge, washed with
70% ethanol, dried and resuspended in 11 mL H2O. After
quantification by PCR each library was amplified, purified and
resuspended in 20 mL H2O. Libraries were the sequenced using a
HiSeq 2000 sequencer (Illumina; University at Buffalo Next
Generation Sequencing Core Facility). Sequence reads were
aligned to non-repetitive sequences in the E. coli H10407 genome
using CLC Genomics Workbench and overall coverage was
determined using custom Python scripts. Sequence reads have
been submitted to the EBI ArrayExpress database and can be
accessed using accession number E-MTAB-2917.
Bioinformatics
ChIP-seq peaks were identified as described previously [25].
We refer to these peaks as ‘‘high stringency’’ peaks. A second
round of peak calling was performed in which the sequence read
threshold values (i.e. the minimum number of sequence reads at a
given genomic position that is required for a peak to be called)
was reduced by 20%. We refer to these peaks as ‘‘low stringency’’
peaks. MEME [39] was used to identify enriched sequence motifs
in the sequences from 50 bp upstream to 50 bp downstream of
the high stringency peak centres. Thus, we identified a motif
closely resembling the known CRP consensus site in many of the
regions surrounding high stringency ChIP-seq peaks. These CRP
site sequences are included in Table 1. Those high stringency
peaks for which MEME did not identify a motif were used for a
second round of analysis using MEME. This also identified a
motif closely resembling the known CRP consensus site. These
CRP site sequences are also included in Table 1. We used
MEME to identify enriched sequence motifs in the low stringency
peak list. This also identified a motif closely resembling the
known CRP consensus site. These CRP site sequences are also
included in Table 1. ‘‘High-confidence’’ ChIP-seq peaks listed in
Table 1 include all the high stringency peaks but only those low
stringency peaks for which we identified a motif using MEME. A
complete list of all peaks, including low stringency peaks for
which a motif was not identified by MEME, is provided in S3
Table. In order to assess the location of CRP sites with respect to
TSSs we used the targets listed in Table 1. For each target the
predicted sequence from MEME was used in a BLAST search
against the E. coli K-12 MG1655 genome. All but 11 CRP sites
in ETEC had a single perfect match in the E. coli K-12
chromosome. For each perfect match the distance from the
centre of the CRP site to all transcription start sites was
calculated. Transcription start site coordinates are from Kim et
al. [40] and Cho et al. [41]. Distances between 2200 and +100
were selected and all other distances were discarded. Distances
were then grouped in bins of 5 bp each and the most common
distance bins were identified. Note that, because the position of
the CRP site was transposed onto the E. coli K-12 genome, the
distance between CRP sites and TSSs
The PWM describing CRP binding sites was generated using
the PREDetector software package and our previous list of 68
CRP binding sites in the E. coli K-12 genome [15,42]. Subsequent
bioinformatic screens of plasmids p666 and p948 were done by
importing the relevant genbank files into PREDetector and
running a binding site search with a cut-off of 7 using settings
that did not exclude CRP sites within genes. The ‘‘score’’ for each
site predicted by PREDetector increases if a closer match to the
PWM is found. To generate the chromosome and plasmid maps
shown in Fig. 1 we used DNA plotter software [43].
Data shown in Fig. 9B–C were extracted from the publically
available datasets of Kansal et al. [29] that measure changes in the
Fig. 10. An osmo-metabolic gene regulatory circuit comprised
of CRP and H-NS controls expression of LT and ST. The diagram
illustrates the regulatory effects of salt, cAMP and glucose on
transcription from the various ST and LT promoter regions.
doi:10.1371/journal.ppat.1004605.g010
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ETEC E24377A transcriptome upon contact with Caco-2
intestinal epithelial cells. The data are hosted under the GEO
accession code GSE40427. For each assay condition (planktonic
and attached ETEC cells) we extracted the signal intensity for
microarray probe sets A1527 (crp), UTI189_C1433 (hns), D4754
(eltA) and D4048 (estA). The average signal intensity was
calculated and the fold change in transcription in attached
compared to planctonic ETEC cells was determined for each time
point. The data in Fig. 9C show a comparison of absolute signal
intensities for probe sets A1527 (crp) and D4048 (estA) compared
for each of the two replicates obtained at 30, 60 or 120 minutes
after attachment to host cells. Signal intensities obtained after
30 minutes growth in LB medium (three replicates) are also
included in this analysis.
Proteins
The CRP and s70 purification was done exactly as described
previously [44,45]. RNA polymerase core enzyme was purchased
from Epicenter. RNA polymerase holoenzyme was generated by
incubating the core enzyme with an equimolar concentration of
s70 at room temperature for 20 minutes prior to use. H-NS was
overexpressed in T7 express cells from plasmid pJ414hns. After
overexpressing H-NS, cells were collected from the culture by
centrifugation and resuspended in buffer A (20 mM Tris-HCl
pH 7.2, 1 mM EDTA and 10% (v/v) glycerol) containing
100 mg/ml PMSF. Cells were lysed by sonication and the sample
was cleared by centrifugation. The supernatent was loaded directly
onto a Heparin column (Amersham) pre-equilibrated with buffer
A. A linear NaCl gradient was applied and H-NS was found to
elute at approximately 500 mM NaCl. The peak fractions were
pooled and diluted 3-fold with buffer A. The sample was then
loaded onto an S-FF column (Amersham) pre-equilibrated with
Buffer A. A NaCl gradient was applied and H-NS eluted at
approximately 550 mM NaCl. The H-NS containing fractions
were then dialysed against a buffer containing 20 mM Tris HCl
(pH 7.2), 300 mM KCl and 10% Glycerol (v/v)for storage at 2
80uC.
DNAse I footprinting and Electrophoretic Mobility Shift
Assays
DNA fragments for DNAse I footprinting or EMSA assays were
excised from pSR by sequential digestion with HindIII and then
AatII. After digestion, fragments were labelled at the HindIII end
using [c-32P]-ATP and T4 polynucleotide kinase. DNAse I
footprints and EMSA experiments were then done as described
by Grainger et al. [45] except that cAMP was added to reactions
at a concentration of 0.2 mM. Radio-labelled DNA fragments
were used at a final concentration of ,10 nM. Note that all in
vitro DNA binding reactions contained a vast excess
(12.5 mg ml21) of Herring sperm DNA as a non-specific compet-
itor. Footprints were analysed on a 6% DNA sequencing gel
(molecular dynamics). The results of all footprints and EMSA
experiments were visualized using a Fuji phosphor screen and Bio-
Rad Molecular Imager FX.
Primer extension assays
Transcript start sites were mapped by primer extension, as
described in Lloyd et al. [46] using RNA purified from strains
carrying the 92 bp PestA1 or 93 bp PestA2 fragment cloned in
pRW50. The 59 end-labelled primer D49724, which anneals
downstream of the HindIII site in pRW50, was used in all
experiments. Primer extension products were analysed on
denaturing 6% polyacrylamide gels, calibrated with size standards,
and visualized using a Fuji phosphor screen and Bio-Rad
Molecular Imager FX.
In vitro transcription assays
The in vitro transcription experiments were performed as
described previously Savery et al. [35] using the system of Kolb
et al. [38]. A Qiagen maxiprep kit was used to purify supercoiled
pSR plasmid carrying the different promoter inserts. This template
(,16 mg ml21) was pre-incubated with purified CRP in buffer
containing 0.2 mM cAMP, 20 mM Tris pH 7.9, 5 mM MgCl2,
500 mM DTT, 50 mM KCl, 100 mg ml21 BSA, 200 mM ATP,
200 mM GTP, 200 mM CTP, 10 mM UTP with 5 mCi [a-32P]-
UTP. The reaction was started by adding purified E. coli
RNA polymerase. Labelled RNA products were analysed on a
denaturing polyacrylamide gel.
b-galactosidase assays and addition of glucose and salt
to growth medium
b-Galactosidase assays were done using the protocol of Miller
[47]. All assay values are the mean of three independent
experiments with a standard deviation ,10% of the mean. Cells
were grown aerobically at 37uC to mid-log phase in LB medium
unless stated otherwise. For all experiments investigating the
effects of glucose and salt M9 minimal medium was used so that
the glucose and salt concentrations could be controlled more
accurately. The amount of glucose is shown as percentage w/v.
The addition of ‘‘salt’’ refers to a 3:1 molar ration of NaCl to KCl.
We have arbitrarily described 30 mM NaCl and 10 mM KCl as
being a ‘‘1%’’ salt solution.
Intranasal mouse infection model assays
Strains of ETEC were grown in Luria Broth (LB) to an OD600
of 1.0. Groups of 10 mice (8–10 week old BALB/c) were infected
intranasally with approximately 16109 colony forming units of
bacteria in 100 ml of inoculums according to Byrd et al. [30]. Mice
were monitored daily for 6 days post-infection for weight and
morbidity.
Ethics statement
The protocol 12-02-015IBT ‘‘Oral Immunization of Mice with
Enterotoxigenic: E coli (ETEC)’’ has been approved by the Noble
Life Sciences IACUC committee. All animal care and use
procedures adhere to the guidelines set by the Public Health
Service Policy, U.S. Dept. of Agriculture (USDA) and the Guide
for the Care and Use of Laboratory Animals of the National
Institutes of Health.
Supporting Information
S1 Fig Binding of CRP to predicted targets in vitro. A)
The data show binding of CRP to a target from each of the bins
shown in Fig. 2. B) CRP binding to remaining targets scoring
.10. CRP was used at concentrations of 0, 175, 350 or 700 nM.
The ‘‘score’’ describes how well the predicted target matches the
PWM.
(PDF)
S2 Fig Promoter DNA fragments used in this work. A)
ETEC H10407 PestA2 containing DNA fragments. B) ETEC
H10407 derived DNA fragments containing PestA1. C) ETEC
H10407 PeltAB containing sequences. D) DNA fragments
containing sequences upstream of the estA2 and eltAB genes of
ETEC E24377A.
(PDF)
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S3 Fig A) Mutations in PestA2 UP-element alter the
migration of the promoter DNA on an agarose gel. The
DNA sequences used are shown in part (i) and the mobility of the
fragments, on an agarose gel, are shown in part (ii). Note that each
sample has been loaded in duplicate. B) Mutating the UP-element
renders PestA2 uninducible by CRP. Part (i) shows LacZ activity
data for the different promoter fragments cloned in pRW50. The
pRW50 derivatives were used to transform M182 or the Dcrp
derivative. Part (ii) shows the result of in vitro transcription assays
using the different promoter fragments, cloned in pSR, as a
template.
(PDF)
S4 Fig Activity of different promoter::lacZ fusions in
the presence of increasing glucose and salt concentra-
tions. The figure shows b-galactosidase activity measurements for
lysates obtained from cultures of M182 carrying the A) estA1 B)
estA2 or C) eltAB promoters cloned in pRW50. Panel D) shows b-
galactosidase activity values for lysates of M182 and M182Dhns
cells, carrying the estA2 promoter, or a derivative lacking the CRP
site, cloned in pRW50. Cells were grown in the presence or
absence of 2% glucose. Assays were done in M9 minimal medium
so that the glucose and salt concentrations could be more
accurately controlled.
(PDF)
S1 Table Putative CRP binding targets on ETEC
plasmids p948 and p666 identified by PREDetector.
(DOCX)
S2 Table Strains, plasmids and oligonucleotides.
(DOCX)
S3 Table All CRP binding sites on the ETEC H10407
chromosome identified by ChIP-seq.
(DOCX)
Acknowledgments
The authors would like to thank Ian Henderson for advice and support,
Doug Browning for critical comments on the manuscript, and George
Munson for helpful discussions.
Author Contributions
Conceived and designed the experiments: JTW DCG. Performed the
experiments: JRJH PS AMS. Analyzed the data: JRJH PS AMS JTW
DCG. Contributed reagents/materials/analysis tools: AMS JTW. Wrote
the paper: JTW DCG.
References
1. Crossman LC, Chaudhuri RR, Beatson SA, Wells TJ, Desvaux M, et al. (2010)
A commensal gone bad: complete genome sequence of the prototypical
enterotoxigenic Escherichia coli strain H10407. J Bacteriol 192:5822–5831.
2. Sack RB (2011) The discovery of cholera - like enterotoxins produced by
Escherichia coli causing secretory diarrhoea in humans. Indian J Med Res 133:
171–80
3. Gupta SK, Keck J, Ram PK, Crump JA, Miller MA, et al. (2008) Analysis of
Data Gaps Pertaining to Enterotoxigenic Escherichia coli Infections in Low and
Medium Human Development Index Countries, 1984–2005. Epidemiology and
Infection 136:721–738.
4. de Haan L, Hirst TR (2004) Cholera toxin: a paradigm for multi-functional
engagement of cellular mechanisms. Mol Membr Biol 21:77–92.
5. Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, et al. (1995) The
three-dimensional crystal structure of cholera toxin. J Mol Biol 251:563–73.
6. Taxt A, Aasland R, Sommerfelt H, Nataro J, Puntervoll P (2010) Heat-stable
enterotoxin of enterotoxigenic Escherichia coli as a vaccine target. Infect Immun
78:1824–31.
7. Yamamoto T, Tamura T, Yokota T (1984) Primary structure of heat-labile
enterotoxin produced by Escherichia coli pathogenic for humans. J Biol Chem
259:5037–44.
8. de Haan L, Verweij WR, Feil IK, Holtrop M, Hol WG, et al. (1998) Role of
GM1 binding in the mucosal immunogenicity and adjuvant activity of the
Escherichia coli heat-labile enterotoxin and its B subunit. Immunology 94:424–
430.
9. Saslowsky DE, te Welscher YM, Chinnapen DJ, Wagner JS, Wan J, et al. (2013)
Ganglioside GM1-mediated transcytosis of cholera toxin bypasses the retrograde
pathway and depends on the structure of the ceramide domain. J Biol Chem
288:25804–9.
10. Nalin DR, Cash RA, Islam R, Molla M, Phillips RA (1968) Oral maintenance
therapy for cholera in adults. Lancet 2:370–3.
11. Guerrant RL, Carneiro-Filho BA, Dillingham RA (2003) Cholera, diarrhea, and
oral rehydration therapy: triumph and indictment. Clin Infect Dis 37:398–405.
12. Busby S, Ebright RH (1999) Transcription activation by catabolite activator
protein (CAP). J Mol Biol 293:199–213.
13. Parkinson G, Wilson C, Gunasekera A, Ebright YW, Ebright RH, et al. (1996)
Structure of the CAP-DNA complex at 2.5 angstroms resolution: a complete
picture of the protein-DNA interface. J Mol Biol 260:395–408.
14. Zheng D, Constantinidou C, Hobman JL, Minchin SD (2004) Identification of
the CRP regulon using in vitro and in vivo transcriptional profiling. Nucleic
Acids Res 32:5874–93.
15. Grainger DC, Hurd D, Harrison M, Holdstock J, Busby SJ (2005) Studies of the
distribution of Escherichia coli cAMP-receptor protein and RNA polymerase
along the E. coli chromosome. Proc Natl Acad Sci U S A 102:17693–8.
16. Rossiter AE, Browning DF, Leyton DL, Johnson MD, Godfrey RE, et al. (2011)
Transcription of the plasmid-encoded toxin gene from enteroaggregative
Escherichia coli is regulated by a novel co-activation mechanism involving
CRP and Fis. Mol Microbiol 81:179–91.
17. Navarre WW, Porwollik S, Wang Y, McClelland M, Rosen H, et al. (2006)
Selective silencing of foreign DNA with low GC content by the H-NS protein in
Salmonella. Science 313:236–8.
18. Liu Y, Chen H, Kenney LJ, Yan J (2010) A divalent switch drives H-NS/DNA-
binding conformations between stiffening and bridging modes. Genes Dev
24:339–44.
19. Lim CJ, Lee SY, Kenney LJ, Yan J (2012) Nucleoprotein filament formation is
the structural basis for bacterial protein H-NS gene silencing. Sci Rep 2:509.
20. Myers KS, Yan H, Ong IM, Chung D, Liang K, et al. (2013) Genome-scale
analysis of Escherichia coli FNR reveals complex features of transcription factor
binding. PLoS Genet 9(6):e1003565.
21. Dame RT, Wyman C, Wurm R, Wagner R, Goosen N (2002) Structural basis
for H-NS-mediated trapping of RNA polymerase in the open initiation complex
at the rrnB P1. J Biol Chem 277:2146–50.
22. Dorman CJ (2007) H-NS, the genome sentinel. Nat Rev Microbiol 5: 157–61.
23. Atlung T, Ingmer H (1997) H-NS: a modulator of environmentally regulated
gene expression. Mol Microbiol 24: 7–17.
24. Steinsland H1, Valentiner-Branth P, Perch M, Dias F, Fischer TK, Aaby P,
Mølbak K, Sommerfelt H (2002) Enterotoxigenic Escherichia coli infections and
diarrhea in a cohort of young children in Guinea-Bissau. J Infect Dis 186:
1740–7.
25. Singh SS, Singh N, Bonocora RP, Fitzgerald DM, Wade JT, et al. (2014)
Widespread suppression of intragenic transcription initiation by H-NS. Genes
Dev 28: 214–219.
26. Yang J, Tauschek M, Strugnell R, Robins-Browne RM (2005) The H-NS
protein represses transcription of the eltAB operon, which encodes heat-labile
enterotoxin in enterotoxigenic Escherichia coli, by binding to regions
downstream of the promoter. Microbiology 151: 1199–1208.
27. Bodero MD, Munson GP (2009) Cyclic AMP receptor protein-dependent
repression of heat-labile enterotoxin. Infect Immun 77:791–8.
28. Sahl JW, Rasko DA (2012) Analysis of global transcriptional profiles of
enterotoxigenic Escherichia coli isolate E24377A. Infect Immun 80: 1232–1242.
29. Kansal R, Rasko DA, Sahl JW, Munson GP, Roy K (2013) Transcriptional
modulation of enterotoxigenic Escherichia coli virulence genes in response to
epithelial cell interactions. Infect Immun 81: 259–70.
30. Byrd W, Mog SR, Cassels FJ (2003) Pathogenicity and immune response
measured in mice following intranasal challenge with enterotoxigenic Esche-
richia coli strains H10407 and B7A. Infect Immun 71: 13–21.
31. Byrd W, Boedeker EC (2013) Attenuated Escherichia coli strains expressing the
colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin
(LThK63) enhance clearance of ETEC from the lungs of mice and protect mice
from intestinal ETEC colonization and LT-induced fluid accumulation. Vet
Immunol Immunopathol 152: 57–67.
32. Gupta S, Chowdhury R (1997) Bile affects production of virulence factors and
motility of Vibrio cholerae. Infect Immun 65: 1131–1134.
33. Stringer AM, Singh N, Yermakova A, Petrone BL, Amarasinghe JJ, et al. (2012)
FRUIT, a scar-free system for targeted chromosomal mutagenesis, epitope
tagging, and promoter replacement in Escherichia coli and Salmonella enterica.
PLoS One 7: e44841.
The Molecular Basis for Control of ETEC Enterotoxin Expression
PLOS Pathogens | www.plospathogens.org 15 January 2015 | Volume 11 | Issue 1 | e1004605
34. Page L, Griffiths L, Cole JA (1990) Different physiological roles of two
independent pathways for nitrite reduction to ammonia by enteric bacteria.
Arch Microbiol 154:349–54.
35. Busby S, Kotlarz D, Buc H (1983) Deletion mutagenesis of the Escherichia coli
galactose operon promoter region. J Mol Biol 167:259–274.
36. Lodge J, Fear J, Busby S, Gunasekaran P, Kamini NR (1992) Broad host range
plasmids carrying the Escherichia coli lactose and galactose operons. FEMS
Microbiol Lett 74:271–6.
37. Kolb A, Kotlarz D, Kusano S, Ishihama A (1995) Selectivity of the Escherichia
coli RNA polymerase E sigma 38 for overlapping promoters and ability to
support CRP activation. Nucleic Acids Res 23:819–26.
38. Singh SS, Grainger DC (2013) H-NS can facilitate specific DNA-binding by
RNA polymerase in AT-rich gene regulatory regions. PLoS Genet 9: e1003589.
39. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, et al. (2009) MEME
SUITE: tools for motif discovery and searching. Nucleic Acids Res 37(Web
Server issue):W202–8.
40. Kim D, Hong JS, Qiu Y, Nagarajan H, Seo JH, et al. (2012) Comparative
analysis of regulatory elements between Escherichia coli and Klebsiella
pneumoniae by genome-wide transcription start site profiling. PLoS Genet
8(8):e1002867.
41. Cho BK, Kim D, Knight EM, Zengler K, Palsson BØ (2014) Genome-scale
reconstruction of the sigma factor network in Escherichia coli: topology and
functional states. BMC Biol 12:4.
42. Hiard S, Maree R, Colson S, Hoskisson PA, Titgemeyer F, et al. (2007)
PREDetector: A new tool to identify regulatory elements in bacterial genomes.
Biochem Biophys Res Commun 357(4):861–4.
43. Carver T, Thomson N, Bleasby A, Berriman M, Parkhill J (2009) DNAPlotter:
circular and linear interactive genome visualization. Bioinformatics 25: 119–20.
44. Savery NJ, Lloyd GS, Kainz M, Gaal T, Ross W, et al. (1998) Transcription
activation at Class II CRP-dependent promoters: identification of determinants
in the C-terminal domain of the RNA polymerase alpha subunit. EMBO J
17:3439–3447.
45. Grainger DC, Goldberg MD, Lee DJ, Busby SJ (2008) Selective repression by
Fis and H-NS at the Escherichia coli dps promoter. Mol Microbiol 68:1366–
1377.
46. Lloyd GS, Hollands K, Godfrey RE, Busby SJ (2008) Transcription initiation in
the Escherichia coli K-12 malI-malX intergenic region and the role of the cyclic
AMP receptor protein. FEMS Microbiol Lett 288: 250–7.
47. Miller J (1972) Experiments in Molecular Genetics. Cold Spring Harbor, NY:
Cold Spring Harbor Laboratory Press.
The Molecular Basis for Control of ETEC Enterotoxin Expression
PLOS Pathogens | www.plospathogens.org 16 January 2015 | Volume 11 | Issue 1 | e1004605
